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Most imaging techniques project a 3-dimensional (3D) tumor into a 2-
dimensional (2D) image that lacks the depth information. The ability to provide not 
only the lateral dimensions of tumors but also the depth profile is important for 
accurately sizing the tumor and is crucial for preliminary staging of the tumor prior to 
surgery, improving biopsy accuracy, and minimizing incomplete surgical removal of 
the tumors. Although computer tomography (CT) and magnetic resonance imaging 
(MRI) can provide tumor 3D images CT scans exposes patients to additional radiation 
risks and MRI is expensive. In addition, these techniques may not be suitable for 
assessing certain tumors such as skin cancers.  
Piezoelectric finger (PEF) is a tissue stiffness sensor developed at Shih and 
Shih’s lab that can measure the elastic modulus of tissues both in vitro and in vivo. 
Because breast tumors are stiffer than surrounding tissues, it is possible to detect and 
image breast tumors by contrasting the higher-elastic modulus regions with the 
surrounding tissues. In addition, a PEF with a larger contact area can assess the 
stiffness of tissues at a larger depth. It is thus possible to use PEFs with different 
contact areas to probe for depth profiles of tumors.  
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The goal of this study is to develop the methodology to use array PEFs not 
only to detect breast tumors and skin tumors but also image their locations and sizes 
in 3D for various applications. In Aim 1, a handheld probe containing an array of four 
PEFs of the same contact area (6.5 mm) is developed together with a custom-built 
circuit board to detect breast tumors in 40 patients. The results show that PEF 
detected 96% of breast tumors, including 100% of palpable and 67% non-palpable 
malignant tumors. Among the 28 patients with mammography records, PEF detected 
92% malignant tumors while mammography only detected 80%. Furthermore, PEF 
detection was not affected by mammography density, indicating that PEF is 
promising for detecting breast tumors in young women and women with dense breasts 
for whom mammography is ineffective. 
In Aim 2, tumor depth profiles was determined using the stiffness 
measurements by a set of PEFs with contact sizes 4.1 - 9.8 mm on model breast 
tumors of clays embedded in gelatin coupled with a spring model. The locations of 
the top of bottom-supported model breast tumors were determined within 1.1 mm of 
the actual values. For suspended model breast tumors both the top and the bottom 
margins were determined within 2.1 mm of the actual values, indicating that it is a 
promising methodology for tumor depth profiling. In addition to the depth accuracy, 
the current spring model-based methodology has the advantage of being instant as 
compared to the inversion simulations (IS) using finite element analysis (FEA) which 
gives similar accuracy but is tedious and time-consuming.  
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In Aim 3, a mechanical model of skin was established as a two-layer structure 
with the stiffer layer representing the epidermis and dermis (skin) on top of the softer 
subcutaneous layer. The elastic modulus and thickness of skin were then 
simultaneously determined using the stiffness measurements obtained with PEFs of 
different contact sizes of <3 mm coupled with an empirical formula for a two-layer 
structure derived from Green’s function calculations. Both the elastic modulus and 
the thickness of the skin layer were resolved within <10% of the actual values in skin 
phantoms, and porcine skins and validated by FEA.  
In Aim 4, the lateral extent and the depth profile of model skin cancers of clay 
embedded in porcine skins were determined using the stiffness measurements with 
PEFs of various contact sizes of <3 mm coupled with a modified spring model taking 
into account of the two-layer nature of skin. The lateral sizes of model skin cancers 
determined by PEF were within an error of 1 mm and the estimated depth profiles 
showed good agreement with the actual thickness with <0.4 mm discrepancy.  
In conclusion, PEF is capable of detecting breast cancer with sensitivity better 
than mammography and independent of mammography density. In addition, using a 
set of PEFs of different contact areas coupled with simple spring-model calculations 
the depth profiles of both breast cancer and skin cancer can be accurately determined 
to facilitate 3D breast cancer/skin cancer imaging. 
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1.  BACKGROUND AND LITERATURE REVIEW 
1.1 Breast Anatomy and Breast Tumors 
1.1.1 Breast Anatomy 
The breast is a mass of glandular, fatty, and fibrous tissues positioned over the 
pectoral muscles of the chest wall and attached to the chest wall by fibrous strands [1]. 
A woman’s breast as shown in Figure 1.1 [2] has glands that produce milk. The milk-
producing part of the breast is organized into 15 to 20 sections, called lobes [3]. 
Within each lobe are smaller structures called lobules, where milk is produced. The 
milk travels through a network of tiny tubes called ducts. The ducts connect and 
assemble into larger ducts, which eventually exit the skin in the nipple. The dark area 
of skin surrounding the nipple is called the areola.  
 
 
Figure 1.1 Breast anatomy [2] 
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Connective tissue and ligaments provide support to the breast and give it its 
shape. Nerves provide sensation to the breast. The breast also contains blood vessels, 
lymph vessels, and lymph nodes. Most of the lymph vessels that go through the breast 
carry the lymph to the lymph node underneath the arm pit, called axillary nodes. The 
other lymph vessels carry the lymph to the lymph nodes that are inside the chest, 
called the internal mammary nodes, or that are above or below the collarbone, called 
the supraclavicular or infraclavicular nodes. Lymph vessels can also carry possible 
diseases to lymph nodes and might increase the spread of the disease, for example 
breast cancer cells [4].  
1.1.2 Breast Tumors 
A breast tumor is a mass of abnormal tissue in the breast. It can occur in both 
men and women, although there is a very small probability for the disease to occur in 
men.  
1.1.2.1 Statistics of Breast Cancer 
Breast cancer is the most common type of cancer for women in the US, except 
for skin cancers. About 1 in 8 (12%) women in the US will develop invasive breast 
cancer during their lifetime. In the US, during 2016, it is estimated that there will be 
843,820 cancer cases among women, and 246,660 of them will be invasive breast 
cancer cases which accounts for 29% of the total cancer cases [5]. 
In the US, Breast cancer is the second leading cause of cancer death in women, 
exceeded only by lung cancer. In 2016, 281,400 women are expected to die of cancer 
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and 40,450 of them will die from breast cancer which accounts for 15% of the total 
cancer death among women. [5, 6]. Worldwide, 500,000 women are estimated to die 
from breast cancer each year [7]. 
1.1.2.2 Types of Breast Conditions 
Changes in the breast may be caused by either benign (non-cancerous) or 
malignant (cancerous) conditions. Benign tumors are very common and they are not 
generally aggressive toward surrounding tissue. But they still may continue to grow, 
pressing on organs and causing pain or other problems. Some of the benign tumors 
are linked with a higher risk of later development of malignant tumor [8-10].  A 
malignant tumor is a group of cancer cells that can grow into (invade) surrounding 
tissues or spread (metastasize) to distant areas of the body [11, 12]. Cancerous tumors 
can start in different areas of the breast, and are named according to the area they 
originate from. Biopsy is needed to understand if the irregularity in the breast is 
cancerous or not. 
They are many types of non-cancerous and cancerous breast conditions. The 
most common types can be summarized as listed below.  
1.1.2.2.1 Non-cancerous Breast Conditions 
Fibrosis and Cysts: They are benign changes in breast tissue that happen in 
many women in their lives and are sometimes called fibrocystic changes. They can 
cause areas of lumpiness, thickening, or tenderness. Fibrosis is the formation of a 
large amount of fibrous tissue, the same material that ligaments and scar tissues are 
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made of. Areas of fibrosis feel firm. Cysts are fluid-filled, round or oval shaped fluid-
filled sacs. It feels like a soft lump in the breast. A cyst cannot be diagnosed by 
physical exam or mammography. It can only be identified with ultrasound.  
Fibroadenomas: They are the most common benign tumors found in the 
female breast. Fibroadenomas are benign tumors made up of both glandular breast 
tissue and connective tissue. They are solid, round, rubbery lumps that are distinct 
from the surrounding breast tissue. And they can move freely in the breast when 
pushed upon. Some fibroadenomas can be felt, but some are only found in an imaging 
test. Women with fibroadenomas have an increased risk of breast cancer – about 1.5 
to 2 times the risk of women with no breast changes [4].  
Hyperplasia: It is an overgrowth of the cells that line the ducts (ductal 
hyperplasia) or the lobules (lobular hyperplasia). It may cause a lump that can be felt. 
Based on the pattern of the cells, hyperplasia can be divided into two groups: usual 
and atypical. In usual hyperplasia, the pattern of cells is very close to normal, while in 
atypical hyperplasia the cells are more distorted and look abnormal. For women with 
atypical hyperplasia, the risk of breast cancer is about 3 to 5 times higher than that of 
a women with no breast abnormalities [8-10].   
Fat necrosis: It happens when fatty breast tissue swells or becomes tender. It 
can occur spontaneously or as a result of an injury to the breast. It can also happen 
after surgery or radiation treatment. As the body repairs the damaged tissue, the 
affected area is replaced with firm scar tissue. As a result, it can form a lump that can 
be felt.  
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1.1.2.2.2 Cancerous Breast Conditions 
Ductal Carcinoma in Situ (DCIS): DCIS is the most common type of non-
invasive breast cancer. It is considered “non-invasive” because the cells have not 
invaded through the walls of the ducts into surrounding breast tissue. It is not life-
threatening since it cannot spread (metastasize) outside the breast. However, DCIS 
could eventually develop into an invasive cancer if it is left in the body. Therefore, it 
is considered pre-cancerous. DCIS is usually found by mammography. As old cancer 
cells die off, calcifications or microcalcifications form within the broken down cells. 
The mammogram will show the cancer cells inside the ducts as cluster of these 
calcifications, which appear either as white specks or as a shadow.  
Invasive (Infiltrating) Ductal Carcinoma (IDC): IDC is the most common 
type of invasive breast cancer, accounting for 80% of invasive breast cancers. It starts 
in a milk duct of the breast, breaks through the wall of the duct, and grows into the 
surrounding tissues. Since it has spread outside the duct walls, it is able to metastasize 
to other parts of the body.  
Invasive (Infiltrating) Lobular Carcinoma (ILC): ILC accounts for 10% of the 
invasive breast cancers. It starts in the lobules of the breast where break milk is 
produced. Like IDC, it is invasive and can spread to other parts of the body. ILC may 
be harder to be detected by a mammogram than IDC.  
Inflammatory Breast Cancer (IBC): IBC is a rare and aggressive form of 
breast cancer. It only accounts for 1-5% of breast cancer cases in the US. IBC is 
caused by cancers blocking lymph vessels in the skin. Usually it does not cause a 
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single lump or tumor. Instead, the skin on the breast looks red and has a pitted 
appearance. IBC has a higher risk of metastasis and a worse prognosis than typical 
IDC or ILC.  
1.1.3 Early Detection of Breast Tumors 
Early detection of diseases, especially cancers, can save thousands of lives 
each year. The five-year survival rate of Stage 0 & I breast cancers which are 
confined to a limited area is 100%. It decreases to 22% for stage IV in which case the 
cancer has spread beyond the breast to other areas of the body [13]. Therefore, 
patients will have better prognosis if breast cancers can be detect early.  
Screening plays an important role in early detection of tumors. For breast 
tumor, screening can find breast cancers while they are still small in size and confined 
to the breast before they cause any symptoms. Breast cancers that cause discomfort to 
the patients and that are big enough to be easily felt tend to have already spread to 
other parts of the body [13].  
Breast self-examination (BSE) is a step-by-step approach that a women can 
use to look at and feel her breasts. BSE seemed promising when it was first 
introduced. However, its effectiveness is being questioned [14-16]. Some studies 
have shown that it does not offer a beneficial effect whereas there is evidence for 
harms [15, 17].  
Most national authorities in the US agree that women should begin 
mammography screening by age 50. The consensus is lower for screening those aged 
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40 to 50 years. The current guidelines from the American Cancer Society (ACS), the 
American Medical Association (AMA) and the American College of Radiology 
(ACR), and the National Cancer Institute recommend annual mammogram for every 
woman at ages 40 and up [13]. After a careful review of data in 2009, the United 
States Preventive Services Task Force (USPSTF) updated its previous 
recommendation to begin routine screening at age 50 years [18]. There is also 
remaining controversy about annual versus biennial mammography screening [19].  
1.1.4 Determination of Breast Tumor Locations and Sizes in 3D 
Accurate preoperative assessment of breast tumor locations and sizes in three 
dimensions (3D) are important for both biopsies and surgeries [20]. Underestimating 
pre-surgical tumor size may lead to incomplete margins in lumpectomy and hence, re-
excision. The current re-excision rate of lumpectomy is 30-60% [21]. Tumor size is 
also a valuable indicator of stages, which are important in planning the appropriate 
treatment and estimating the prognosis [22]. Besides, precise measurements of tumor 
locations and sizes in 3D are required to monitor response of chemotherapy and 
radiotherapy for breast tumors. 
1.1.5 Breast Tumor Imaging Modalities 
1.1.5.1 Current Modalities 
Clinical breast examination (CBE), ultrasound, mammography, and magnetic 
resonance imaging (MRI) are the main breast tumor detection and localization 
methodologies used currently. Each of them has their advantages and disadvantages 
as summarized below.  
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Clinical breast examination (CBE): CBE, or better known as palpation, is the 
physician’s palpating the breast to detect any possible masses inside the breast. CBE 
is highly dependent on the physician’s skills, expertise and experience [23, 24]. Some 
indications such as skin and nipple retraction are only detectable by CBE [25]. 
Although the techniques for CBE are well established, its effectiveness is still 
dependent on how good the physician is. CBE alone is sometimes not enough to 
detect breast cancer in its very early stages [26, 27]. It has difficulty detecting lesions 
with indistinct borders, lesions in large breasts, and non-palpable lesions [26, 28, 29]. 
Besides, CBE cannot provide quantitative value of the tumor size.  
Ultrasound Imaging (Ultrasonography): Ultrasound is sound wave with a 
frequency greater than upper limit of the human hearing range, usually 20 kHz. 
Ultrasound can be directed as a beam and can be reflected by objects of small sizes. It 
obeys the theories of reflection, refraction, and scattering. Ultrasound is not 
radioactive, and therefore it is widely used in medical imaging. Typical ultrasound 
imaging operates in the frequency range of 1 to 18 MHz. The choice of frequency is a 
compromise between spatial resolution of the image and imaging depth: lower 
frequencies produce less resolution but image deeper into the body. High frequency 
sound waves have a smaller wavelength and thus are capable of reflecting or 
scattering from smaller structures.  
Ultrasound examination is performed on patients in a supine position as 
shown in Figure 1.2. Ultrasound machine sends ultrasound to the tissue and monitors 
the echoes of ultrasound waves. The main part of the machine is the ultrasound probe 
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which consists of an array of piezoelectric transducers. When strong short electrical 
pulse voltages are applied to these transducers, they vibrate due to converse 
piezoelectric effect and generate ultrasound sent to the tissue. The sound wave is 
partially reflected from the layers between different tissues or scattered from smaller 
structures. If the breast tissue is uniform and there is no tumor inside, the ultrasound 
is echoed back from the muscles and bones underneath. If there is a tumor inside, the 
ultrasound is echoed when it hits the interface between the normal tissue and the 
tumor. When the echo comes back to the transducer, it vibrates the transducers and 
generates electricity due to direct piezoelectric effect. By measuring how long it takes 
the echo to be received and how strong the echo is, a 2D image of the scanned tissue 
can be formed. An approximate location of the tumor or any other abnormal in the 
tissue can be obtained by scanning the entire breast.  
 
 
Figure 1.2 A picture showing how ultrasound examination is performed on breasts 
[30].  
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Ultrasound imaging is a useful technique for evaluating the suspicious lesions 
in the breast. It also confirms the presence of a lump that was detected by 
mammogram. One of the main reasons ultrasound is used in breast imaging is to 
differentiate between the cystic (fluid filled) lesions from solid lesions. Some 
microcalcifications in ductal carcinoma in situ may not be identified by ultrasound 
[31-33]. Besides, it underestimates the tumor size [34-36], which may lead to 
incomplete excision in lumpectomy [20]. It is hard to make sure that the image 
contains the whole breast. Because it is user dependent, ultrasound is not a good 
screening test for breast cancer [37-39].  
Mammography: Mammography is a specific type of imaging technique which 
uses low‐dose x-ray to create an image of the breast. During the procedure, the breast 
is compressed by parallel plates as shown in Figure 1.3, which can even out the 
thickness of breast tissue to increase image quality by reducing the thickness of tissue 
that x-rays must penetrate, to decrease the amount of scattered radiation, to reduce the 
required radiation does, and to hold the breast still.  
It is an excellent tool for early detection of breast cancer in women, even if 
they experience no symptoms. Mammogram is the gold standards used in early 
detection of breast cancer because it can show changes in the breast up to two years 
before a patient or physician can feel them. Mammography is an FDA approved 
technique for breast cancer screenings.  There is no proven screening test that has 
been shown to be better than mammography today.  Early detection using 
mammography provides more opportunity to detect the tumors while they are small, 
 11 
so offering more treatment options. The current guidelines from the American Cancer 
Society (ACS), the American Medical Association (AMA) and the American College 
of Radiology (ACR), and the National Cancer Institute recommend annual 
mammogram for every woman at ages 40 and up [13]. After a careful review of data 
in 2009, the United States Preventive Services Task Force (USPSTF) updated its 
previous recommendation to begin routine screening at age 50 years [18]. There are 
reports pointing out that in addition to unnecessary surgery and anxiety, the risks of 
more frequent mammograms include a small but significant increase in breast cancer 
induced by radiation [40, 41].  
 
 
 
Figure 1.3 A schematic showing how mammogram is performed on breasts. 
 
 
 
 
While mammography has a great potential for early detection of breast cancer, 
it has a high false positive rate. After 10 mammograms, the risk of a false-positive 
mammogram is over 40% [42-44].  Also the likelihood of having a biopsy after 10 
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mammograms is over 10%, but only a small percentage of those have a cancer. So 
most of the biopsies performed based on the results of the mammogram are 
unnecessary. Mammography is also not very sensitive for young women under 40 and 
women over 40 who have mammographically dense breasts [45-48]. According to the 
BI-RADS (Breast Imaging Reporting and Data System) reporting system, the density 
of breasts can be divided into four levels, which are almost entirely fatty (Grade 1), 
scattered fibroglandular density (Grade 2), heterogeneously dense (Grade 3) and 
extremely dense (Grade 4) as shown in Figure 1.4. The Table 1.1 below shows that 
the sensitivity of mammography is 87% for breasts with a density grade of 1 and the 
sensitivity is only 62.9% for grade 4 dense breasts [49]. The sensitivity of 
mammography decreases significantly with women with dense breasts [41, 48, 49].  
 
 
Figure 1.4 Mammogram images of breasts of different density grades. According to 
the BI-RADS reporting system, the levels are almost entirely fatty (Grade 1), 
scattered fibroglandular density (Grade 2), heterogeneously dense (Grade 3) and 
extremely dense (Grade 4) [50]. 
Grade 1 Grade 2 Grade 3 Grade 4 
 13 
Table 1.1 Sensitivity of Mammography for Breasts with Different Densities [49] 
Density 
grade 
Ratio of fatty tissue to glandular tissue 
Mammography 
sensitivity 
Grade 1 Almost entirely fat (< 25% glandular) 87.0% 
Grade 2 Scattered fibroglanular densities (25-50% glandular) 81.5% 
Grade 3 Heterogeneously dense (51-75% glandular) 69.4% 
Grade 4 Extremely dense (greater than 75% glandular) 62.9% 
 
 
 
 
Although mammography takes two pictures: one viewed from top to bottom 
(craniocaudal, CC) and the other from a 45 angle (mediolateral oblique, MLO), it is 
still difficult to pinpoint the actual location and extent of the tumor.  Compression of 
the breast can also lead to distortion of the location and extent of the tumor. Vague 
lesion boundaries can introduce error to the measurements [26]. Moreover, standard 
imaging projections do not always capture the maximum tumor extent [51]. In 
addition, patients are in a different position during regular mammography imaging 
from the supine position during surgery. Such differences can further distort the 3D 
localization of the tumor. 
Magnetic Resonance Imaging (MRI): MRI produces high quality images of 
inside of the human body. It is based on the principles of nuclear magnetic resonance 
(NMR), a physical phenomenon in which nuclei in a magnetic field absorb and reemit 
electromagnetic radiation.  
Human body is largely composed of water molecules, each of which contains 
two hydrogen nuclei, or protons. At the atomic level, when protons are placed in a 
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large external magnetic field, some protons align with the field and have a lower 
energy state and some align against the field and have a higher energy state. The 
protons are continually oscillating back and forth between the two states but any 
given instant and with a large enough sample, there will be a light majority aligned 
with the field. If an electromagnetic radio frequency (RF) pulse is applied at the 
resonance frequency, the protons can absorb that energy and jump to a high energy 
state. After the RF transmitter is turned off, the excited protons come back to the 
lower energy state and the absorbed RF energy is retransmitted, which yields a 
changing voltage in receiver coils to give the signal. By applying additional gradient 
magnetic fields that vary linearly over space, specific slices of the body can be 
imaged. The image is obtained by taking the 2D Fourier transform of the spatial 
frequencies of the signal. Tumors can be detected because the protons in different 
tissues return to their equilibrium state at different rates. By changing the parameters 
on the scanner this effect is used to create contrast between different types of body 
tissue.  
In detecting and screening breast tumor, breast MRI is becoming an important 
tool nowadays. It can provide images with high contrast and high resolution and help 
detect breast cancer in its earliest stage. Besides, it does not have ionizing radiation. 
However, breast MRI may miss some cancers [52, 53]. It cannot visualize the calcium 
deposits [54, 55], known as calcifications or microcalcifications, which typically 
surround ductal carcinoma in situ (DICS) lesions. Moreover, a recent study indicated 
that MRI also underestimates the sizes of breast lesions especially those of ductal 
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carcinoma in situ (DCIS) [56]. The discordance between the tumor size on MRI and 
the pathological size may contribute to re-excisions in patients who undergo 
lumpectomy. 
1.1.5.2 Emerging Modalities 
Elastography: Elastography is a new medical imaging modality that maps the 
elastic properties of soft tissue. The main idea is that whether the tissue is hard or soft 
will give diagnostic information about the presence or status of disease. For example, 
breast tumors are usually stiffer than the surrounding normal tissues. Unlike palpation 
which is a qualitative method with low sensitivity, elastography is able to provide 
quantitative modulus results of breast to distinguish tumors from the normal tissue.  
In elastography, external static compression (ultrasound elastography) or 
harmonic shear waves (magnetic resonance elastography) is applied to the tissue, and 
the resulting tissue displacements are then monitored using ultrasound (ultrasound 
elastography) or MRI (magnetic resonance elastography). These displacements are 
then used to reconstruct tissue stiffness using inversion technique based on tissue 
biomechanical model [57, 58].  
Ultrasound elastography utilizes either strain or transient elastography. Strain 
elastography is also known as static or compression elastography. With this technique, 
compression is applied to tissue with an ultrasound probe. It results in tissue 
displacement (strain) which can be measured by tracking longitudinal movement of 
tissue before and after compression. Strain elastography provides strain ratios 
calculated by comparing the strain of a lesion to the surrounding normal tissue. Soft 
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tissue has higher strain values than stiff tissue. Transient elastography, also known as 
shear-wave elastography, utilizes a gentle compression force generated by the 
ultrasound probe and induces transversely oriented shear waves within tissue. The 
speed of the shear waves, which is directly proportional to Young’s modulus, can be 
measured by the extremely fast ultrasound acquisition system. Therefore, transient 
elastography provides quantitative information about the Young’s modulus of the 
tissue. Multiple studies have shown that ultrasound elastography may provide 
additional diagnostic information to further characterize breast lesions and has the 
potential to improve the specificity of low suspicion lesions evaluated with 
conventional ultrasound [59-62].  
Using magnetic resonance elastography (MRE), shear modulus of the tissue 
can be measured. Acoustic shear waves are sent to the tissue, and an MRI based 
method is used to image the propagation of the waves inside the tissue. An algorithm 
is used to process the wave images and generate quantitative images that show the 
shear modulus values. McKnight et al. took the MRE of the breasts of six healthy 
women and six patients with known breast cancer and found that the shear stiffness of 
the tumors ranged from 18 to 94 kPa, while the shear stiffness of adipose breast tissue 
in the breast cancer patients ranged from 4 to 16 kPa [58]. MRE is being investigated 
as a complementary technique to conventional imaging methods to provide additional 
information about suspicious regions [63-65] and the combined technique has shown 
promise to increase diagnostic specificity [65-67].  
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Tactile imaging:  Tactile imaging is a newly developed technique which 
emulates human tactile sensation. It measures the force or pressure on the breast 
surface and uses a mapping algorithm to form a composite tactile map of the tissue.  
Egorov et al. developed a tactile imaging tool for breast tumor detection called 
Breast Mechanical Imager (BMI, trade name “SureTouch”) [68-71] as shown in 
Figure 1.5. It is a compact device consisting of a hand held probe with a pressure 
sensor array, an electronic unit, and a touchscreen laptop computer. During 
measurement, the sensor array is pressed against the examined site. The changes in 
the surface stress patterns as a function of displacement, applied load and time 
provide information about the elastic composition and geometry of the underlying 
tissue structures. By using artificial neural network, an inversion technique, the 3D 
image of the mechanical properties of the breast can be constructed and the size, 
shape, stiffness, and mobility of detected lesions can be calculated. A clinical study 
with 179 cases has been done and demonstrated that the BMI can detect breast lesions 
and provide a reliable calculation of lesion features [70].  
Yen et al. developed a stiffness measurement device that could be attached to 
a conventional ultrasound probe as shown in Figure 1.6 [72, 73]. When the device is 
slide across the lesion maintaining a constant compression depth, it measures the 
normal and lateral force on the tissue surface. The build-in inverse biomechanical 
model which is based on an artificial neural network can calculate the stiffness ratio 
of the lesion to its surrounding tissue. Simulations and experiments have been 
performed on phantoms with embedded inclusions, and they both show that the 
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stiffness ratio of the inclusion to its surrounding material can be accurately predicted. 
A preliminary test was performed on six patients and it showed that the stiffness 
ratios of fibroadenoma were in the range from 2.7 to 5.2, whereas the infiltrating 
ductal carcinoma were larger than 8.7 [73].  
 
 
Figure 1.5 A picture of the Breast Mechanical Imager (BMI, trade name “SureTouch”) 
[70].  
 
 
 
Lee et al. developed a tactile sensation imaging system (TSIS) based on an 
optical phenomenon known as the total internal reflection (TIR) [74-76]. In the 
system, a light is illuminated at the critical angle to be totally reflected within a multi-
layer polydimethylsiloxane waveguide. When the waveguide is compressed by an 
external force dui to the stiff tissue inclusion, the contact area of the waveguide 
deforms and causes the light to scatter. The scattered light is captured by a high 
resolution camera and saved as an image. The size, depth and Young’s modulus can 
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be estimated based on a combination of a forward algorithm using 3D finite element 
method and an inversion algorithm using artificial neural network. A pilot clinical 
study with 3 patients was performed and it showed that the device could predict the 
sizes of breast tumors [76].  
 
 
Figure 1.6 A stiffness measurement device which contains a handle, a 6-axis force 
sensor and a probe that can fix the ultrasound probe [73].  
 
 
 
Uribe et al. developed a vibrating piezoelectric bimorph sensor (VPBS) which 
is composed by two piezoceramic plates attached to a common cantilever [77-79] as 
illustrated in Figure 1.7. One piezoceramic plate of the bimorph is used to generate 
the vibration of the beam by applying a sinusoidal voltage to its electrode and the 
common cantilever. The other plate is used to sense the vibration. The bimorph 
contacts with tissue surface by a spherical plastic tip. When the stiffness of the tissue 
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increases, there is a shift in the resonance frequency to higher values. The experiment 
was performed on gelatin phantoms with different concentrations and it showed that 
by monitoring the resonance frequency the device was able to tell the difference in 
stiffness [77-79].  
 
 
 
Figure 1.7 A schematic of the vibrating piezoelectric bimorph sensor (VPBS) [77]. 
 
 
 
Gwilliam et al. compared the performance of human finger and robotic tactile 
sensing on the same set of artificial tissue models [80]. They investigated the effects 
of various tissue parameters including lesion size, lesion depth, and surrounding 
tissue stiffness. They concluded that electronic palpation is more effective at 
detecting lumps than the human finger.  
Most of the emerging methods including the elastography [57-59], BMI [69, 
70], the ultrasound probe attachment [72, 73], the TSIS [74-76], and the VPBS [77, 
78] do not measure tissue stiffness directly. Rather, they measure the stress or strain 
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distribution on the tissue surface and use an inversion technique such as artificial 
neural network technique and simulation to determine if there is a tumor and the 
diameter of the tumor if there is one.  
1.1.6 Breast Tissue and Tumor Stiffness 
There is a significant correlation between breast tissue histology and its 
stiffness. Many researchers have used the elasticity difference between the healthy 
and cancerous breast tissue to distinguish them [57, 58]. In addition to that, breast 
tumors can be imaged using the elastic modulus or stiffness contrast. The elastic 
modulus value of the breast tumor at a specific strain can also tell the histological 
properties of the tumor.  
The stiffness of breast tumor has been reported in many studies [81-83]. The 
values vary depending on the tumor types and the measurement methods. It is 
assumed that different types of tissues (tumor, fat, gland, etc.) tested in the 
experiments were homogeneous and their behavior in compression were isotropic. 
Samani et al. characterized the mechanical response of 169 fresh ex vivo breast tumor 
specimens by the force-displacement slopes as they were undergoing indentation by a 
small flat-ended cylindrical indenter [81]. The elastic moduli of fat and fibroglandular 
tissue as well as benign and malignant breast tumors were calculated and compared. 
Wellman et al. measured the elastic modulus of different tissues and tumors of the 
breast immediately after they were removed from the body, using punch indentation 
method at different strains [82]. Krouskop et al. evaluated the viscoelastic properties 
of 112 excised breast tumors using an Instron testing machine with 5% pre-
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compression strain [83]. They all reported that there is a significant difference 
between the healthy breast tissue and the tumor. A summary of the elastic modulus of 
normal breast tissues and tumors is shown in Table 1.2 below. As can be seen, the 
elastic modulus of normal breast tissues ranged from 3.24-33 kPa with an average of 
13.5±2.6 kPa, while the elastic moduli of breast tumors ranged from 6.41-107 kPa 
with an average of 45.8±5.0 kPa. These results show that healthy breast tissue and 
tumors can be differentiated using the elastic modulus difference at low strain values. 
 
 
Table 1.2 A summary of the elastic moduli of various breast tissues from Refs. [81, 
83, 84]. The number in the parenthesis indicate the number of samples over which the 
elastic modulus was obtained. The average E in column 5 is the elastic modulus (E) 
averaged over different references. 
 
Tissue type E (kPa) Reference Average E (kPa) 
Normal 
tissue 
Fat 
4.8±2.5 (26) [82]  
 
9.0±2.5 
3.25±0.91 (71) [81] 
19±7 (8) [83] 
Gland 
17.5±8.6 (7) [82]  
 
17.9±4.7 
3.24±0.61 (26) [81] 
33±11 (31) [83] 
Tumor 
Fibroadenoma 
45.5±20.1 (5) [82]  
 
53.0±10.1 
6.41±2.86 (16) [81] 
107±31 (18) [83] 
Lobular 
Carcinoma 
34.7 (1) [82]  
25.2±6.7 15.62±2.64 (4) [81] 
Infiltrating 
Ductal 
Carcinoma 
47.1±19.8 (25) [82]  
 
60.9±13.5 
42.52±12.47 (9) [81] 
93±12.47 (23) [83] 
Ductal 
Carcinoma in 
Situ 
71.2 (1) [82]  
37.5±1.4 
 
16.38±1.55 (4) [81] 
25±4 (23) [83] 
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1.2 Skin Anatomy and Skin Cancers 
1.2.1 Skin Anatomy 
Skin is the largest organ of the body, with a total surface area of about 2 m2. It 
works as a barrier and provides protection from mechanical impacts and pressures, 
variations in temperature, chemicals and pathogens. Besides, it regulates several 
aspects of physiology, including body temperature via sweat and air, and changes in 
peripheral circulation and fluid balance via sweat. Skin is also an organ of sensation. 
It contains an extensive network of nerve cells that permit the sensations of touch, 
heat, and cold.  
Human skin is a complex organ with a layered structure that can vary in 
thickness depending on what part of the body it covers [85]. Skin has three layers  as 
shown in Figure 1.8 [86].  
Epidermis is the outermost layer of skin. It provides a waterproof barrier and 
creates the skin tone. It is the thinnest on the eyelids at 0.05 mm and the thickest on 
the palms and soles at 1.5 mm, and it is constantly renewing itself [87, 88]. The 
innermost layer of the epidermis consists of a single layer of basal cells standing on 
the basement membrane. These cells divide to form the predominant keratinocytes of 
the stratum spinosum. Keratinocytes make keratin to protect the body. Also contained 
in the basal layer (stratum basale) are the melanocytes which produce the pigment 
called melanin. They give the tan or brown color to skin and help protect the deeper 
layers of the skin from the ultraviolet light. As the keratinocytes are pushed towards 
the surface, they become flattened and the remnants of their nuclei cause the 
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cytoplasm to appear granular (stratum granulosum). Finally, the cells die and create 
the protective outermost layer, the stratum corneum, which provides the greatest 
barrier to water loss and invasion of foreign substances.  
Dermis is the second layer of the skin and is beneath the epidermis. The 
dermis is much thicker than the epidermis and contains connective tissue, hair 
follicles, sweat glands, blood vessels, and nerves. The dermis ranges in thickness 
from 0.3 mm on the eyelids to 4 mm or more on the soles and palms [89]. The dermis 
is composed of two layers: the papillary layer and the reticular layer. The thin 
papillary layer lies directly beneath the stratum basale, and consists of slender and 
randomly ordered collagen fibers. The thicker reticular layer (4/5 of the dermis) is 
comprised by dense irregular connective tissue containing thick bundles of interlacing 
collagen fibers and some coarse elastic fivers that run in several directions.  
Hypodermis, also known as subcutaneous tissue, is the innermost and thickest 
layer of the skin. The thickness is 3-100mm [90]. It invaginates into the dermis and is 
attached to the latter by collagen and elastin fibers. It is essentially composed of 
adipocytes, a type of cells specialized in accumulating and storing fats. It also 
protects the skin and allows for mobility of the skin over the underlying organs. 
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Figure 1.8 A schematic of human skin [91] 
 
 
 
1.2.2 Skin Cancers 
Within the skin and its many layers, there is a diverse range of cells and cell 
types. They are constantly renewing themselves. In principle, any cell that undergoes 
division has chance to become malignant due to genetic mutations during mitosis. 
Therefore, skin cancer, which is the uncontrolled growth of abnormal skin cells, is 
very common.  
1.2.2.1 Statistics of Skin Cancers 
Skin cancer is the most common form of cancer in the US. More than 3.5 
million skin cancers are diagnosed annually, accounting for nearly 40% of all cancer 
cases. One in five Americans will develop skin cancer in the course of a lifetime [92]. 
Skin cancer can be divided into melanoma and non-melanoma skin cancers. The rates 
of melanoma have been rising for at least 30 years [93], according to National Cancer 
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Institute. In 1980, there were 10.5 new cases of melanoma per 100,000 people in the 
US. The number increases and in 2000, it increased to 19.0 new cases of melanoma 
per 100,000 people. In 2011, 22.7 new cases of melanoma were found per 100,000 
people. It is estimated that 73,870 new melanomas will be diagnosed in the US in 
2015 and 9,940 people are expected to die of melanoma [94]. Non-melanoma skin 
cancers refer to basal and squamous cell carcinomas. Each year in the US, nearly 5 
million people are treated for non-melanoma skin cancers [95, 96]. And about 3,000 
people die each year from non-melanoma skin cancers [97].  
1.2.2.2 Types of Skin Cancers 
There are three major types of skin cancers: 
Basal Cell Carcinoma (BCC): BCC is abnormal, uncontrolled lesions that 
arise in the skin’s basal cells in epidermis. It is the most frequently occurring form of 
skin cancers, accounting for 80% of skin cancer cases. Most of the lesions develop on 
sun-exposed areas, especially the head and neck. BCC typically grows slowly and 
generally spreads only locally. But if it is left untreated, it can grow into nearby areas, 
invade and destroy underlying structures and cause significant functional and 
cosmetic impairment. Besides, most of BCCs are non-pigmented [98]. 
Squamous Cell Carcinoma (SCC): SCC is an uncontrolled growth of 
abnormal squamous cells, which compose most of the skin’s upper layer (epidermis). 
It is the second most common malignancy of the skin (after BCC), accounting for 
about 16% of skin cancer cases. Similar to BCC, SCC often appear on sun-exposed 
areas of the body such as the face, ears, neck, lips, and backs of the hands. But they 
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can also develop in scars or chronic skin scores elsewhere. It can become disfiguring 
and sometimes deadly if untreated. An estimated 700,000 cases of SCC are diagnosed 
each year in the US, resulting in approximately 2,500 deaths [99]. 
Melanoma: melanoma is a form of cancer that begins in melanocytes. It only 
accounts for less than 2% of skin cancer cases but causes a large majority of skin 
cancer deaths [94]. It can develop anywhere on the skin. It can be subdivided into 4 
major pathologic subsets: lentigo maligna melanoma (LMM), superficial spreading 
melanoma (SSM), nodular melanoma (NM), and acral lentiginous melanoma (ALM). 
For all but NM, the growth pattern is biphasic. The initial growth occurs radially, 
sometimes persisting for years, but with little tendency to metastasize. Vertical 
growth then follows and develops much faster. NM growth pattern has only one 
phase, with growth in the vertical direction. It is during this vertical growth phase that 
the tumor can invade the underlying tissue and metastasize [100].  
1.2.3 Diagnosis of Skin Cancers 
Since most of the nonmelanoma skin cancers (BCC and SCC) are non-
pigmented, it is difficult for the dermatologist to determine the lateral extent of the 
cancers by eye and remove them accordingly. 
For melanomas, the Breslow thickness (as shown in Figure 1.9), which 
measures the distance between the upper layer of epidermis and the deepest point of 
tumor penetration [101], is one of the most important prognostic factors in melanoma 
[102]. If the thickness is smaller than 1mm (T1), the 5 year survival rate is 95-100%. 
If the thickness is larger than 4mm (T4), the 5 year survival rate is only 37-50% [103].  
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Figure 1.9 Breslow Thickness diagram for melanoma staging [104].  Malignant cells 
occupy surface layer only (Tis), <1mm (T1), 1-2mm (T2), 2-4mm (T3), and >4mm 
(T4).   
 
 
 
1.2.3.1 Current Modalities 
Physical exam is performed to detect skin cancers in clinics. The 
dermatologist uses a bright light and occasionally a magnifying lens to examine the 
skin and look for suspicious growths, moles, or lesions. The ABCDE guide which is a 
set of visual parameters is used to determine whether a skin lesion has a high 
probability of being a melanoma [105, 106]. A stands for asymmetry. Normal moles 
or freckles are completely symmetrical while melanomas are usually asymmetric. B 
stands for border, since the edges of melanomas are ragged, notched, or blurred. C 
means color. A lesion that has more than one color needs to be further evaluated. D is 
diameter. If the lesion is larger than 6 mm, further examinations are required. E 
stands for evolution. If the symmetry, border, color or diameter of a lesions changes 
over time, it is likely to be malignant. The ABCDE is an easy guide to the usual signs 
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of melanoma, but it cannot tell whether is lesion is indeed malignant or not. It does 
not provide any quantitative measurement results.  
During the examination, a dermoscope may also be used, which is a 
noninvasive diagnostic tool that utilizes a handheld magnification device with a liquid 
at skin surface or a cross-polarized light source as shown in Figure 1.10. It allows 
detailed visualization of specific morphologic structures and colors from the 
epidermis to the superficial dermis which are invisible to the naked eye. However, it 
cannot be used to measure the lateral sizes or thickness of skin cancers.  
 
 
 
Figure 1.10 A picture of the dermoscope [107]. 
 
 
 
The most important and widely used method for skin lesion characterization is 
pathological evaluation. Suspicious areas are selected by the dermatologist upon 
visual inspection, and the lesions are partially or wholly biopsied. A number of 
different biopsy techniques can be used including shave, punch, and excision. The 
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excised sample is then sectioned and stained for pathological investigation and 
diagnosis. The protocol for skin lesion diagnosis is the gold standard, but it is very 
time-consuming. Besides, the dermatologist does not always choose the correct area 
for biopsy. Partial biopsy cannot give the lateral sizes or thickness of the entire lesion, 
so the dermatologist do not know how much to cut during surgical removal of the 
lesion.  
Currently, Mohs surgery is used to determine the border of the non-pigmented 
nonmelanoma skin cancers and to remove them at the same time. In the surgery, thin 
layers of skin tissues are removed progressively and examined under a microscope 
until all the margins of the sample are free of cancer. It can remove as much of the 
skin cancer as possible, while doing minimal damage to surrounding healthy tissue. 
Since most of the nonmelanoma skin cancers occur on head, neck and back of hands, 
patients would like to remove the cancer with as little healthy tissue as possible. 
Therefore, Mohs surgery is widely used in hospitals nowadays. The cure rate is more 
than 90% [108, 109]. However, it is very time consuming. After the tissue removal, 
the patient needs to wait for the pathological results. If the margin of the sample still 
has cancer cells, the patient has to have another surgery. Therefore, a fast method that 
can determine the lateral extent of nonmelanoma skin cancers is needed. 
1.2.3.2 Emerging Modalities 
There has been much interest in recent years to develop imaging methods for 
skin cancer diagnosis.  
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Laser-induced fluorescence spectroscopy (LIF): LIF is a non-invasive 
technique used for detection of cancer in a variety of organ systems. It can be applied 
to detect non-melanoma skin cancers [110-112]. LIF relies on the innate fluorescence 
of several common biological constituents such as elastin, collagen, and flavin when 
excited by a light source. By measuring the fluorescence of tissue it can be possible to 
learn about the biochemical state of the tissue. Studies have shown that in vivo LIF at 
410 nm excitation and using the intensity of emission signal is effective for detection 
of BCC and SCC. However, the accuracy depends on the color of the skin. In patients 
with dark skins, the dark color and weaker fluorescence intensity for normal skin will 
cause more overlap of normal and cancer spectra which will lead to high rate of false 
positive [111, 113].  
High-frequency ultrasound (HIUS): HFUS with frequencies between 20-100 
MHz has been investigated for non-invasive evaluation of skin cancers [114-119]. 
Images are obtained in vertical sections with penetration and resolution varying with 
respective frequencies. Lower frequencies (20 MHz) depict flat and regular surfaces 
effectively and have a penetration depth of 3.8 mm with an axial resolution of 39 µm 
and a lateral resolution of 210 µm. Higher frequencies provide excellent study of 
superficial structures and irregular surfaces with a resolution of 9.9 µm and 84 µm, 
but have a decreased penetration of 1.1 mm [120, 121]. It has been investigated to 
determine the lateral size and thickness of melanoma as shown in Figure 1.11, but 
studies have shown that it tends to overestimate melanoma thickness [118, 122]. 
HFUS has not yet been established for nonmelanoma skin cancer diagnosis in clinics.  
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Figure 1.11 High frequency ultrasound imaging of two melanoma lesions [114]. 
Lesions were generally hypoechoic and well demarcated from the dermis.  
 
 
 
Optical coherence tomography (OCT): OCT is a novel imaging technique 
based on interferometry. Comparing to HFUS, instead of sound wave, it uses infrared 
light. OCT has high depth resolutions (about 15 μm) and it has been shown that layers 
of skin and blood vessels can reliably be visualized using OCT. However, its 
penetration depth is only 1.0-2.0 mm [123-127]. It cannot be used to measure the 
thickness of melanoma deeper than 2 mm [128]. The basement membrane of skin 
cannot be distinguished, such that early tumor invasion cannot be determined by OCT. 
Preliminary studies have described the features of nonmelanoma skin cancers and 
suggested that this tool may aid in the diagnosis of nonmelanoma skin cancers [129]. 
An OCT image of a basal cell carcinoma and the corresponding histopathology of the 
same area (hematoxylin and eosin stain, magnification × 40) are shown in Figure 1.12 
[130]. White arrow indicates a shadow in the OCT image. Black arrows point to 
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similar morphologies in the images. However, systematic studies evaluating the 
sensitivity and specificity of OCT for diagnosis are lacking [131].  
 
 
 
Figure 1.12 (A) An optical coherence tomography (OCT) image of a basal cell 
carcinoma; (B) Corresponding histopathology (hematoxylin and eosin stain, 
magnification × 40) from the same area [130].  
 
 
 
In vivo confocal microscopy:  In vivo confocal microscopy is an imaging 
modality for “optical sectioning” of tissue meaning the imaging of thin sections at 
high resolution and contrast without physically dissecting the tissue. It has two types: 
fluorescence confocal laser scanning microscopy (FLSM) and Reflectance mode 
confocal microscopy (RCM). In FLSM, exogenous fluorophores are injected and 
excited using a laser source. Emitted fluorescence is used to visualize the 
morphological details. RCM is based on the reflectance, scattering and absorption of 
monochromatic light by endogenous chromophores such as melanin, hemoglobin and 
other cellular microstructures. Both methods can visualize cellular and subcellular 
structures and can be comparable to routine histology. A RCM image of a basal cell 
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carcinoma and the corresponding histopathology of the same lesion are shown in 
Figure 1.13 [132]. It is clear that tumor nodules (TN) are separated from the dermal 
collagen by dark cleft-like spaces (red arrowheads). Dilated blood vessels (BV) are 
seen in the dermis. However, the penetration depth of in vivo confocal microscopy is 
only 0.2-0.25 mm [133]. Thus in vivo confocal microscopy is not able to visualize the 
depth invasion of skin tumors. Besides, this modality cannot evaluate lesions with 
significant hyperkeratosis (thickening of the stratum corneum).   
 
 
 
Figure 1.13 (A) A reflectance mode confocal microscopy (RCM) image of a basal 
cell carcinoma; (B) Corresponding histopathology of the same lesion [132].  
 
 
 
1.2.4 Skin Tissue and Cancer Stiffness 
To assess the mechanical properties of the skin, different noninvasive methods 
have been developed. The most commonly used methods are based on the 
measurement of suction [134], which requires applying a negative pressure to the skin, 
torsion and traction, by applying a linear displacement in the horizontal plane of the 
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skin. A tensile test, in which two tabs are glued to the skin and driven apart from each 
other, is also used to measure the mechanical behavior of skin. In the literature, the 
Young’s modulus of the skin varies between 0.42 and 0.85 MPa for torsion tests 
[135], 4.6 and 20 MPa for the extension tests [136] and between 0.05 and 0.15 MPa 
for the suction tests [134, 137]. However, all these methods modify the natural state 
of stress on the skin during measurements and the values of mechanical properties 
might be affected.  
The indentation and compression methods are also used to measure the 
stiffness of skin without prestressing the skin before the test. Geerligs et al. utilized a 
micro-indentation device with a spherical tip to measure the mechanical properties of 
the skin in vivo. Young’s modulus of the skin was derived to be between 1 and 2 MPa 
using a numerical model [138]. Tilleman et al. investigated the elastic properties of 
cancerous skin tissues. It was reported that the average Young’s modulus of 23 basal 
cell carcinoma tissue specimens was 52 kPa [139], while healthy skin has a stiffness 
of 100 to 2000 kPa [135, 137, 139]. Melanoma can be either softer or stiffer than 
normal skin [135, 140], depending on its malignancy. Therefore, there is a significant 
correlation between changes in tissue stiffness and abnormal pathological process. 
And thus, it is feasible to use stiffness contrast to differentiate cancerous tissues from 
normal skin.  
1.3 Piezoelectric Finger (PEF) 
Piezoelectric finger (PEF) is a piezoelectric cantilever, with two piezoelectric 
layers glued onto top and bottom of a stainless steel substrate, which can measure the 
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elastic modulus of a soft material or tissue using indentation method with the help of 
a cubic or cylindrical probe at the tip, all electrically.  
PEF was invented in our laboratory at Drexel University. The initial work of 
PEF has been done by Markidou et al. [141], Szewzcyk et al.  [142, 143], and 
Yegingil et al. [144-146].  
Markidou et al. [141] developed a unimorph piezoelectric cantilever (as 
shown in Figure 1.14) to measure the elastic and shear moduli of samples that are 
equal to or smaller than cantilever contact area using compressive and shear tests. DC 
voltages were applied to the piezoelectric layer in the cantilever and the cantilever 
would bend due to inverse piezoelectric effect. The tip deflection of the cantilever 
was measured by a laser displacement meter. They found that at low DC voltages, the 
tip displacement of the cantilever was linear with the applied voltage, which made it 
possible to apply different DC voltages to the cantilever and obtain the deduced 
elastic and shear moduli of a sample from the stress vs. strain curve. They designed 
two kinds of tips: a straight tip to measure the elastic moduli via compression tests 
and an L-shape tip to measure the shear moduli via shear tests, as schematically 
shown in Figure 1.14 (a) and (b). Using gelatin and commercial rubber material as 
model soft tissues, they showed that the piezoelectric cantilever could measure the 
elastic and shear moduli of soft material samples in the small strain range (<1%).  
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Figure 1.14 (a) A schematic of a piezoelectric unimorph cantilever for compression 
tests; (b) a schematic of a piezoelectric cantilever with an L-shape tip for shear tests.  
 
 
 
Szewczyk et al. [142, 143] added another layer of piezoelectric material glued 
to the bottom of stainless steel. They named the initial top piezoelectric layer as 
“driving electrode” and the second piezoelectric layer as “sensing electrode” as 
shown in Figure 1.15. When a DC voltage were applied to the top driving electrode, 
the cantilever would bend and  an induced voltage would be generated on the bottom 
sensing electrode due to direct piezoelectric effect. Szewczyk et al. investigated the 
relationship between the tip displacement of the cantilever and the induced voltage on 
the sensing electrode and found that they were linearly correlated. Using a straight tip 
the same with the one Markidou did, Szewczyk et al. did compression and flat punch 
indentation tests on soft samples. In the compression test, the surface area of the 
sample was equal to or smaller than the contact area of the tip as shown in Figure 
1.15 (a), while in the indentation test the surface area of the sample was much larger 
than the contact area of the cantilever tip as shown in Figure 1.15 (b).  
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Figure 1.15 (a) A schematic of a piezoelectric bimorph cantilever in contact with a 
small sample in a compression test; (b) a schematic of a piezoelectric bimorph 
cantilever in contact with a large sample in an indentation test.  
 
 
 
Yegingil et al. [144-146] combined the sensing electrode designed by 
Szewczyk et al. and the L shaped tip developed by Markidou et al. and developed a 
piezoelectric finger (PEF) which has two layers of piezoelectric material glued on the 
top and bottom of a stainless steel. It has a special designed square probe made with 
stainless steel so that the PEF can do both compression and shear tests within one 
sensor. As shown in Figure 1.16 (a) in compression tests, the PEF is held parallel to 
the sample, while in shear tests the PEF is held perpendicular to the sample as shown 
in Figure 1.16 (b).  
Yegingil et al. carried out compression, shear, indentation and indentation 
shear tests on gelatin samples using PEF. In compression and shear tests, the surface 
area of the sample was equal to or smaller than the contact area of the tip, while in 
indentation and indentation shear tests, the surface area of the sample was much 
larger than the tip area. They showed that the elastic and shear moduli of the samples 
could be deduced either by the induced voltage measurements across the sensing 
piezoelectric layer. Later they constructed a model tissue consisting of modeling clay 
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imbedded in gelatin and performed PEF measurements on it. Two dimensional elastic 
and shear moduli maps were generated which could indicate the size and location of 
the clay inclusion accurately. Similar experiments were done on excised breast tissues 
and they found that PEF was capable of detecting tumors in them using the 2D 
modulus map, and that PEF could tell the malignancy of the tumor using the shear 
modulus (G) to elastic modulus (E) ratio, G/E [145]. Moreover, they investigated the 
depth sensitivity limit of a PEF and empirically determined that the depth sensitivity 
limit was twice the linear dimension of the indentation area (or probe width) [146]. 
 
 
 
Figure 1.16 Schematics of a piezoelectric finger (PEF) with a special designed probe 
that can be used for both compression tests (a) and shear tests (b).  
 
 
 
The PEF design uses 127 µm thick lead zirconate titanate (PZT) material 
(T105-H4E-602, Piezo Systems Inc., Cambridge, MA) for both piezoelectric layers 
and 50 µm thick stainless steel (Alfa Aesar, War Hill, MA) for the substrate the 
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square tip. The manufacturing, properties and characterization of the PEF will be 
explained in Chapter 3 in greater detail.  
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2. OBJECTIVES AND SPECIFIC AIMS 
2.1 Motivations 
Breast cancer is the most common type of cancer among women in the US. 
Early detection of breast cancer can result in better chances of effective treatment. 
Furthermore, accurate localization and sizing of breast cancer in three dimensions 
(3D) are important for biopsies, surgeries and monitoring response of chemotherapy 
and radiotherapy. Current breast tumor detection and localization methods include 
clinical breast examination (CBE, or palpation), ultrasound, mammography, and 
magnetic resonance imaging (MRI) but they all have limitations. For example, 
mammography, the FDA approved gold standard screening tool for breast cancer, has 
low sensitivity in tumor detection for dense breasts. The compression of breast during 
mammography testing may lead to distortions of the tumor locations and sizes. 
Ultrasound may underestimate the tumor size, leading to incomplete excision in 
lumpectomy.  The emerging methods including the elastography [147-150], the BMI 
[69, 70], the ultrasound probe attachment [72], the TSIS [74, 75], and the VPBS [77, 
78] do not measure tissue stiffness directly. Rather, they measure the stress or strain 
distribution on the surface and use an inversion technique or simulations to determine 
if there is a tumor and the location and size of the tumor, which requires much 
computation and time. In addition, all these methods have not been proven capable of 
detecting breast cancer in dense breasts. Therefore, a method that is capable of not 
only detecting breast tumors but also providing the locations and sizes without 
simulations is desired, especially for dense breasts.  
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Skin cancer, which is the uncontrolled growth of abnormal skin cells, is the 
most common form of cancer in the US. Most of nonmelanoma skin cancers, i.e. 
basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) are non-pigmented, 
and thus it is difficult for dermatologists to determine the lateral extent of the cancers 
and remove them accordingly. The thickness of melanoma is one of the most 
important prognostic factors which will help the dermatologist decide the surgical 
margins. Currently, Pathological investigation is the current gold standard for skin 
cancer evaluation but it is tedious and time-consuming. A tool that can not only detect 
the skin cancer but also determine 3D profile is desired.  
Meanwhile, it is well known that cancers have a different stiffness from 
normal tissue. Breast tumors are stiffer compared to the surrounding tissue and skin 
cancers can be either stiffer or softer than normal skin. Piezoelectric finger (PEF) is a 
tissue stiffness sensor that can measure the elastic modulus of tissues both in vitro and 
in vivo. Therefore, it is possible to detect and image tumors by contrasting the high 
(or low) elastic modulus regions with the surrounding tissues. Besides, a PEF with a 
larger contact area can assess the stiffness of tissues at a larger depth. It is thus 
possible to use PEFs with different contact sizes to deduce the depth profile of tumors.  
There are many differences between breast cancers and skin cancers. 
Mechanically speaking, the normal breast tissue is quite uniform, while the normal 
skin has a layered structure with a stiff layer (epidermis and dermis) on top of a soft 
substrate (hypodermis). Breast tumors are stiffer than normal tissues and they are 
embedded in normal tissues. On the other hand, skin cancers can be either softer or 
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stiffer than normal skin and they start from the surface of skin and grow into deep 
tissue. The sizes of breast cancers and skin cancers are quite different. The breast 
cancer has a size of a few centimeters while the thickness of skin cancer is in 
millimeter and sub-millimeter scale. Thus, we may not apply the same method to 
deduce the depth profile of breast cancers and skin cancers.  
2.2 Goal and Aims 
2.2.1 Goal  
The goal of the study is to not only detect breast tumors and skin tumors but also 
image their locations and sizes in 3D.  
2.2.2 Objectives  
The objectives of the study are (1) to use array piezoelectric fingers (PEFs) of 
the same contact area to provide a 2D tissue elastic modulus map to detect the breast 
tumor and the skin cancer by elastic modulus contrasts, and (2) to develop the 
methodology to determine the tissue depth profiles including cancer depth profiles by 
measuring the elastic modulus of tissue on the same spot using PEFs of various 
contact sizes.  
2.2.3 Specific Aims  
To achieve the goal and objectives, the study was organized into four specific 
aims as follows.  
Aim 1: Image breast tumors in vivo to generate a two dimensional (2D) elastic 
modulus map using an array of PEFs of the same contact sizes.  
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• Develop a breast tumor detection system with a hand-held probe with 
4×1 PEF array 
• Validate the system on breast tumor models 
• Perform in vivo breast tumor detection on 40 patients.  
• Compare the detection sensitivity of PEF with mammography, 
especially for patients with dense breasts 
• Determine the lateral size of breast tumor and compare with pathology 
Aim 2: Determine the depth profile of model breast tumors using the elastic 
modulus measurements from a set of PEFs of different contact sizes 
• Determine the depth sensitivity of a PEF empirically 
• Use a 2-spring model to deduce the depth profile of bottom supported 
model breast tumors and compare with the actual values 
• Compare spring model-based methodology with inversion simulations 
using finite element analysis (FEA) 
• Extend the model to 3 springs and apply it to estimate the depth profile 
of suspended model breast tumors 
• Image model breast tumors in 3D using the lateral and depth profile 
determined by PEF  
Aim 3: Simultaneous determination of the elastic modulus and thickness of skin 
(epidermis and dermis) using a set of PEFs of different contact sizes 
 45 
• Model the skin with a two-layer structure with a stiff layer 
representing the dermis on top of the soft hypodermis layer 
• Couple PEF measurements with an empirical formula for a two-layer 
structure to determine the elastic modulus and thickness of dermis 
• Validate the methodology using FEA with finite skin thickness 
• Apply the methodology to skin phantoms and excised porcine skins 
Aim 4: Determine both the lateral extent and depth profile of model skin cancers 
using a set of PEFs of different contact sizes 
• Determine the lateral extent of model skin cancers using PEF with a 
small contact size 
• Determine the depth profile of model skin cancers using PEFs with 
different contact sizes coupled with a modified 2-spring model 
• Image skin cancers of clay embedded in porcine skins in 3D 
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3. IMAGE BREAST TUMORS IN VIVO USING PIEZOELECTRIC FINGER 
(PEF) ARRAY 
In this chapter, a breast tumor detection system with a hand-held probe with 
an array of piezoelectric fingers (PEFs) of the same contact size is developed to 
image breast tumors in a two dimensional (2D) elastic modulus map. Breast tumor 
models consisting of modeling clays and gelatin matrix are constructed to validate the 
measurements by the PEF system. The system is then applied to perform in vivo 
breast tumor detection on 40 patients and the results are compared with 
mammography. The lateral sizes of detected breast tumors by PEF are compared with 
those provided by pathology.  
3.1 Piezoelectric Finger (PEF) 
3.1.1 Manufacturing of Piezoelectric Finger 
Piezoelectric finger (PEF) has been briefly introduced in Section 1.3. The PEF 
has two piezoelectric layers, driving layer on the top and sensing layer on the bottom, 
as shown in Figure 3.1 (a). All the PEFs used are hand-built in our laboratory. The 
driving and sensing PZT layers used in the PEFs are lead zirconate titanate (PZT) 
5H4E material (Piezo Systems Inc., Cambridge, MA), and both layers are 127μm 
thick. The stainless steel (Alfa Aesar, War Hill, MA), which is 50μm thick, is used as 
the substrate and the loop probe. 
The PEF used in this chapter were all 6.5±0.5 mm wide. The lengths of 
driving and sensing PZT layers were 22±0.5 mm and 12±0.5 mm, respectively. The 
substrate stainless steel was 33±0.5 mm long. To make the PEF, the PZT layers were 
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bonded to the substrate stainless steel using a nonconductive epoxy (Henkel Loctite, 
Westlake, OH) at the edges and a small patch of conductive epoxy (ITW Chemtronics, 
Kennesaw, GA) at the center. The nonconductive epoxy was used so that there was 
no short circuit between the top and bottom electrodes of the PEF. After curing at 
room temperature overnight, a stainless steel strip was bent into a rectangular loop 
and glued to the free end of the cantilever using the same nonconductive epoxy. The 
stainless loops used in this chapter were 10 mm high, 6.5 mm wide and 6.5 mm deep.  
Wires were soldered on the top, bottom layers of the PZT and the stainless substrate. 
The PEF was then clamped to an acrylic fixture (as shown in Figure 3.1 (b)) made in 
the Drexel machine shop with 5 layers of scotch tapes (Scotch Magic tape, 3M, St. 
Paul, MN ) as a spacer for further characterization.  
 
 
 
Figure 3.1 (a) A schematic of a piezoelectric finger (PEF); (b) A picture of the PEF. 
Clamp 
Driving Electrode 
Stainless Steel 
Sensing Electrode Spacer 
(a) 
(b) 
 48 
3.1.2 Characterization of Piezoelectric Finger 
3.1.2.1 Spring Constant Determination of PEFs   
The effective spring constant (K) of a PEF is very important for its application 
in elastic modulus measurements since too low or too high value would not be 
suitable for tissue applications. Previous studies have indicated that the effective 
spring constant of the PEFs should be between 100 N/m to 400 N/m for soft material 
applications. 
According to previous research results in our laboratory, the effective spring 
constant of a PEF can be theoretically calculated using the following formula [151]: 
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where tn is the neutral plane location, E1, E2 and E3 are the elastic moduli of the top 
piezoelectric layer (i.e. driving electrode), middle stainless steel substrate, and the 
bottom piezoelectric layer (i.e. sensing electrode), respectively, t1, t2 and t3 are the 
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thickness values of the top piezoelectric layer, middle stainless steel substrate, and the 
bottom piezoelectric layer respectively, D is the bending modulus, K is the effective 
spring constant of the PEF, w is the width of the PEF, and L1, L2 are the length of the 
section of the PEF with the bottom piezoelectric layer and the length of the section of 
the PEF with no sensing electrode, respectively. The elastic modulus E1 and E3 of the 
PZT and E2 of the stainless steel are 62 GPa and 200 GPa, respectively.  
By using the equations above, the theoretical effective spring constant of the 
PEF with the geometry described in Section 3.1.1 is 225.7 N/m. The effective spring 
constant of PEFs can also be measured experimentally. A set of weights were made to 
be hung on the tip of the cantilever. Using a laser displacement meter (LC-2450, 
Keyence Corporation, Osaka, Japan) mounted above the PEF we measured the tip 
displacement that resulted from hanging the weights on the free end of the cantilever. 
Since the effective spring constant K = F/d, where F is the force applied to the free 
end of the cantilever and d is the displacement of the cantilever tip, we determined K 
by calculating the slope of the linear curve that resulted from plotting the force 
applied by the weights versus the resulting displacement. As shown in Figure 3.2, the 
force is linear to the tip displacement (R2 = 0.996) and the slope is 0.223. Therefore, 
the effective spring constant of that PEF is 223 N/m, which is very close to the 
theoretical value 225.7 N/m.  
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Figure 3.2 Force versus tip displacement of a PEF, whose driving electrode was 22 
mm long, sensing electrode was 12 mm and width was 6.5 mm. The data was fit to 
linear function and the effective spring constant (K) is determined by the slope of the 
fit, which is 223 N/m, close to the theoretical calculation 225.7 N/m.  
 
 
 
3.1.2.2 PEF Tip Displacement and Induced Voltage Measurements 
The driving PZT bends when an electric field is applied to it, which in turn 
causes cantilever to bend and thus to generate an instantaneous induced voltage 
across the thickness of the sensing electrode. Since the PZT material is not absolutely 
insulated, the induced voltage peak decays to zero over time and can be monitored by 
an oscilloscope (Infiniium S4832D digital oscilloscope, Agilent, Palo Alto, CA). The 
magnitude of the induced voltage created is obtained by measuring the zero to peak 
value of the induced voltage.   
The correlation between the PEF’s tip deflection and the induced voltage 
production on the sensing electrode was investigated with the electric field (HP 
E3631A Triple Output Power Supply, Hewlett-Packard, Agilent, Palo Alto, CA) 
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applied to the driving electrode. The axial tip displacements and the corresponding 
induced voltages are plotted versus the direct current (DC) applied voltages of 6, 8, 
10, 12, 14, 16, and 18 V for a 6.5±0.5 mm wide PEF in Figure 3.3. It demonstrates 
that as the magnitude of the applied voltage to the driving electrode of the PEF 
increases, the tip displacement and the induced voltage generated on the sensing 
electrode increases accordingly. It is also shown in the figure that both the PEF tip 
displacement and the induced voltage are proportional to the applied DC voltage. And 
thus, the induced voltage from the sensing electrode can be used to represent the tip 
displacement. A PEF can both apply a force and detect the corresponding 
displacement in one device using electrical means, offering the potential to palpate 
electrically on soft samples like a finger.  
In Figure 3.4, the induced voltage from sensing electrode is plotted versus the 
corresponding axial tip displacement when DC voltages applied to the driving 
electrode were 4, 6, 8, 10, and 12 V with and without a soft sample. It shows that the 
induced voltage created on the sensing electrode is indeed linear to the tip 
displacement of the PEF (R2 = 0.993). Besides, no matter whether there was a soft 
sample placed underneath the PEF or not, the slope of the induced voltage versus tip 
displacement remained the same, indicating the induced voltage can indeed be used to 
represent the tip displacement.  
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Figure 3.3 Tip displacement of the PEF and induced voltage from the sensing 
electrode versus direct current (DC) voltages applied to the driving electrode. 
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Figure 3.4  PEF induced voltage from the sensing electrode versus tip displacement 
with and without gelatin sample when direct current (DC) voltages were applied to 
the driving electrode.  
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3.1.3 PEF Indentation Elastic Modulus Measurements 
A PEF measures the tissue stiffness as follows. Applying a direct current (DC) 
voltage to the top driving electrode of a PEF causes the PEF to bend due to the 
converse piezoelectric effect. Furthermore, the bending of the PEF generates an 
induced piezoelectric voltage in the sensing PZT layer. It has been shown in section 
3.1.2.2 that the induced voltage is proportional to the PEF tip displacement, d. 
Therefore, the induced voltage can be used to represent the d [142, 144]. As a result, 
the elastic modulus, E, of the tissue is deduced as  
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where Vin,0 and Vin are the induced voltages without and with the tissue, respectively, 
ν is the Poisson’s Ratio of the tissue, A is the contact area defined by the stainless 
steel square at the tip of the PEF, and K is the effective spring constant of the PEF. 
To use Eq. (1) to deduce the elastic modulus at a particular location of the 
sample, a series of DC voltages, Vap’s, were applied to a free PEF to obtain the 
corresponding induced voltages without the tissue, Vin,0’s. The PEF probe was then 
brought in contact with the sample. The same series of Vap’s were applied to the PEF, 
and the corresponding set of induced voltages, Vin’s which were different from the 
Vin,0 were recorded. An example of d0 and d measured by an LC-2450 laser 
displacement meter (Keyence, Itasca, IL) and induced voltages Vin,0 and Vin versus Vap 
is shown in Figure 3.5 (a). To deduce the elastic modulus of the sample 
    )(1)21( 0,22
1
inin VVKA  was then plotted versus Vin as shown in Figure 3.5 (b). 
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The elastic modulus of the sample (gelatin in this case) was 8.4 kPa as determined by 
the slope of the curve. LabVIEW (National Instruments, Austin, TX) programming 
was used to conduct the measurement, record and plot the data, and deduce the E 
values, which will be explained in Section 3.2.2. 
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Figure 3.5 (a) The tip displacement and induced voltages from the sensing electrode 
without and with gelatin sample when the voltages applied to the driving electrode of 
PEF were 4, 6, 8, 10, and 12 V; (b)     )(15.0 0,22
1
inin VVKA  versus Vin. The slope of 
the linear fitting is 8.4 kPa which is taken as elastic modulus of the gelatin. 
 
 
 
 
3.2 PEF Array Breast Tumor Detection System 
The capabilities of a single piezoelectric finger have been investigated in 
previous studies [144, 146, 151]. PEF has been tested on 77 cases of excised breast 
tissues [151] and demonstrated capable of detecting most types of breast tumors 
including invasive carcinoma (IC), hyperplasia, fibrocystic, ductal carcinoma in situ 
(DCIS), micro-calcifications and even a 3-mm satellite IC missed by mammography 
and by physician’s palpation. To apply the PEF technique for breast tumor detection 
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in vivo, a system including a PEF array is developed. PEF array has the advantage of 
using more than one PEF to measure the elastic modulus of the soft sample or tissue 
at different locations simultaneously, which will provides faster measurements. 
Besides, it is a portable device that can be used in both laboratory and hospitals.  
3.2.1 PEF Array Probe Design 
A PEF compression array which consists of four 6.5±0.5 mm wide PEFs was 
developed. An acrylic box that is 51 mm in length, 51 mm in width, and 30 mm in 
height was designed to hold and protect the PEF array. As the PEF casing was hand-
held by an operator who then pushed the bottom of the PEF casing against the breast 
to facilitate the PEF elastic modulus measurements, we positioned the probe surface 
to be slightly recessed from the bottom of the PEF casing (as shown in Figure 3.6) 
such that the pressure from the operator’s pushing was exerted on the bottom of the 
casing but not the PEF probe surface. This allowed the probe surface of a PEF which 
is at the free end of the cantilever to be free from the pressure. Therefore, the elastic 
modulus measurement of a PEF would be insensitive to the pressure the operator 
applies to the housing of the device.  
During tests, the wires soldered on the driving and sensing electrodes should 
not be pulled, otherwise the moving wires may bring noise to the measured induced 
voltages. To solve this problem, two copper foil squares with a length of 4 mm and a 
width of 3 mm were glued on the top and bottom of stainless steel substrate at the end 
of the PEF using nonconductive epoxy as illustrated in Figure 3.6. Wires with one 
end soldered on the driving and sensing electrodes were soldered on the two copper 
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foils on the top and bottom of stainless steel, respectively. The copper foil acts as a 
connector and another wire soldered on the copper foil connected it to the DB-25 
connector at the rear of the housing box. During measurements, the DB-25 connector 
would be connected to the electrical controller and the electrodes of the PEF would 
not be moving.  
 
 
 
Figure 3.6 A schematic of the cross section of the PEF array and its housing box 
 
 
 
 
3.2.2 Instantaneous Modulus Measurement by LabVIEW Program  
In previous studies of PEF, applying DC voltages to the driving electrode of 
PEF using DC power source, measuring induced voltages from the sensing electrode 
of PEF using oscilloscope, and calculating the elastic moduli were all done manually. 
Controlling the equipment to acquire data (applied voltages and induced voltages) 
manually is very tedious and time consuming, and also involves post analysis of data 
to obtain the measured moduli. However, in vivo experiment requires faster 
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controlling, data acquisition and calculation because of the limited time during the 
experiments in the hospital.  
To speed up the measurements, a circuit board was designed by M Squared 
Electronics. The circuit board could output a stimulus pulse that can range from 0 – 
30 V DC to apply voltages to PEFs.  It is also able to measure the induced voltages 
from the sensing electrode of a single PEF. It communicates with computer using RS-
232 serial port and responds to a set of ASCII commands.  
A software program was developed to control the circuit board, record the 
data, and do further calculation and analysis. LabVIEW (National Instrument) was 
chosen because the built-in user interface components (such as buttons, graphs, etc.) 
and the large library of drivers for data acquisition require less programming. The 
front panel of the written LabVIEW code is shown in Figure 3.7. The DC voltages 
that will be applied to the sensor, the Poisson’ ratio, ν, of the sample, the effective 
spring constant, K, of the PEF are required as the input of the LabVIEW code. 
The flow chart of part of the program to control the circuit board to apply a 
voltage to the driving electrode and read the response from the sensing electrode is 
illustrated in Figure 3.8. The magnitude of the applied voltage is input by the user and 
sent to the circuit board. Then the program takes a short break (380 ms) to wait for 
the board to be ready. After applying the previous set voltage to the driving electrode, 
the board will measure the induced voltage and return the value to the program using 
a range of 0000 to 1023 counts. The actual sensor voltage can be calculated using the 
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returned counts. After calculation, the buffers will be cleared for future inputs and 
outputs.  
 
 
Figure 3.7 The front panel of the LabVIEW program for elastic modulus 
measurement.  
 
 
 
 
Figure 3.8 The flow chart of the program to control the circuit board for applying a 
voltage to the driving electrode of PEF and measuring the induced voltage from the 
sensing electrode.  
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The software program is able to calibrate the PEF by obtaining the induced 
voltage without any sample underneath the hand-held probe with the applied DC 
voltages which are the input by the user. After placing the hand-held probe on the 
sample and click the ‘measure’ button on the panel of the software, the program will 
send the command to the circuit board to apply voltages to the driving electrode of 
each PEF in the array and read the induced voltage from the sensing electrode of the 
same PEF sequentially, and calculate the modulus and record the data in the excel 
datasheet. Each PEF will do three repeated measurements and an average of the 
elastic moduli is calculated and recorded as well. The flow chart of the measurement 
part of the software is shown in Figure 3.9. 
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Figure 3.9 The flow chart of the measurement part of the program 
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3.2.3 Breast Tumor Detection System 
The PEF breast tumor detection system consists of a hand-held 4×1 PEF array 
probe, a custom-build electronic board, and a laptop computer as shown in Figure 
3.10. The electronic board, designed and fabricated by M Squared Electronics, 
worked to generate the applied voltages on the driving PZT of a selected PEF and to 
read the induced voltages from the sensing PZT of the PEF. It communicates with the 
laptop through a RS232-USB port. Figure 3.11 (a) and (b) shows a top and bottom 
view of the PEF array unit. As can be seen from Figure 3.11 (b), the bottom surface 
of the handheld unit was mostly flat to flatten out tissues surrounding the area under 
testing and make sure that the contact area of each of the four PEF was fully in 
contact with the tissue. Note that because the PEFs were in a cantilever geometry they 
had only one end fixed to the housing, which is different from sensors in 
“SureTouch” [68-70] that have all edges fixed to the housing of the device. This 
allowed the probe surface of a PEF at the free end of the cantilever to be free from the 
pressure exerted on the housing as long as the PEF was “recessed” from the bottom 
surface of the housing. Such an arrangement allows (1) protection of the PEFs from 
unintentional touching of the PEF tip which can damage the PZT layer and (2) 
desensitization of the PEFs from the pressure exerted by the hand on the housing 
against the breast (see Section 3.3.4). Figure 3.12 shows that the PEF array breast 
tumor detection system is performed on patients in a supine position. We define the 
maximum depth over which the elastic modulus of the tissue could be measured by 
the PEF as the depth sensitivity of the PEF. It has been shown in an earlier study [146] 
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that the depth sensitivity of a single PEF was all about twice the width of the contact 
area and independent of the inclusion elastic modulus values. Therefore, the current 
PEF with a 6.5 mm wide contact area had depth sensitivity about 13-15 mm. By 
further pushing the probe housing 6 mm (see Section 3.3.4) on the skin, the 
measurement can reach a depth of 2 cm, which was sufficient for detecting tumors in 
a normal-size breast as indicated by the results from the in vivo study below. For 
larger breasts and deeper tumors, PEFs with a larger contact width can be used, which 
was not within the scope of the present study.  
 
 
Figure 3.10 A photograph of PEF array breast tumor detection system which consists 
of PEF probe, electronic board, and a laptop for control and display. 
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Figure 3.11 (a) The top view of the PEF probe; (b) the bottom view of the PEF probe 
 
 
 
 
 
Figure 3.12 A schematic showing how the PEF breast cancer detection system was 
performed on patients 
 
 
 
3.3 Measurements on Model Breast Tumor Samples 
Breast tissue models with varying sizes and geometries of tumors were made 
and the PEF array breast tumor detection system was utilized to measure the elastic 
moduli of samples to investigate the accuracy of PEF measurements and validate the 
technique.  
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3.3.1 Model Breast Tumor Samples 
Model breast tissue samples consisting of a gelatin (Now Foods, 
Bloomingdale, IL) matrix with model tumors of modeling clays (Crayola, Easton, PA) 
were prepared. The concentration of the gelatin matrix was 0.10 g/ml and its elastic 
modulus was similar to that of normal breast tissues, about 10 kPa [151-154]. The 
model clay was chosen because its elastic modulus of 60 kPa was similar to those of 
breast tumors measured ex vivo using PEF reported in Ref. [151]. In addition, these 
choices were consistent with the elastic modulus values of normal breast tissues and 
those of breast tumors reported in the literature, which were 3-33 kPa and 6-107 kPa, 
respectively [81, 83, 155-158] as shown in Table 2.2.  
The gelatin matrix was prepared by mixing the gelatin powder in water with 
the concentration of 0.10 g/ml at 80 °C on the hot plate and stirring for 10 minutes. 
Then a part of the gelatin was slowly poured into the mold to avoid any bubbles 
which might introduce modulus variation inside the gelatin matrix. After pouring 
gelatin into the mold, it was cooled in 4 °C refrigerator for 10 minutes to solidify. 
Models clays were made into desired sizes and geometries to mimic the tumors and 
placed on the solidified gelatin in the mold. Afterwards, the rest of the gelatin was 
slowly poured into the mold and then cooled in 4 °C refrigerator for 10 minutes to 
solidify. The sample was taken out of the refrigerator and allowed to equilibrate at 
room temperature for 1 hour prior to the measurements. The gelatin was discarded 
after it was used for the day and a fresh gelatin sample was made every time.  
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An example of the model breast sample with four suspended model tumors of 
green modeling clay (seen in Figure 3.13 (a)) was prepared and shown in Figure 3.13 
(b). The diameters of model tumors were 11.5±0.3mm, 10.3±0.3mm, 7.8±0.2mm, and 
6.2±0.2mm, respectively. The depths of model tumors—which measure how far the 
top of the model tumors were under the gelatin surface—were 6.8±0.4mm, 
9.3±0.3mm, 8.0±0.3mm, 5.5±0.2mm, respectively.  
3.3.2 Scanning Model Breast Tumor Sample  
Before the scanning using the PEF array breast tumor detection system, a grid 
was drawn on the model surface for location tracking. The PEF probe was then 
placed on the first location and the elastic modulus measurements were performed by 
activating the four PEFs sequentially. Each elastic modulus measurement required 
five applied voltages to the driving PZT of a PEF and deducing the elastic modulus as 
the slope of     )(1)21( 0,22
1
inin VVKA   versus Vin as described in Section 3.1.3. 
Three repeated elastic modulus measurements were made for each location to obtain 
an average elastic modulus and standard deviation.  
Using the average elastic modulus, E obtained at each location, a color-coded 
E map was then created to visualize where and how big the tumor was. As an 
example, Figure 3.14 shows a color-coded elastic modulus map of the model tissue 
shown in in Figure 3.13 where the green color represents the elastic of the gelatin 
matrix while the red color represents the elevated elastic modulus of the modeling 
clay. The actual locations of the tumors are marked by the black circles. As can be 
seen, the higher modulus regions in the map were consistent the sizes and locations of 
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the model clay inclusions. PEF array system indeed detected all the model tumors. 
The locations of model tumors determined by the PEF array system also agreed with 
their actual locations. Therefore, the PEF array breast tumor detection system is 
capable of locating and sizing a hard inclusion embedded in a soft material.  
 
 
 
 
Figure 3.13 (a) Model tumors 1, 2, 3, and 4 made of green modeling clay. The 
diameters of the model tumors were 11.5±0.3 mm, 10.3±0.3 mm, 7.8±0.2 mm, 
6.2±0.2 mm, respectively; (b) a photograph of the model breast made of gelatin with 
the four model tumors suspended in it. The distances from the top of the model 
tumors to the gelatin surface were 6.8±0.4 mm, 9.3±0.3 mm, 8.0±0.3 mm, 5.5±0.2 
mm, respectively.  
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Figure 3.14 Elastic modulus map of the model breast of gelatin with clay model 
tumors shown in Figure 3.13 scanned by the PEF breast tumor detection system. The 
actual locations of the tumors are marked with black circles.  
 
 
 
3.3.3 Lateral Tumor Size Determination  
To determine the size of the tumor at a certain x distance, the elastic modulus 
at that x distance was plotted versus y distance. As an example the elastic modulus of 
Tumor 1 in the model breast sample shown in Figure 3.13 at x = -2 cm is plotted 
versus y distance in Figure 3.15. The model tumor had a diameter of 11.5±0.3 mm 
and a depth of 6.8±0.4 mm inside the gelatin. The data was then fitted to a Gaussian 
distribution (red line in the figure). The size of the tumor at x = -2 cm was determined 
to be the width at the half peak height of the Gaussian fit, 13.1 mm. The half peak 
height method takes the elastic moduli of the surrounding matrix and those over the 
inclusion into the consideration. In this example, the half peak is 18.4 kPa which is 
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calculated by averaging the elastic modulus of the gelatin matrix (baseline of the 
Gaussian fit, 11.6 kPa) and the elastic modulus of the peak position in the Gaussian 
fit, 25.2 kPa. The width of the bell shaped curve at the half peak provides the size of 
the tumor at x = 2 cm. It is understandable since the half peak of the modulus is 
obtained when the PEF is scanning over the edge of the tumor where half of the PEF 
is over the tumor and the other half of the PEF is over the gelatin matrix. That is way 
we use the width of the half peaks of the Gaussian fit to determine the tumor size.  
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Figure 3.15 The measured elastic modulus versus Y distance at X = -2 cm extracted 
from the 2D elastic modulus map shown in Figure 3.14. The size of the tumor taken 
as the width at the half peak height of the Gaussian fit was 13.1 mm.  
 
 
 
The lateral sizes of the model tumors as determined by the widths of the half 
peak heights are listed in Table 3.1. Also shown were the actual sizes measured with 
a caliper. The sizes estimated by PEF were larger than the actual ones by about 1-2 
mm in the direction parallel to the PEFs and by about 1.5-3 mm in the direction 
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perpendicular to the PEFs. The larger errors in the direction perpendicular to the PEFs 
were presumably due to the larger interval perpendicular to the PEF array— 1 cm as 
opposed to the 7.5 mm in the parallel direction— between two adjacent 
measurements. 
 
 
Table 3.1 (a):  The sizes of model tumors in Figure 3.13 measured in the direction 
parallel to the PEF array. 
Model 
Tumor  
Size in the direction parallel to the PEF array  
Measured  Actual  Error  
1 13.1±0.6 mm  11.5±0.3 mm 1.6 mm 
2 12.2±0.5 mm  10.3±0.3 mm  1.9 mm 
3 9.1±0.7 mm  7.8±0.2 mm  1.3 mm 
4 7.0±0.5 mm  6.2±0.2 mm  0.8 mm 
 
 
 
Table 3.1 (b):  The sizes of model tumors in Figure 3.13 measured in the direction 
perpendicular to the PEF array. 
Model 
Tumor  
Size in the direction perpendicular to the PEF array 
Measured  Actual  Error  
1 13.0±0.5 mm  11.5±0.3 mm  1.5 mm 
2 13.0±0.6 mm  10.3±0.3 mm  2.7 mm 
3 10.7±0.5 mm  7.8±0.2 mm  2.9 mm 
4 8.1±0.6 mm  6.2±0.2 mm  1.9 mm 
 
 
 
3.3.4 Depression Depth  
As the PEF casing was hand-held by an operator who then pushed the bottom 
of the PEF casing against the sample to facilitate the PEF elastic modulus 
measurements, different operators would not use the exact the same force. And 
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therefore, they would have different depression depths in the samples during 
measurements as illustrated in Figure 3.16.  
 
 
 
Figure 3.16 A schematic of the probe of PEF being pushed in with a depression depth 
during the measurement 
 
 
 
The effect of the depression depth has been examined in model tissues, which 
showed the size of the tumor determined by the PEF was essentially the same when 
the depression depth was 4 mm or larger. As an example, we show the photograph of 
a model breast tumor consisting of a suspended model clay inclusion embedded in 
gelatin in Figure 3.17 (a). The measured elastic modulus maps in green (for the elastic 
modulus of the normal tissue) and red (for the elastic modulus of the tumor) obtained 
using the PEF array breast tumor detection system with a 2-mm, 4-mm, and 6-mm 
depression depth are shown in Figure 3.17 (b)-(d), respectively. The actual size of the 
model tumor was 2.0 cm in the x (horizontal) direction and 2.1 cm in the y (vertical) 
direction. The distance from the top of the tumor to the gelatin surface was 8.4±0.4 
mm.  
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Figure 3.17 (a) A photography of the model tissue consisting of a suspended 
modeling clay in gelatin where the distance from the top of the tumor to the gelatin 
surface was 8.4±0.4 mm; elastic modulus map of the model tissue as measured by the 
PEF array with a (b) 2-mm, (c) 4-mm, and (d) 6-mm depression depth.  
 
 
 
To determine the size of the tumor in the x and y directions we examined the 
x- and y-elastic modulus profile around the tumor as follows. As an example, the 
elastic modulus profile versus x distance at y = 4 cm with 2-mm, 4-mm, and 6-mm 
depression depths is shown in in Figure 3.18. The elastic modulus profiles were then 
fit to a Gaussian form as indicated by the solid lines in the figure. The size of the 
tumor was then taken as the width of the Gaussian function at half the peak height. 
Using this method, we found the tumor size at y = 4 cm was 1.7±0.1 cm, 1.9±0.2 cm, 
(a) (b) 
(c) (d) 
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and 1.9±0.1 cm with a 2-mm, 4-mm, and 6-mm depression depth, respectively. As 
can be seen, with an experimental uncertainty of 0.2 cm, the estimated tumor size was 
essentially the same for all depression depth, which was especially true when the 
depression depth was 4 mm or larger. Also note that the estimated tumor size was 
very close to the actual tumor size in the x direction, 2 cm, indicating the accuracy of 
the methodology. Moreover, the base of the Gaussian curves which represented the 
elastic modulus of the normal tissue remained the same regardless of the depression 
depths, indicating that the elastic modulus of the normal tissue was independent of the 
depression depth. 
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Figure 3.18 Elastic modulus versus x distance at y = 4 cm of the tumor shown in 
Figure 3.17 obtained with a 2-mm, 4-mm and 6-mm depression depth. The solid lines 
represent the Gaussian fits of the elastic modulus profiles. The sizes of the tumors 
were determined as the widths at half the peak height of the Gaussian fits as 
1.7±0.1cm, 1.9±0.2cm, and 1.9±0.1cm for 2 –mm, 4-mm, and 6-mm depression 
depths, respectively. 
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The above conclusion for the model tumor shown in Figure 3.17 and for its x-
elastic modulus at y = 4 cm have been applied to other model tumors and their x- and 
y-elastic modulus profiles as well. Therefore, it suffices to say that the tumor size 
estimated with half peak method was independent of the depression depth and close 
to the actual tumor size.    
 
3.3.5 PEF simultaneous measurements 
Although one advantage of using a PEF array is that all PEFs can carry out 
measurements simultaneously, during the measurements mentioned in Section 3.3.2 
the PEFs in the array were activated sequentially to avoid the interference by the 
neighboring PEFs when more than one PEF were activated simultaneously. Studies 
have been done to investigate the interference of neighboring PEFs when they were 
doing the measurements at the same time.  
A pure gelatin sample with a concentration of 0.08 g/ml was made in this 
study. The PEF array hand-held probe was placed on the sample. PEFs were activated 
sequentially to measure the elastic modulus of the pure gelatin: the first PEF (PEF#1) 
in the array was activated and did the measurement, after that PEF #1 was deactivated 
and the second PEF (PEF #2) was activated to the measure the modulus. It continued 
until the fourth PEF (PEF #4) finished measuring. The hand held probe was then 
moved to the next location and the same procedure was performed. The moduli read 
from each PEF were averaged and are shown as black bars in Figure 3.19.  
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When two PEFs were activated simultaneously, there were two options. One 
was that two adjacent PEFs were activated at the same time: voltages were applied to 
PEF #1 and #2 at the same time and induced voltages from these two PEFs were 
obtained. Afterwards, PEF #3 and #4 were activated at the same time and the same 
tests were done. The moduli measured from each PEF are shown as red bars in Figure 
3.19. The other one was that two alternate PEFs were activated: voltages were applied 
to PEF #1 and #3 simultaneously and modulus measurements were done by them. 
Then PEF #2 and #4 were activated at the same time.  
Four PEFs could also be activated at the same time. The measured elastic 
moduli from each PEF were averaged and plotted in Figure 3.19 as well. When a 
single PEF was activated each time, the measured elastic modulus of the gelatin 
sample was about 8 kPa. When two PEFs were activated at the same time, the 
measured elastic modulus was a little smaller, about 7 kPa. However, when four PEFs 
were doing the measurement simultaneously, the calculated elastic modulus was only 
about 4 kPa. Therefore, it can be conclude that when PEFs were activated 
simultaneously the measured elastic moduli were different from those measured when 
PEFs were activated sequentially. It is quite reasonable. When voltages were applied 
to multiple PEFs, they bent at the same time pressing the sample and thus created an 
extra stress and strain in the sample. Therefore, the PEF would generate a different 
modulus values. The elastic moduli measured by two alternate PEFs were slightly 
larger than those by two adjacent PEFs, because the neighbor PEF would cause a 
larger effect on the location of the sample that is being measured. Besides, the PEFs 
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in the center (PEF #2 and #3) would give smaller modulus values than the PEFs at the 
end (PEF #1 and #4). It is due to the fact that the PEFs at the end had only one 
neighbor PEF, while the PEFs in the center had two neighbor PEFs and would receive 
more interference from them.  
Although using a PEF array has the potential to carry out measurements 
simultaneously, in the current study PEFs were activated sequentially. Studies using a 
PEF array that can mitigate the interference of neighboring PEFs and carry out 
simultaneous measurements can be a future study topic.  
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Figure 3.19 Elastic moduli measured by each PEF in the array when a single PEF, 
two adjacent PEFs, two alternate PEFs and four PEFs were activated.  
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3.4 In Vivo Breast Tumor Measurements 
3.4.1 Scanning Breast Tumors in vivo  
The in vivo testing was carried out on patients in a supine position as 
illustrated in Figure 3.12. It enrolled women 18 years of age and older seen in Dr. Ari 
Brooks’ clinical practice at Drexel University College of Medicine who have been 
diagnosed with a palpable breast mass or who have had an abnormal result in a breast 
imaging study from May 2011 to April 2012. Forty subjects were enrolled under an 
IRB approved protocol. A summary of the age, race, and tumor type distributions of 
these subjects is given in Table 3.2. 39 of the patients had a breast abnormality 
identified by either palpation, mammography, or ultrasound and 1 patient had no 
breast abnormality. In all patients, the operator had no knowledge if there was a 
tumor within the tested area nor did she know the location or the extent of the tumor. 
The accuracy of the PEF measurement was assessed by comparing with the PEF 
results with the pathology reports. The PEF results were also compared to those of 
mammography and other imaging modalities when available. 
 
 
 
Table 3.2 Summary of the 40 subjects in the in vivo study 
Age 
(20-77) 
 
20-40 
41-50 
51-60 
61-80 
15 
10 
8 
7 
Race 
African American 
Asian 
Caucasian 
24 
2 
14 
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Tumor Type 
Malignant 
Ductal carcinoma in situ (DCIS) 
Invasive ductal carcinoma (IDC) 
Benign 
   Cyst 
   Fibroadenoma 
   Adenosis stromal fibrosis 
   Apocrine metaplasia 
   Fat necrosis 
   Stromal fibrosis 
Usual ductal hyperplasia 
   Other 
No Tumor 
14 
2 
12 
25 
5 
7 
1 
1 
3 
1 
2 
5 
1 
 
 
 
As noted in Section 3.3.5, the PEFs in the current hand-held probe could not 
do measurements simultaneously. Due to the limited scanning time (30 minutes) of in 
vivo measurements, we carried out our study in four phases. In the beginning, a long 
duration time of 5 sec was used for each applied DC voltage to fulfill to the 
requirement of DC voltages. Under such conditions, only a quadrant of a breast could 
be completed in 30 min (Phase I, n=18). Because of this constraint, the surgeon 
would tell the operator which breast and which quadrant to test. Other than that, the 
operator had no knowledge if there was a tumor in that quadrant, or the size, or the 
location of the tumor. In Phase II (n=9) the duration of applied DC voltage was 
shortened to 3 sec. As a result, one half of a breast could be completed. Because of 
this, the surgeon would tell the operator which half of a breast to test. Other than that 
the operator did not know if there was a tumor in that half of a breast, or the location, 
or the size of the tumor. In phase III (n=7), we decreased the duration of the applied 
voltage to 2s so that a whole breast could be completed in 30 minutes. Because of this, 
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the surgeon would tell the operator which breast to scan. However, again the operator 
did not know if there was a tumor in that breast, or the location or the size of the 
tumor. In phase IV (n=6) we further reduce the duration of the applied DC voltage to 
0.8s. As a result, both breasts could be completed in 30 min. In this final phase, the 
operator would scan both breasts while having no knowledge as to whether there was 
a tumor in either breast, or the location, or the size of the tumor. Note that all testing 
protocols such as shortening of the DC voltage duration time or the automated data 
acquisition were all well validated in model tissue studies before testing in vivo.  
To create a coordinate system on a breast, a rectangular grid with a 1-cm 
increment was created on the breast with a washable marker. At each spot, the 
handheld unit was pressed against the breast with the same depression depth as 
marked on the outside of the housing. Three independent measurements were made to 
obtain an average and a standard deviation of the elastic modulus of the spot. The step 
size of the measurement was 7.5 mm in the x direction (which was parallel to the PEF 
array) and 1 cm in the y direction (which was perpendicular to the PEF array). The 
measurements were repeated until the entire assigned area was scanned. A 2-D elastic 
modulus map of the scanned area of the breast was then created with green 
representing the E values of the normal breast tissues and red representing the 
elevated E values of the tumors. This color-coded map allows the tumor to be easily 
identified and located.   
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3.4.2 Effect of Depression Depth  
During measurements, the handheld unit was pressed against the breast with a 
depression depth as illustrated in Figure 3.16. To examine the effect of the depression 
depth on the detection of the tumors, we examined the effect of different depression 
depths: 2 m, 4 mm, and 6 mm on the tumor size determination in 15 patients.  
As an example E versus x at y = 5 cm obtained with 2-mm, 4-mm, and 6-mm 
depression depths are shown as black full circles, red open squares, and blue full 
diamonds in Figure 3.20. The elastic modulus of the normal tissue did not change 
with depression depth. The larger measured modulus with a 6-mm depression depth 
than with a 2-mm depression depth at the center of the tumor was understandable 
since the PEF probe surface was now closer to the top surface of the tumor as a result 
of the larger depression depth. The data was then fitted to a Gaussian distribution 
(solid line). The size of the tumor with each depression depth was determined as the 
width at the half peak height of the Gaussian fit, which was 3.1 cm, 3.0 cm, and 3.2 
cm, respectively as shown in Figure 3.20, indicating that the choice of the depression 
depth did not alter the measured tumor size. The reason is that increasing the 
depression depth did not alter the elastic moduli of the normal tissues at the bottom of 
the bell-shaped curves but only heightened the elastic moduli within the perimeter of 
the tumor as the depression pushed the PEFs closer to the tumor.  
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Figure 3.20 The measured elastic modulus at y = 5 cm versus distance around a tumor 
center at x = 7 mm with a 2-mm, 4-mm, and 6-mm depression depth. 
 
 
 
For the 15 cases tested with three depression depths (2 mm, 4 mm, and 6 mm) 
during Phases I and II, PEF detected 16 out of 17 lesions with all three depths. The 
one lesion missed was due to the fact that the area with the lesion was not scanned. 
Furthermore, the sizes of the same tumor as determined by the three different 
depression depths were all within 10% of each other as similar to the results shown in 
Figure 3.20, indicating that for practical purpose, the measured tumor size was largely 
independent of the depression depth of 2 mm, 4 mm or 6 mm. Since the resultant 
tumor sizes were fairly insensitive to the choice of the depression depth, in the 
following, unless specified, all PEF measurements were carried out with a 4-mm 
depression depth. 
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3.4.3 Elastic Moduli of Breast Tumors and Normal Tissues in vivo 
The result of the PEF scan on each subject was presented as a color-coded 
elastic modulus (E) map on a breast in polar coordinates in angle (in o’clock) and 
distance (in centimeter) with the nipple as the origin. As an example, the E maps of 
four subjects obtained in phase I- IV are shown in Figure 3.21 (a)-(h), respectively. 
These represent two of the partial scans obtained in Phase I and Phase II due to the 
time limitation as mentioned above. The green color represents the elastic modulus 
values of the normal breast tissues ranging 8-11 kPa, and the red color represents the 
elevated elastic modulus values of ≥ 15 kPa (which was at least 35% larger than the E 
of the normal tissues). Note that most of the patients had an E value of the normal 
breast tissues ranging 8-11 kPa. Within the same patient the E values of the normal 
breast tissues were quite uniform with a standard deviation less than 15%. The E map 
in Figure 3.21(a) obtained in Phase I shows that PEF detected a 2.4 cm × 2.5 cm 
lesion at 3 o’clock on the border of nipple of Subject 1, which was consistent with the 
mammography result shown in Figure 3.21(b). The E map shown in Figure 3.21(c) 
detected two lesions in Subject 2: a 1.5 cm × 2.1 cm lesion at 5 o’clock and 4 cm 
from the nipple, and a 2.4 cm × 2.0 cm lesion at 7 o’clock and 4 cm from the nipple. 
These lesions were missed by the mammogram shown in Figure 3.21(d) but were 
eventually confirmed as two DCIS by the pathology report. Furthermore, Subject 2’s 
mammography report indicated that the breast was dense with a density score of 3-4. 
These results illustrate that PEF could detect tumors in dense breasts that were 
difficult to detect by mammography. It is of interest to note that the two lesions in 
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Subject 2 were also found by MRI (not shown). ). Figure 3.21(e) represents an E map 
of a complete scan of the left breast of Subject 3 obtained in Phase III which indicates 
a 1.9 × 1.3 cm lesion at 3 o’clock and 5 cm from the nipple. The lesion was only 
shown in craniocaudal projection of the mammogram (see Figure 3.21(f)) and 
confirmed by biopsy as invasive carcinoma. The E map obtained in Phase IV shown 
in Figure 3.21(g) detected a 1.9 × 2.1 cm lesion at 10 o’clock 6 cm from nipple in 
right breast of Subject 4 which was confirmed as invasive carcinoma by pathology. 
The same PEF measurement was performed on the left breast as well and the E map 
did not show any lesions in the scanned area (see Figure 3.21(h)).  
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Figure 3.21 The E map of the right breast of Subject 1 in Phase I indicating a 
2.4×2.5cm lesion at 3 o’clock on the border of nipple, consistent with an irregular 
mass with a spiculated margin in the subareolar region found in (b) the 
mammography of the same breast shown in (a); (c) the E map of the right breast of 
Subject 2 in Phase II, indicating a 1.5×2.1 cm lesion at 5 o’clock and 4 cm from 
nipple and a 2.4×2.0 cm lesion at 7 o’clock and 4 cm from nipple, both confirmed by 
pathology as DCIS but missed by (d) the mammography of the same breast shown in 
(c), which showed a dense breast with no visible sign of lesions; (e) the E map of the 
left breast of Subject 3 in Phase III, indicating a 1.9×1.3 cm lesion at 3 o’clock and 5 
cm from nipple, which was confirmed by biopsy as invasive carcinoma and shown by 
(f) the mammogram of the same breast in (e) with an irregular mass 5 cm from the 
nipple; (g) the E map of the right breast and (h) that of the left breast of Subject 4 in 
Phase IV obtained within 30 min indicating a 1.9×2.1 cm lesion at 10 o’clock 6 cm 
from the nipple of the right breast which was confirmed as invasive carcinoma by 
pathology report while no lesions in the left breast. 
 
 
 
Denoting the maximum elastic modulus (E) measured by PEF using Equation 
3-4 within the region above the tumor as Et, and the elastic modulus of the normal 
breast tissue away from the tumor as En, Et (various colored symbols) and En (open 
Nipple 
(e) 
1cm 
Nipple 
(g) 
1cm 
Nipple 
(h) 
1cm 
(f) 
 84 
squares) of the 40 subjects versus subject age are plotted in Figure 3.22. Note that Et 
was the effective elastic modulus of the tumor embedded/surrounded by normal 
breast tissues. The actual elastic modulus was not measurable in an in vivo study as 
the breast tumors were not removed from the patients. As can be seen from Figure 
3.22, for all the 40 subjects, En hovered around 10 kPa while Et for all tumors were 
much larger than En for all patients from Phase I to IV.  
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Figure 3.22 Et, En versus age where En is the elastic modulus of the normal breast 
tissues and Et is the maximum elastic modulus of the tumor region.  
 
 
 
The distributions of Et (red circles) and En (black squares) are further plotted 
in Figure 3.23. The solid and dashed lines are the fitted Gaussian distributions. Figure 
3.22 and Figure 3.23 together indicate that the distribution of Et and that of En barely 
overlapped. To further illustrate the separation of Et and En, the ratio Et/En of the 
same patient versus patient age is shown in Figure 3.24 where the En was normalized 
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as unity for each patient. Clearly, Et/En was well separated from unity with a cutoff of 
about Et/En=1.35, indicating that Et was larger than En by at least 35%, which was 2.3 
times larger than the standard deviation of En (not shown). Therefore, we used 
Et/En=1.35 as a cutoff for tumors, i.e., the values of the Et/En of all the tumors 
identified in this study were larger than or equal to 1.35.  This cutoff worked well for 
all ages and the p value of the t test between Et and En was much smaller than 0.001 
indicating they are indeed different. Besides, Figure 3.24 shows that the malignant 
tumors (n=17), including both IC (n=14) and DCIS (n=3) appeared to have a higher 
Et/En than benign tumors (n=39). It was reflected in a larger averaged Et/En of 
malignant tumors which was 2.33±0.55 (open circles and triangles) than that of 
benign tumors which was 1.93±0.49 (crosses). Although the measured Et could 
depend on both the E of the tumor and how close the tumor was to the breast surface, 
by averaging over a sufficient number of tumors, a larger averaged Et/En for the 
malignant tumors than for the benign tumors may reflect that malignant tumors are 
stiffer than benign tumors, which was consistent with the finding in the earlier ex vivo 
studies [29].    
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Figure 3.23 Distribution of En and Et where En is the elastic modulus of the normal 
breast tissues and Et is the maximum elastic modulus of the tumor region based on 
lesions of the 40 subjects. The solid line and dashed lines are the fitted Gaussian 
distributions for En and Et, respectively. 
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Figure 3.24 Et/En versus patient age of 40 subjects where Et is the maximum elastic 
modulus of the tumor region and En the elastic modulus of the normal breast tissues. 
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3.4.4 PEF Detection Sensitivity  
In the 40 subjects enrolled in the study, a total of 48 lesions were confirmed 
by pathology or other imaging modalities such as mammography, ultrasound, and 
MRI. PEF detected 20 out of 20 lesions (20/20) in phase I, 10 of 11 lesions (10/11) in 
phase II, 7 out of 8 lesions (7/8) in phase III, and 9 of 9 lesions (9/9) in phase IV. As 
can be seen, PEF detected all the lesions in Phase I and Phase IV and missed only 1 
lesion which was malignant in Phase II and 1 lesion which was benign in Phase III.   
The reason that PEF missed a malignant lesion in Phase II was because PEF scanned 
only half of the breast and did not scan the part containing the lesion while the missed 
benign tumor in Phase III was a nonpalpable lesion detected mammography. Clearly, 
as PEF progressed to faster scans with a shorter duration of each applied voltage, the 
detection accuracy remained consistent through the four phases, indicating that the 
shortened duration time of each applied DC voltage did not affect PEF’s detection 
sensitivity. With all four phases, PEF detected 45 of the 47 lesions (45/47) including 
15 malignant lesions (15/16) with only 1 missed malignant tumor in Phase II and 1 
missed benign tumor in Phase III as explained above. A breakdown of the detection 
sensitivity in terms malignant or benign lesions in each of the phases is shown in 
Table 3.3.  
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Table 3.3 Detection sensitivity of PEF in different phases in terms of lesions and 
patients 
 
Detection sensitivity in terms of 
lesions 
Detection sensitivity in terms of 
patients 
 
Lesions 
detected by 
PEF 
Malignant 
lesions detected 
by PEF 
Patients 
detected by 
PEF 
Malignant 
patients detected 
by PEF 
Phase I 20/20 (100%) 7/7 (100%) 18/18 (100%) 6/6 (100%) 
Phase III 10/11 (91%) 5/6 (83%) 8/9 (89%) 4/5 (80%) 
Phase III 7/8 (88%) 2/2 (100%) 5/6 (83%) 2/2 (100%) 
Phase IV 9/9 (100%) 1/1 (100%) 6/6 (100%) 1/1 (100%) 
Total 46/48 (96%) 15/16 (94%) 37/39 (95%) 13/14 (93%) 
 
 
 
 
3.4.5 Comparison of PEF Tumor Detection sensitivity with Mammography  
We compared the tumor detection sensitivity of PEF with that of 
mammography among the 28 patients who had mammography records throughout 
each of the four phases.  Because we had different number of patients in different 
phases, the PEF detected 17/17, 7/8, 4/5, and 3/3 lesions for phase I-IV, respectively 
and 31/33 overall while mammography detected 16/17, 6/8, 5/5, and 3/3 lesions for 
the corresponding phases and 30/33 overall. Overall, PEF detected about the same 
numbers of lesions as mammography for patients with mammography records, 
indicating that PEF do not generate more false positives than mammography. We also 
compare the detection sensitivity of malignant tumors between PEF and 
mammography in Table 3.4 for patients with mammography records as well. The PEF 
detected 7/7, 5/6, 1/1, and 1/1 malignant lesions for phase I-IV, respectively and14/15 
(93%) overall while mammography detected 6/7, 4/6, 1/1, and 1/1 malignant lesions 
for phases I-IV, respectively and 12/15 (80%) overall. Note the one malignant tumor 
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missed by PEF in phase II was because PEF did not scan that half of the breast. That 
PEF had higher malignant tumor detection sensitivity (93%) than mammography 
(80%) while had similar all-tumor detection sensitivity with mammography indicates 
that PEF could detect malignant tumors not detectable by mammography without 
significantly increasing false positives.  
 
 
Table 3.4 Detection sensitivity of PEF and Mammography based on 28 patients with 
mammography reports 
 Detection sensitivity of PEF Detection sensitivity of 
Mammography 
Total lesions 
detected by 
PEF 
Malignant 
lesions detected 
by PEF 
Total lesions 
detected by 
mammography 
Malignant lesions 
detected by 
mammography 
Phase I 17/17 (100%) 7/7 (100%) 16/17 (94%) 6/7a (86%) 
Phase II 7/8 (88%) 5/6 (83%) 6/8 (75%) 4/6b (67%) 
Phase III 4/5 (90%) 1/1 (100%) 5/5 (100%) 1/1 (100%) 
Phase IV 3/3 (100%) 1/1 (100%) 3/3 (100%) 1/1 (100%) 
Total 31/33 (94%) 14/15 (93%) 30/33 (91%) 12/15 (80%) 
a
 Mammography missed 1 invasive carcinoma  
b Mammography missed 2 DCIS as shown in Figure 3.21 (d) 
 
 
 
We also compared the locations of the lesions found in these 28 
mammography reports as determined by PEF and by mammography. The position of 
a tumor determined by a different method may differ due to the fact that breasts are 
soft and movable and different methods may manipulate the breasts differently and 
thus produce somewhat different tumor locations. For example, PEF and US 
examined un-compressed breasts when the patients are supine while mammography 
and MRI require breasts to be compressed between two plates when the patients are 
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standing or on the stomach and pathology examined surgically excised breast tissues 
ex vivo. Because PEF does not require compressing a breast between two plates like 
mammography or MRI, the location, i.e., polar angle in o’clock determined by PEF 
may not be the same as that determined by mammography. For these reasons, we 
allowed some angular tolerance when comparing the tumor locations found by PEF to 
those found by mammography. With the 2 o’clock tolerance, we found that the 
locations determined by PEF agreed with those determined by mammography among 
tumors found by both PEF and mammography.  
3.4.6 Comparison with Palpation  
Compared to palpation, PEF detected 32/32 palpable tumors (11 malignant 
and 21 benign). More importantly, PEF detected 12 of the 14 non-palpable lesions 
(12/14) including 2 of 3 non-palpable cancers (2/3). As mentioned above, one non-
palpable malignant lesion was not scanned by PEF in phase II because PEF did not 
scan the area containing the tumor. Not counting this one, the sensitivity for the non-
palpable lesions would be 92% (12/13) instead of 86% (12/14). 
3.4.7 Tumor Size Comparison with Pathology  
To determine the size of the tumor at a certain y location, the elastic modulus 
at that y value was plotted versus x distance. The data was then fitted to a Gaussian. 
The size of the tumor at that y value was determined as the width at the half peak 
height of the Gaussian fit distribution. The size of the tumor in the y direction at a 
certain x was obtained in a similar fashion. As an example the elastic modulus versus 
x distance at y = 5 cm obtained with a 4-mm depression under the handheld probe on 
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patient is shown in Figure 3.20. The size of the tumor at y= 5 cm was determined as 
the width at the half peak height of the Gaussian fit, 3.0 cm. The reported tumor sizes 
in the x and y directions were the largest in those directions.  
The tumor sizes determined by the PEF array system were compared with 
those reported in the pathological reports which were available only for malignant 
tumors. Since the orientation of the tumor during PEF measurement might not be 
exactly the same as that during pathological analysis, we defined the size of the tumor 
as the largest dimension by both the PEF and pathology. The size determined by PEF 
versus the size by pathology is plotted in Figure 3.25. The size of the smallest cancer 
PEF detected was 0.5 cm. For some of the cancers (6/11), the size obtained by PEF 
was the same as that determined by pathology, for others (4/11) PEF indicated a 
larger size than pathology. Since PEF was able to determine the model tumor sizes 
fairly accurately, the larger size obtained by PEF for some of the cancers might be the 
manifestation of the stroma surrounding the cancer as stroma was made of collagens 
which were also stiffer than normal breast tissues. Note that in one subject, the size 
determined by PEF was 5.9±0.5cm, which was much larger than the pathological size 
of 1.3 cm. This was because the patient had three cancerous lesions that were close to 
one another. The sizes of these three lesions were 1.3cm, 0.7cm, and 0.4 cm from 
pathology report. Because they were close together, PEF could not resolve them as 
separate tumors. As a result, the PEF size was much larger than the size determined 
by pathology.  
 92 
0 2 4 6 8 10
0
2
4
6
8
10
S
iz
e
 m
e
a
s
u
re
d
 b
y
 P
E
F
(c
m
)
Size from pathology (cm)
 
Figure 3.25 Tumor size determined by PEF versus tumor size measured by pathology. 
 
 
 
3.4.8 Breast Density  
PEF uses tissue elastic modulus contrast, i.e., Et/En instead of density contrast 
to detect tumors. Therefore, the sensitivity of PEF does not depend on the 
mammography density of the breast. To illustrate this point, the patients were divided 
into two groups, low-density group (with density score 1 or 2) and high density group 
(density score 3 or 4) and En and Et versus patient number were separate into these 
two groups in Figure 3.26. The breast density score is classified using BI-RADS 
(American College of Radiology Breast Imaging Reporting and Data System) scoring 
system. Density score 1 indicates that the breast is entirely fat and grade 4 means the 
breast is extremely dense. The result shows that denser breasts had a larger En. 
However, for all density scores, the Et, were well separated from En, indicating that 
PEF was able to detect tumors in both dense breasts and non-dense breasts. 
Remarkably, PEF detected tumors with 100% sensitivity in women 40 years old or 
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younger who generally have dense breasts and for whom mammography is not very 
sensitive [159]. Combining this with the results PEF detected more malignant tumors 
than mammography (Section 3.4.5) without significantly increasing false positives 
indicates that PEF could be a potential tool for detection breast cancer in young 
women and women with dense breasts. 
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Figure 3.26 Maximum elastic modulus of tumor region, Et, and elastic modulus of 
normal tissues, En, versus mammography density score. 
 
 
 
 
3.5 Conclusions 
Piezoelectric finger (PEF) is a piezoelectric cantilever, with two piezoelectric 
layers glued onto top and bottom of a stainless steel substrate, which can measure the 
elastic modulus of a soft material or tissue using indentation offering the potential to 
palpate electrically on samples like a finger. A portable PEF array breast tumor 
detection system which consists of a hand-held probe with 4×1 PEF array, an 
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electrical board and a laptop has been developed for in vivo breast tumor detection. 
Towards the goal, a hand-held acrylic box was designed to hold the PEF array and 
prevent overloading pressure on the PEFs from the operator’s pushing. Custom 
software was developed in LabVIEW to acquire, analyze, display, and record the 
elastic moduli of tissue in real time. The effect of the duration of each applied DC 
voltage was examined and eventually shortened from 5 s to 0.8 s that towards the end 
of the study, both breasts could be scanned within 30 minutes.  
The PEF breast tumor detection system was tested on model breast tumors 
consisting of a gelatin matrix with modeling clays inclusions. A two dimensional 
color coded elastic modulus map was created based on the measurement results. 
Green color represents the elastic of the gelatin matrix while red color represents the 
elevated elastic modulus of the modeling clay. It shows that PEF array system indeed 
detected all the model tumors and the locations of model tumors determined by the 
PEF array system also agreed with their actual locations. Moreover, the effect of the 
depression depth was examined in model tissues, which showed the size of the tumor 
determined by the PEF was essentially the same when the depression depth was 2 mm, 
4mm, and 6 mm.  
The in vivo investigation was carried out in the form of blind tests out on 40 
subjects who were in a supine position.  The tests were carried out in four phases: 
with DC voltage durations 5, 3, 2, to 0.8 sec corresponding to scanning a quadrant, a 
half, a whole breast, and both breasts within in 30 min, respectively. The detection 
results for all four phase were similar, indicating that faster measurements did not 
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affect the accuracy of the measurements. It is also shown that for the 15 cases tested 
for depression depths of 2-6 mm the detection results in terms of detection sensitivity 
and tumor size were unaffected by different depression depths.  
Overall, PEF detected 46 of the 48 lesions (46/48) in 40 patients enrolled in 
the study. The smallest malignant tumor detected by PEF in this study was 5 mm. For 
the 28 patients with mammography reports, PEF detected 31/33 of all lesions and 
14/15 of malignant lesions as compared with 30/33 of all lesions and 12/15 of 
malignant lesions by mammography, indicating that PEF could detect malignant 
tumors not detectable by mammography without significantly increasing false 
positives. In addition, PEF detected 100% of palpable and 67% non-palpable 
malignant tumors, suggesting PEF was capable of detecting both palpable and non-
palpable lesions in vivo. The tumor sizes estimated by PEF were larger than those 
determined by pathology, likely a manifestation of the hard stroma surrounding the 
cancer. Furthermore, PEF detection was independent of breast density, suggesting 
that PEF could be a potential tool for detecting breast cancer in young women and 
women with dense breasts. 
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4. DETERMINE THE DEPTH PROFILE OF MODEL BREAST TUMORS  
Accurate preoperative assessment of breast tumor locations and sizes in 3D 
are important for both biopsies and surgeries. Ideally, if there is a technique that can 
detect not only the presence but also the 3D location and size of the tumor, it will help 
with more accurate biopsies and surgeries. It is well known that breast tumors are 
stiffer compared with the surrounding normal tissue. The PEF array has shown to be 
able to detect breast tumors in vivo and determine the 2D locations and sizes of the 
tumors. Previous study has shown that the depth sensitivity of a PEF depends on the 
width of the contact. In other words, with a larger contact size a PEF can assess the 
elastic response of deeper tissues. Therefore, a set of PEFs of different contact sizes 
have the potential to provide the stiffness profile in depth direction and determine the 
tumor depth.   
In this chapter, the depth profile of model breast tumors are determined based 
on the elastic modulus measurements from a set of PEFs of different contact sizes. 
Firstly, the depth sensitivity of a PEF which measures how deep a PEF can detect is 
determined empirically. Then a 2-spring model is used to deduce the depth profile of 
bottom supported model breast tumors from PEF measurements and compared with 
an inversion technique using finite element analysis (FEA). The model is further 
extended to 3 springs for suspended breast tumor depth profiling and the 3D image of 
the tumor is constructed.  
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4.1 Depth Sensitivity of a PEF 
The depth sensitivity of a PEF is defined as the depth beneath the surface at 
which the elastic modulus of the tissue can be measurable by the PEF on the surface. 
In previous studies with a single PEF without a housing, the depth sensitivity of a 
PEF was shown to be about the twice of the contact width. However, it is unknown 
whether the depth sensitivity of a PEF will change if it is placed in the housing. 
Therefore, the depth sensitivity of PEFs with different contact sizes in the housing 
were determined. For this purpose different depths of modeling clay inclusions were 
embedded in gelatin matrix and PEFs of different contact sizes in the housing were 
used to measure the elastic moduli over the gelatin and inclusions. If the inclusion is 
within the depth sensitivity of a PEF, the PEF should be able to differentiate the 
effective modulus of the inclusion from the modulus of surrounding gelatin.  
Four PEFs were used in the study. PEF A was 4.1±0.2 mm wide, PEF B was 
6.5±0.2 mm wide, PEF C was 8.2±0.2mm wide, and PEF D was 9.8±0.3mm wide. 
All the four PEFs had two 127 µm thick lead zirconate titanate (PZT) layers (T105-
H4E-602, Piezo Systems Inc., Cambridge) bonded to a 50 µm thick stainless steel 
(Alfa Aesar, War Hill, MA) layer using a nonconductive epoxy (Henkel Loctite, 
Westlake, OH) at the edges and a small patch of conductive epoxy (ITW Chemtronics, 
Kennesaw, GA) at the center. The PZT layer on the top of the stainless steel was used 
as driving electrode, and the PZT layer on the bottom of the stainless steel was 
sensing electrode as schematically shown in Figure 3.1 (a) and explained in great 
detail in Section 3.1. The driving PZT layers were 22.3±0.3 mm, 22.6±0.4 mm, 
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22.1±0.4 mm, and 22.4±0.4mm long and the sensing PZT layers were 10.1±0.3 mm, 
10.5±0.3 mm, 10.3±0.4 mm, and 10.6±0.3 mm for PEFs A, B, C, and D, respectively, 
as shown in Table 4.1. Stainless strips were bent into rectangular loops and glued to 
the free end of the cantilever using the nonconductive epoxy. The width of the 
rectangular loop was equal to the width of the PEF.  
During the measurement, the PEFs were clamped in the acrylic housing as 
shown in Figure 3.6 in Section 3.2.1. The contact area of the stainless loop to the 
sample was a square with each side equal to the width of the PEF. For PEFs A, B, C, 
and D, the contact areas of the stainless loops to the samples were 16±2 mm2, 42±3 
mm2, 67±4 mm2, and 96±6 mm2, respectively. As the square stainless tip cross 
section was much smaller than the sample surface, the contact area of the square 
stainless loop was defined as the area of indentation.  
 
 
Table 4.1 The dimensions of the PEFs used to determine the depth sensitivity 
PEF 
cantilever 
Contact 
width 
(mm) 
Length of 
driving PZT 
(mm) 
Length of 
sensing PZT 
(mm) 
Contact 
area 
(mm2) 
A 4.1±0.2 22.3±0.3 10.1±0.3 17±2 
B 6.5±0.2 22.6±0.4 10.5±0.3 42±3 
C 8.2±0.2 22.1±0.4 10.3±0.4 67±3 
D 9.8±0.3 22.4±0.4 10.6±0.3 96±6 
 
 
 
To examine the depth sensitivity of PEFs in the housing, a model consisting of 
gelatin matrix (Now Foods, Bloomingdale, IL) and modeling clay (Crayola, Easton, 
PA) inclusions, with known elastic moduli (60 kPa) were built. The inclusions were 
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bottom supported and buried at various depths underneath the surface of the gelatin. 
PEF measurements were carried out on the gelatin surface above the center of each 
inclusion to determine the effective elastic modulus of the model tissue which 
included the gelatin on the top and the modeling clay inclusion at the bottom. As the 
bottom-supported inclusions became too deep below the surface and it was beyond 
the depth sensitivity of the PEF, the effective modulus would converge to the elastic 
modulus of the gelatin matrix. The depth sensitivity limit of a PEF was therefore 
determined as the depth of the modeling clay inclusion which was defined as the 
distance from the gelatin surface to the top surface of the inclusion. Beyond this depth, 
the effective elastic modulus measured by the PEF was indistinguishable from that of 
the gelatin matrix.  
As an example, a schematic of the model A is shown in Figure 4.1. Ten 
cuboid inclusions, each with 16±0.5 mm by 16±0.5 mm in top surface but a different 
height, were put on the bottom of the container. The gelatin matrix was prepared by 
mixing the gelatin powder in water with a concentration of 0.06 g/ml at 80 °C on the 
hot plate and stirring for 10 minutes. The mixture was poured into the container and 
cooled in 4 °C refrigerator for 10 minutes to solidify. Before the measurement, the 
sample was left in room temperature for 1 hour to equilibrate. The total height of the 
model was 24±0.5 mm and the depths of the inclusions were 2.1±0.3 mm, 4.0±0.3 
mm, 6.1±0.4 mm, 8.2±0.4 mm, 10.1±0.3 mm, 12.0±0.3 mm, 14.2±0.4 mm, 15.9±0.4 
mm, 17.8±0.4 mm, and 20.1±0.5 mm.  
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Figure 4.1 A schematic of the model A with bottom supported clay inclusions 
embedded at different depths in the gelatin 
 
 
 
To experimentally determine the depth sensitivity of the PEFs, elastic 
modulus measurements were carried out at the gelatin surface above the centers of the 
bottom supported modeling clay inclusions using the breast tumor detection system 
and the LabVIEW as described in Chapter 3. The measured effective elastic moduli 
of the model tissue above the center of the modeling clay inclusions were plotted 
versus the known depths of the inclusions for PEFs A (green), B (blue), C (red), and 
D (black) in Figure 4.2. As can be seen from the figure, the measured effective elastic 
modulus decreased with an increase in tumor depth and saturated at about 5 kPa, 
which was the elastic modulus of the gelatin matrix as marked by two horizontal 
magenta dashed lines in Figure 4.2. The PEF’s depth sensitivity was empirically 
defined as the largest depth at which the measured effective elastic modulus on the 
gelatin surface was larger than and distinguishable from the elastic modulus of gelatin 
matrix. Using this criterion, the depth sensitivity of PEFs A, B, C, and D were 8.3, 
12.0, 14.2, and 17.8 mm, respectively. The uncertainty of the determined depth 
sensitivity was about 2 mm, since the difference between the depths of adjacent clay 
Gelatin Clay inclusion 
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inclusions was 2 mm. To reduce the uncertainty, the effective elastic modulus 
measured by the PEF was plotted versus the depths of the inclusions and fitted to an 
exponential function as shown in Figure 4.3. The elastic modulus of the gelatin 
matrix was about 5 kPa and marked as shaded area in the figure. The depth sensitivity 
of this PEF was determined as the depth at which the fitted curve encountered the 
range of elastic modulus of the gelatin matrix. Using this criterion, the depth 
sensitivity of PEF A was determined to be 8.3±0.3 mm. With the same method, the 
depth sensitivity of PEF B, C, and D were determined to be 13.4±0.4, 16.3±0.4, and 
18.7±0.5 mm, respectively.  
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Figure 4.2 Effective elastic modulus of bottom-supported modeling clay inclusions 
(16 mm by 16 mm in top surface) embedded at various depths in a gelatin matrix 
using PEFs with different contact widths. The dashed area showed the range of the 
gelatin matrix (En = 5 kPa). 
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Figure 4.3 Effective elastic moduli of bottom-supported modeling clay inclusions 
embedded at various depths in a gelatin matrix measured by PEF A (a), PEF B (b), 
PEF C (c) and PEF D (d) and fitted to an exponential function. 
 
 
 
The dependence of the depth sensitivity on the PEF width (the length or width 
of the contact) is summarized in Figure 4.4 where the depth sensitivity is plotted 
against PEF contact width. As can be seen, the depth sensitivity is linear with PEF 
contact width with a slope of about 2 (R2=0.998), indicating that the depth sensitivity 
of a given PEF in the housing is about twice its contact width, consistent with 
previous studies with a single PEF.   
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Figure 4.4 Depth sensitivity versus contact size of the PEF fitted to a linear function 
(red line) 
 
 
 
4.1.1 Effect of Elastic Modulus of Normal Tissue 
It is unknown that whether the elastic modulus of normal tissue would affect 
the depth sensitivity of the PEF or not. To answer it, different depths of modeling 
clay inclusions were embedded in a different concentration of gelatin matrix and 
PEFs of different contact sizes were used to measure the elastic moduli over the 
gelatin and inclusions. The depth sensitivity of PEFs were determined with the 
method described in Section 4.1 and compared with those shown in Figure 4.4.  
The same four PEFs were used as shown in Table 4.1. Similar to Model A, 
Model B was built consisting of gelatin matrix (Now Foods, Bloomingdale, IL) and 
modeling clay (Crayola, Easton, PA) inclusions, with known elastic moduli (60 kPa). 
The ten inclusions had the same size with those in Model A and they were bottom 
supported and buried at various depths underneath the surface of the gelatin. The 
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gelatin matrix was prepared by mixing the gelatin powder in water with a 
concentration of 0.12 g/ml so the elastic modulus of the gelatin matrix in Model B 
after solidifying is about 10 kPa, about twice the elastic modulus of the gelatin matrix 
in Model A. These elastic moduli were consistent with the elastic modulus of normal 
breast tissues reported in literature and in Chapter 3. PEF measurements were carried 
out on the gelatin surface above the center of each inclusion. The effective elastic 
moduli of the model tissue were determined, plotted versus the depths of the 
inclusions (as shown in Figure 4.5), and fitted to an exponential function. The depth 
sensitivity of PEFs were defined as the depth at which the fitted curve come across 
the elastic modulus of the gelatin matrix. With this method, the depth sensitivity of 
PEFs A, B, C, and D were determined to be 8.5±0.3, 13.1±0.4, 16.6±0.4, and 
18.9±0.4 mm, respective.  
We further plot the depth sensitivity of PEFs when the elastic modulus of 
gelatin (En) was 10 kPa with those when En was 5 kPa in Figure 4.6. As can be seen, 
the depth sensitivity of PEFs when En was 10 kPa were about the same with those 
when En was 5 kPa, twice the contact width of the PEF. Therefore, we can conclude 
that the depth sensitivity of PEFs do not change with the elastic modulus of gelatin 
matrix (normal tissue).  
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Figure 4.5 Effective elastic modulus of bottom-supported modeling clay inclusions 
(16 mm by 16 mm in top surface) embedded at various depths in a gelatin matrix 
using PEFs with different contact widths. The dashed area showed the range of the 
gelatin matrix (En = 10 kPa).  
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Figure 4.6 Depth sensitivity versus the contact size of the PEF when elastic modulus 
of gelatin (En) was 5 kPa (blank) and 10 kPa (shaded) respectively. 
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4.1.2 Effect of Elastic Modulus of Tumor 
To illustrate the effect of the elastic modulus of tumor in determining the 
depth sensitivity of PEFs, different depths of modeling clay inclusions with various 
known elastic moduli were buried in a gelatin matrix and the effective elastic moduli 
over the gelatin and inclusions were measured using PEFs of different contact widths. 
The depth sensitivity of PEFs was determined based on the measurement results and 
compared.  
The same four PEFs were used as shown in Table 4.1. Similar to Model A and 
B described in Section 4.1.1, the models used in this section were built consisting of 
gelatin matrix and modeling clay inclusions. The elastic moduli of the modeling clay 
inclusions were 38, 60 and 145 kPa, which were similar to those of breast tumors 
measured ex vivo using PEF reported in Ref. [151]. In addition, these choices were 
consistent with the elastic modulus of breast tumors reported in the literature, which 
were 3-33 kPa and 6-107 kPa, respectively [81, 83, 155-158] as shown in Table 1.2. 
The inclusions had the same size with those in Model A and they were bottom 
supported and embedded at different depths underneath the surface of the gelatin 
matrix, which was prepared by mixing the gelatin powder with water with a 
concentration of 0.06 g/ml. After the gelatin was solidified, the elastic modulus of the 
gelatin matrix was about 5 kPa, the same with that in Model A. The effective elastic 
modulus on the gelatin surface over the center of each inclusion was measured by the 
four PEFs, plotted versus the known depth of the inclusion and fitted to an 
exponential decay function. When the fitted curve met the range of the elastic 
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modulus of the gelatin matrix, the corresponding depth was defined as the depth 
sensitivity of the PEF. By this means, the depth sensitivity of the four PEFs were 
determined when the elastic moduli of the clay inclusions were 38, 60, and 145 kPa, 
respectively and plotted in Figure 4.7. The dashed line in the figure had a slope of 2. 
It can be seen clearly that no matter whether the elastic modulus of the clay inclusion 
(Et) was 38, 60 or 145 kPa, the depth sensitivity of each PEF was about twice the 
width (contact width) of the PEF, indicating the depth sensitivity of PEFs is not 
affected by the elastic modulus of inclusions (tumors).  
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Figure 4.7 Depth sensitivity versus the contact width of the PEF when elastic 
modulus of clay inclusion (Et) was 38 kPa (black square), 60 kPa (red circle) and 145 
kPa (green triangle). The blue dashed line had a slope of 2.  
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4.1.3 Effect of Tumor Size 
When we determine the depth sensitivity of the PEF, a larger size in top 
surface of the inclusion may introduce a larger effective elastic modulus measured by 
the PEF, which would make it more distinguishable from the gelatin matrix. In this 
case, the depth sensitivity of the PEF determined using the method describe in 
Section 4.1, which compares the fitted effective elastic modulus with the background 
elastic modulus of the gelatin matrix, would be larger. Therefore, the depth sensitivity 
of the PEF with this method may be affected by the size of the inclusions (tumors). 
To study this effect, models consisting of modeling clays with known elastic modulus 
(60 kPa) and various sizes in top surfaces and gelatin matrix were built. The effective 
elastic modulus measurements were done by PEFs of different contact widths on the 
gelatin surface with inclusions underneath and the depth sensitivity of these PEFs 
were determined based on the measurement results and compared.  
Four PEFs were used in this section and the sizes are shown in Table 4.1. 
Similar to previous models in this chapter, the models used in this section were built 
consisting of gelatin matrix and modeling clay inclusions. The elastic modulus of the 
modeling clay inclusions was 60 kPa and the gelatin matrix had a concentration of 
0.06 g/ml. After solidified, the elastic modulus of the gelatin matrix was about 5 kPa. 
The cuboid clay inclusions had a top surface of 16×16 mm2, 5.5×5.5 mm2, and 
3.0×3.0 mm2 and different heights. They were bottom supported and the depths of 
these inclusions, which were defined as the distance from the gelatin surface to the 
top of the inclusion, ranged from 2 mm to 20 mm with a 2-mm increment. The 
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effective elastic modulus which was measured by PEFs on the gelatin surface over 
the center of each inclusion was plotted versus the known depth of the inclusion as 
shown in Figure 4.3, Figure 4.8 and Figure 4.9 for inclusions with a top surface of 
16×16 mm2, 5.5×5.5 mm2, and 3.0×3.0 mm2, respectively. The data was then fitted to 
the exponential decay function. The depth sensitivity of the PEF was defined as the 
depth at which the fitted curve met the band of the elastic modulus of the gelatin 
matrix. In this way, the depth sensitivity of the four PEFs were obtained with 
different sizes in the top surface of the inclusions and plotted in Figure 4.10. 
Obviously, the depth sensitivity of the PEFs determined from small inclusions 
(3.0×3.0 mm2, green triangle) were less than those determined from large inclusions 
(16×16 mm2, black square). The depth sensitivity of the PEFs from 16×16 mm2 
inclusion was twice the contact widths of the PEFs indicated by the blue dashed line 
in the figure, while the those from 3.0×3.0 mm2 was only about 1.65 times the contact 
widths of the PEFs, which was illustrated by the magenta dot line. The 5.5×5.5 mm2 
inclusion gave the depth sensitivity similar to the 16×16 mm2 inclusion. As can be 
seen from Section 3.3.1, most of the breast tumors detected by PEFs in the in vivo 
study were larger than 10 mm. Therefore, it is safe to say that the depth sensitivity of 
the PEF is about twice the contact widths when we use the PEFs of different contact 
sizes to determine the depth profile of the breast tumors that have been detected by 
the PEFs.  
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Figure 4.8 Effective elastic modulus of bottom-supported modeling clay inclusions 
(5.5 mm by 5.5 mm in top surface) embedded at various depths in a gelatin matrix 
using PEFs with different contact widths. The dashed area showed the range of the 
gelatin matrix (En = 5 kPa).  
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Figure 4.9 Effective elastic modulus of bottom-supported modeling clay inclusions 
(3.0 mm by 3.0 mm in top surface) embedded at various depths in a gelatin matrix 
using PEFs with different contact widths. The dashed area showed the range of the 
gelatin matrix (En = 5 kPa). 
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Figure 4.10 Depth sensitivity versus the contact size of the PEF when the top of the 
clay inclusions were 16×16 mm2 (black square), 5.5×5.5 mm2 (red circle), and 
3.0×3.0 mm2 (green triangle). The blue dashed line had a slope of 2 and the magenta 
dot line had a slope of 1.65 
 
 
 
4.2 Determine the Depth Profile of Bottom Supported Model Breast Tumors  
Since the depth sensitivity of a PEF in the housing is about twice the width of 
the contact, a PEF with a larger contact width can measure the elastic response from 
deeper tissues. Based on the effective elastic modulus measurement results on the 
same sample using a set of PEFs with different contact sizes, we should be able 
deduce the depth profile of breast tumors.  
It is known that the effective elastic modulus measured by indentation on the 
surface of the breast depends on the elastic modulus of normal breast tissue (En), the 
elastic modulus of tumor underneath (Et), and the size and depth of the tumor. And 
thus, deducing the depth profile of the tumor from the measured effective elastic 
modulus is an inverse process. Using PEFs with different contact sizes, the effective 
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elastic modulus can be directly obtained. The elastic modulus of normal breast tissue 
can be acquired by using PEFs on regions without tumors. The lateral size of the 
breast tumor is easily calculated based on the effective elastic modulus of the entire 
breast as explained in detail in Section 3.3.3. The elastic modulus of tumor is 
unknown because the tumor is embedded in the tissue and the depth profile of the 
tumor is what we want to know. A spring model in which the effective elastic 
modulus is calculated using an equation similar to the one for effective spring 
constant when two springs are connected in series is developed to deduce the depth 
profile in this section. It is applied to bottom supported model breast tumors and the 
results are compared with those obtained by an iterative technique that simulates the 
indentation experiment in each iteration until finding the depth profile of the tumor 
that has the same effective elastic moduli with the ones measured by PEFs. The 
spring model is then extended and applied to suspended model breast tumors.  
4.2.1 Bottom Supported Model Breast Tumor Samples 
Gelatin models with bottom supported clay inclusions as illustrated in Figure 
4.11 were built to mimic the simplified breast tumors. The clays which have an elastic 
modulus of 60 kPa were made into cylindrical shapes with a radius of 15 mm and 
different heights. They were put in the center of petri dishes. Gelatin powders were 
mixed with water at 80 °C using a concentration of 0.08 g/ml, which was chosen so 
that the elastic modulus of gelatin was about 8 kPa. The gelatin solution was poured 
into the dishes and filled them. It was then cooled in 4 °C refrigerator for 10 minutes 
to solidify. Before each measurement, the sample was left in room temperature for 1 
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hour to equilibrate the temperature. The walls of the petri dishes were removed to 
eliminate the constraint to the boundaries of samples.  
Four PEFs as listed in Table 4.1, whose contact widths are 4.1±0.2 mm, 
6.5±0.2 mm, 8.2±0.2 mm, and 9.8±0.3 mm respectively, were used to measure the 
elastic moduli of the models on the surface, especially on pure gelatin area and on the 
center of inclusions. After the measurements, the depths of the bottom supported 
inclusions (t1) were measured using a caliper and shown in Table 4.2.  
 
 
 
Figure 4.11 A schematic of the gelatin models with a bottom supported clay inclusion 
to mimic the breast tumors 
 
 
Table 4.2 Depths of the inclusion in the bottom supported breast tumor models 
Sample # Inclusion depth (mm) 
1 2.1±0.4 
2 3.5±0.5 
3 4.3±0.6 
4 5.2±0.4 
5 5.9±0.5 
6 7.1±0.6 
7 8.2±0.6 
8 9.3±0.6 
9 10.1±0.5 
10 10.9±0.6 
11 12.2±0.6 
Gelatin (En = 8 kPa) 
Inclusion 
(Et = 60 kPa) 
t1 
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4.2.2 2-Spring Model to Deduce the Depth Profile 
4.2.2.1 2-Spring Model 
As we know, when two springs are connected in series as shown in Error! 
Reference source not found.(a), the overall spring constant k can be calculated using 
the following equation: 
2
2
1
121
k
l
k
l
k
ll


                                                      (4-1) 
where l1 and l2 are the length of the two springs, respectively; k1 and k2 are the spring 
constants of the two springs, respectively.  
For bottom supported breast tumors, when the distance from the sample 
surface to the bottom of the tumor is larger than the depth sensitivity of a single PEF 
(d), the part of the tumor beyond the depth sensitivity could not be measured by the 
PEF and therefore the part is negligible. The normal tissue and the rest part of the 
tumor are like two elastic springs connected in series as can be seen in Figure 4.12 (b). 
Based on the Equation 4-1 the effective elastic modulus E measured by a single PEF, 
can be expressed as  
tn E
td
E
t
E
d 11                                                      (4-2) 
where d is the depth sensitivity of a single PEF; t1 is the distance from the surface of 
the normal tissue to the top of the tumor; En and Et are the elastic moduli of the 
normal tissue and tumor, respectively.  
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Figure 4.12 (a) A schematic illustrating two springs with a spring constant k1, and k2, 
respectively, were connected in series; (b) A schematic illustrating the bottom 
supported breast tumor with a depth of t1. Its effective elastic modulus was measured 
with a PEF with a depth sensitivity of d.  
 
 
 
The En was obtained by using the PEF on normal tissue area. Et was unknown 
since the tumor was embedded in the normal tissue. In the paper published previously, 
the elastic moduli from two PEFs with different contact sizes were plugged into the 
equation to deduce the Et and t1 simultaneously. However, we may get negative t1 
sometimes. To solve this problem, we assume Et values to be 40 and 60 kPa since our 
previous ex vivo breast tumor study has shown that the elastic moduli of excised 
breast tumors were in the range of 30 to 72kPa [151]. Because Et is much larger than 
En, the term (d-t1)/Et is small and a change in Et will not have a large impact on the 
deduced t1. Extreme Et values (i.e. Et = 100 and 200 kPa) were also used to see how 
the assumption of Et affected the deduced depth profile. 
 
 
 
Tumor 
(Et) 
Normal 
tissue 
(En) 
t1 
(a) (
b) 
d 
(b) 
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4.2.2.2 Results using 2-Spring Model 
The 2-spring model was applied to bottom supported breast tumor models to 
estimate the depth profile of the tumors. The deduced t1 values of the tumors were 
plotted versus the true values as listed in Table 4.2 and were shown in Figure 4.13. 
Using large Et values in the calculation gives large deduced t1.  However, no matter 
which Et value was used in the equation, the deduced t1 was within ±1.2 mm from the 
true t1. It indicates that the t1 values deduced from spring model theory were not 
sensitive to the assumed Et values. The colored lines in the figure showed the linear 
fitting to the data. It could be found that the deduced t1 using spring model theory had 
good linear correlation (R2>0.995) with the true value. The slopes of the fitted curves 
were very close to 1. The slope, intercept, and R2 of the linear fitting curve are listed 
in Table 4.3.  
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Figure 4.13 The estimated t1 values using spring model theory with different Et (40, 
60, 100, and 200kPa) versus the actual values. The colored lines are the liner fitting.  
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Table 4.3 The linear fitting of the deduced tumor depth (t1) of bottom supported 
tumors using spring model theory with different Et versus the actual t1 
Et (kPa) 
Slope Intercept 
R2 
Value Standard Error Value Standard Error 
40 1.02 0.06 -0.11 0.42 0.99521 
60 0.99 0.06 0.37 0.39 0.99676 
100 0.99 0.06 0.66 0.36 0.99752 
200 0.99 0.06 0.84 0.35 0.99764 
 
 
 
The ratio of the deduced t1 using spring model theory over actual t1 is shown 
in Figure 4.14. The ratio was close to 1 with an error less than 40%. The error of the 
estimation of t1 was larger when the tumor was closer to the sample surface. It was 
due to the reason that the ratio was calculated by dividing the deduced t1 by actual t1. 
It would be exaggerated when t1 was small. When Et was close to the true elastic 
modulus of the tumor (60 kPa), the ratio of deduced t1 over actual t1 was closer to 1, 
compared to the ratio when Et was 100 or 200 kPa. Besides, when Et was 100kPa 
(blue up triangles), the data was almost overlap with the ones when Et was 200kPa 
(green down triangles). It proves that the assumed Et values would not have much 
effect in the results of deduced t1 and we can use the assumed values in the spring 
model theory to deduce the depth profile of bottom supported breast tumors.  
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Figure 4.14 The ratio of deduced t1 using sprint model theory to actual t1. The dashed 
line shows where the ratio is 1. 
 
 
 
4.2.3 Inversion Technique to Deduce the Depth Profile Using Finite Element 
Analysis (FEA) 
An inversion technique based on Finite element analysis (FEA), a numerical 
method to find approximate solutions to boundary value problems for partial 
differential equations, has been developed to deduce the depth profile of bottom 
supported breast tumors. In FEA, an object is broken down into a large number of 
finite elements and simple mathematical equations are used to predict the behavior of 
each element. It then adds up all the individual behaviors of finite elements to 
approximate the behavior of the actual object. ABAQUS CAE 6.10 (SIMULIA, 
Dassault Systèmes) finite element software was used for the analysis.  
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4.2.3.1 FEA Model creation and validation 
An axisymmetric model was used to minimize the computation time, since 
both the gelatin samples and the inclusions are cylinders. The model consisted of a 
clay inclusion embedded in a homogeneous gelatin matrix, the same with the bottom 
supported breast tumor model described in Section 4.2.1. The radius of the gelatin 
matrix (normal tissue) was 50 mm and the radius of the clay inclusions (tumor) was 
15 mm. The height of the gelatin matrix (normal tissue) was 20 mm and the clay 
inclusion (tumor) varied during the simulation. A uniform displacement was applied 
to part of the surface of the gelatin (normal tissue) to simulate the indention with 
different-sized, rigid, flat-ended indenters performed by a PEF. The reaction force 
exerted on the gelatin surface could be simulated and summed, and the effective 
elastic modulus of the model could be deduced and compared with the experimental 
results from PEFs.  
 
 
 
Figure 4.15 The breast tumor model created in ABAQUS which consisted of a gelatin 
matrix (normal tissue) and a bottom supported clay inclusion (tumor) 
Gelatin  
(normal tissue) 
Clay inclusion 
(tumor) 
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4.2.3.1.1 Material properties 
The gelatin matrix (normal tissue) and clay inclusions (tumor) were defined as 
isotropic, linearly elastic materials. The mechanical properties were assigned as listed 
in Table 4.4. Young’s moduli of gelatin (normal tissue) and clay inclusion (tumor) 
were taken from averages of PEF measurements. The density of the gelatin (normal 
tissue) was calculated to be 1080 kg/m3 as the concentration of gelatin was 0.08 g/ml.  
The density of clay inclusion was deduced by measuring the weight and volume of a 
cubic clay. Poison’ ratio values were 0.49999 since most of the soft tissues are nearly 
incompressible with Poisson’s ratio ranging from 0.49000 to 0.49999 as reported in 
literatures [160, 161]. 
 
 
Table 4.4 Mechanical properties of the model breast tumors 
 Density (kg/m3) Young’s modulus (kPa) Poisson’s ratio 
Gelatin 
(normal tissue) 
1080 8 0.49999 
Clay inclusion 
(tumor) 
1500 60 0.49999 
 
 
 
4.2.3.1.2 Contact interaction and boundary conditions 
There are two parts in the simulation model: the gelatin (normal tissue) and 
the clay inclusion (tumor). The contact characteristics for the two parts must be 
carefully defined. In the bottom supported breast tumor model described in Section 
4.2.1, the gelatin was crosslinked and had the clay embedded in it. They were bond 
together. Therefore, in the simulation model, the contact surfaces of gelatin and clay 
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inclusion were defined as “tie” in constraint. The contact surfaces in gelatin were set 
as “master surface” and the surfaces in clay inclusion were set as “slave surface”. 
The boundary condition of the simulation was defined that the bottom of the 
model was “encastred” because the bottom of the gelatin (normal tissue) was fixed on 
the petri dish. The left edge of the model was the symmetry axis and it was set as 
“XSYMM” since it was an axisymmetric model. A uniform displacement (0.05 mm) 
was applied to the gelatin surface to simulate the indentation performed by PEF. The 
areas in the model where the displacement was applied were the same with the 
contact areas of the PEFs listed in Table 4.1. The radius of the area that the 
displacement applied to was 2.3 mm, 3.7 mm, 4.5 mm, and 5.6 mm for PEFs A, B, C, 
and D, respectively. 
After simulation, the reaction forces exerted on the model surface were 
summed to calculate the effective elastic modulus. Based on Hayes’ solution [162], 
elastic modulus can be deduced using the following equation: 
whaa
F
E
),/(2
)1( 2


                                                   (4-3)                                          
where E is elastic modulus; F is the indentation force, which can be calculated from 
the simulation results; ν is Poisson’s ratio, which is 0.49999 according to Table 4.4; w 
is the indentation depth, which is 0.05 mm as determined in the boundary condition; a 
is the radius of the indenter; h is the thickness of the tissue; κ is a scaling factor that 
depends on the aspect ratio a/h and Poisson’s ratio ν and it can be determined by 
another FEA simulation.  
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4.2.3.1.3 Mesh development 
It is well known that the grid density plays a key role in the accuracy of finite 
element simulations. To validate the adequacy of mesh, the elastic modulus of the 
clay inclusion (tumor) was changed to 8 kPa which was the same with the elastic 
modulus of the surrounding gelatin (normal tissue). Although the model still had two 
parts, they had the same elastic moduli, and the effective elastic modulus of the entire 
model should be 8 kPa. To determine the appropriate mesh density, multiple trials of 
meshes with general element sizes of 2.0×2.0 mm2, 1.0×1.0 mm2, 0.75×0.75 mm2, 
0.5×0.5 mm2, 0.25×0.25 mm2, and 0.125×0.125 mm2 were run. The size of the 
smallest mesh tested was partially determined by computer constraints. All the cases 
were examined with four PEFs with different contact sizes.  
The effective elastic modulus of the model was calculated with different mesh 
sizes after simulations and it was compared to 8 kPa which was the elastic modulus of 
the model. Figure 4.16 plots the relationship between the effective elastic modulus 
calculated from simulations and the mesh density for the four PEFs. It is evident that 
coarser meshes over predicted the effective elastic modulus of the model. If the mesh 
size was 0.75×0.75 mm2 or less, the prediction of effective elastic modulus was 
within 1% of the defined elastic modulus of the model (8 kPa) for all the four PEFs. 
Therefore, mesh size of the simulations in this chapter was 0.75×0.75 mm2 or less. 
Sometimes the mesh at the contact area was made denser to achieve smoother 
stress/strain distributions. Figure 4.17 shows the deformed mesh with displacement 
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and reaction force distribution in the model during the indentation performed by PEF 
D, which had an indenter radius of 5.6 mm.  
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Figure 4.16 Change in effective elastic modulus calculated from simulations with 
different finite element mesh density. The dash line showed the defined elastic 
modulus of the model (8 kPa). 
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Figure 4.17 Deformed mesh (0.75×0.75 mm2) of the model during indentation 
performed by PEF D, which had a indenter radius of 5.6 mm. (a) showed the 
displacement distribution and (b) showed the reaction force. 
 
 
 
4.2.3.2 Inversion technique 
To determine the depth profile of the breast tumors, an iterative inversion 
algorithm was developed. The algorithm is based on the fact that the measured elastic 
moduli by PEFs depend on the depth of the breast tumor t1 which was defined as the 
distance from the model surface to the top surface of the tumor, if other parameters 
are fixed, including elastic moduli of the normal tissue (En), elastic modulus of the 
tumor (Et), the size of the contact of the PEF, and the lateral size of the tumor. The 
smaller t1 is, the closer the tumor to the surface, and the more portions of the tumor 
the PEF could detect, and therefore the larger the effective elastic modulus is from the 
PEFs.  
(a) 
(b) 
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In the algorithm, the elastic moduli measured by PEFs with different contact 
sizes on the center of the tumor (E) and on the normal tissue (En), and the lateral size 
of the inclusion deduced from PEF measurements as described in Section 3.3.3 were 
known and used as the input of iterations. Based on the experimental E values, we 
could have an initial guess of t1. If the experimental elastic moduli measured on the 
center of the tumor were the same with En for certain PEFs, it indicated that these 
PEFs could not detect the inclusion. Therefore, the depth of the tumor (t1) should be 
larger than the depth sensitivity of these PEFs. On the other hand, if the experimental 
elastic modulus was larger than the En, t1 should be smaller than depth sensitivity of 
the PEF. Based on the lateral size of the tumor and the initial guess t1, a breast tumor 
model was constructed in ABAQUS. In the simulation, both En and Et are required. 
En was obtained by PEF measurements on normal tissue area, while Et could not be 
measured directly, since the tumor was embedded in the normal tissue. Our previous 
ex vivo breast tumor study has shown that the elastic moduli of excised breast tumors 
were in the range of 30 to 72kPa [151]. Therefore, Et was assumed to be 40 and 60 
kPa in the simulation. Extreme Et values (Et = 100 and 200 kPa) were also used to see 
how the assumption of Et affected the deduced depth profile. 
After the simulation, the effective elastic moduli on the center of the tumor 
using different contact sizes could be deduced from the reaction forces using the 
Equation 4-3. The effective elastic moduli from simulations were compared with the 
experimental ones. If the elastic moduli from simulation were larger than the 
experimental ones, it indicated that the tumor in the simulation was too close to the 
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sample surface, and thus the t1 was revised by take twice of the initial guessed value. 
On the other hand, if the elastic moduli from simulations were smaller than the 
experimental ones, t1 was revised by taking half of the initial value. The revised t1 
was then used to construct a second model for simulation, and the simulation results 
were compared with the experimental results. It was repeated until the elastic moduli 
from simulations were within 10% of the experimental values which was the standard 
deviation of the PEF measurements. The t1 used in the last simulation was the 
estimated depth of the tumor. The flow chart of the iteration algorithm is shown in 
Figure 4.18.  
 
 
 
Figure 4.18 The flow chart of the inversion technique which used iterations to deduce 
the depth profile of inclusions 
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4.2.3.3 Results Using Inversion Technique 
The inversion technique was applied to the bottom supported breast tumor 
models described in Section 4.2.1 to estimate the depths of the tumors. The elastic 
moduli of the models measured by PEFs with different contact sizes and the deduced 
lateral size of the tumor were input into the iterative algorithm along with an initial 
guess.   
As an example, the elastic moduli of the sample #1 in which the tumor depth 
was 2.1±0.4 mm as listed in Table 4.2 were measured by PEFs and were shown in 
Figure 4.19. The elastic moduli measured on the center of the sample were 21.1±1.8, 
25.7±2.2, 30.1±3.5, and 35.4±3.4 kPa from PEFs A, B, C, and D, respectively. The 
elastic modulus of normal tissue (En) was 8.1±0.9 kPa as indicated as green shaded 
area in the figure. It is obvious that the elastic modulus on the tumor area from the 
PEF with a 4.1 mm wide contact was larger than En. Therefore, the tumor supposed 
be within the depth sensitivity of that PEF. As discussed in Section 4.1, the depth 
sensitivity of a PEF is about twice of the contact width, so the tumor depth (t1) should 
be less than 8.2 mm. Assuming the elastic modulus of the pure tumor was 40 kPa and 
the initial guess of t1 was 8 mm, a bottom supported breast tumor model was built and 
simulated in ABAQUS. The elastic moduli of the center of the tumor area using 
different sizes of indenters were calculated based on the simulation results and 
compared with experimental results as shown in Figure 4.20. The elastic moduli from 
simulation were at least 57% smaller than those from experiment, indicating the 
tumor should be closer to the surface and the initial guess of t1 was too large. In the 
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second iteration, t1 was 4 mm, which was half of the initial value. The simulations 
and comparisons were repeated until t1 was 1.5 mm, in which case the difference 
between Esimulation and Eexperiment was within 10% of Eexperiment. Therefore, based on the 
inversion technique, the depth of the tumor (t1) in model sample #1 was estimated to 
be 1.5 mm, which was very close to 2.1±0.4 mm, the true depth measured by caliper. 
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Figure 4.19 Elastic modulus (E) measured on the center of bottom supported breast 
tumor model sample #1 in which the tumor depth was 2.1±0.4 mm by PEFs with 
different contact sizes. The green bar showed the elastic modulus of the pure gelatin 
area (8.1±0.9 kPa).  
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Figure 4.20 The elastic modulus (E) of the bottom supported tumor model sample #1 
from PEFs (black) and ABAQUS simulations during inversion iterations with an 
initial guess of t1=8 mm 
 
 
 
Table 4.5 Tumor depth (t1) used in iterations and the difference between Esimulation and 
Eexperiment for tumor model sample #1 with an initial guess of t1=8 mm 
Iteration# t1 (mm) 
Difference between Esimulation and Eexperiment 
PEF A PEF B PEF C PEF D 
1 8.00 -57% -62% -66% -70% 
2 4.00 -44% -45% -49% -53% 
3 2.00 -17% -9% -18% -27% 
4 1.00 31% 15% 5% 1% 
5 1.50 10% 5% -6% -8% 
 
 
 
4.2.3.3.1 Effect of the Initial Guess 
In the inversion technique, based on the elastic moduli from PEFs, we need to 
have an initial guess of the tumor depth (t1). It is of interest to see whether the 
estimated tumor depth (t1) depends on the initial guess or not. To address this 
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question, different initial guesses were tested in the inversion technique and the 
estimated t1 were compared here.  
Taking the tumor model sample #1 as we discussed before as an example. The 
PEF elastic modulus results have shown that the tumor depth (t1) should be smaller 
than 8.2 mm. In the iterations listed in Table 4.5, the initial guess of t1 was 8 mm and 
after 5 iterations it was obtained that t1 was 1.5 mm. Different from that, we change 
the initial guess of t1 to 1 mm. After the simulation, the deduced elastic moduli were 
larger than the experimental results as shown in Figure 4.21, indicating the initial 
guess was too small. Therefore, the tumor depth was within the range of 1 mm and 
8.2 mm. The midpoint 4.5 mm was taken as the t1 in the second iteration. After 7 
iterations as listed in Table 4.1, the tumor depth of the sample #1 was determined to 
be 1.55 mm, which agreed with 1.5 mm, the t1 determined with an initial guess of 8 
mm. Therefore, it can be concluded that the results of the iterations does not depend 
on the initial guess of t1. The iterations in both directions: t1 from large to small and t1 
from small to large, could determine t1 precisely.  
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Figure 4.21 The elastic modulus (E) of the bottom supported tumor model sample #1 
from PEFs (black) and ABAQUS simulations during inversion iterations with an 
initial guess of t1=1 mm 
 
 
 
Table 4.6 Tumor depth (t1) used in iterations and the difference between Esimulation and 
Eexperiment to determine t1 of the tumor model sample #1 with an initial guess of t1=1 
mm 
Iteration# t1 (mm) 
Difference between Esimulation and Eexperiment 
PEF A PEF B PEF C PEF D 
1 1.00 31% 15% 5% 1% 
2 4.50 -47% -49% -53% -57% 
3 2.75 -31% -30% -35% -41% 
4 1.88 -5% -6% -20% -25% 
5 1.44 12% 7% -5% -1% 
6 1.66 4% 0% -11% -16% 
7 1.55 7% 3% -8% -9% 
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4.2.3.3.2 Effect of the Assumed Et 
In the inversion technique, both the elastic moduli of normal tissue (En) and 
that of tumor (Et) are required. En could be obtained by PEF measurements on normal 
tissue area, while Et could not be measured directly, since the tumor was embedded in 
the normal tissue. Same with the 2-spring model, in inversion technique Et was 
assumed to be 40 and 60 kPa in the iterations. Extreme Et values (i.e. Et = 100 and 
200 kPa) were also used to see how the assumption of Et affected the deduced depth 
profile. 
The deduced tumor depth (t1) using the inversion technique with different Et 
values (40, 60, 100, and 200 kPa) was plot versus the actual t1 measured by caliper in 
Figure 4.22. When using a larger Et (i.e. Et = 200 kPa, green triangles), the estimated 
t1 was larger, compared with using small Et (i.e. Et = 40 kPa, black square). However, 
the difference was less than 1mm which was negligible. The colored lines in the 
figure show the linear fitting of data with different Et values and the fitted slopes and 
intercepts are listed in Table 4.7. It is obvious that there was very good correlation 
(R2>0.998) between the t1 deduced from the inversion technique and t1 measured by 
caliper, no matter which Et was used in the iterations. And the slopes from the linear 
fitting were close to 1 with an error smaller than 5%.  
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Figure 4.22 The deduced tumor depth (t1) using the inversion technique with different 
Et (40, 60, 100, and 200kPa) versus its actual value. The colored lines are the linear 
fitting. 
 
 
 
Table 4.7 The linear fitting of the deduced tumor depth (t1) of bottom supported 
tumors using the inversion technique with different Et versus the actual t1 
Et (kPa) 
Slope Intercept 
R2 
Value Standard Error Value Standard Error 
40 1.05 0.02 -0.67 0.06 0.99926 
60 1.01 0.02 -0.11 0.12 0.99896 
100 0.99 0.02 0.39 0.05 0.99893 
200 1.01 0.02 0.50 0.05 0.99865 
 
 
 
The ratio of the deduced t1 over actual t1 was plotted in Figure 4.23. When the 
tumor depth was small (i.e. d=2.1±0.4mm), the error of the estimation of t1 was larger. 
It was reasonable since we calculated the ratio by dividing the estimated t1 by actual 
t1. When t1 was small, even a small difference between the estimation and actual 
values may lead to a large error. Besides, when measuring the t1 with a caliper, the 
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smaller the t1 was, the larger the uncertainty of measurements. Therefore, the deduced 
t1 was more different from the actual values when dt1 was small. 
When Et in the simulation was 60kPa (red circles) which was the exact elastic 
modulus of the inclusion, the ratios were 1 and on the dashed line. When Et was 
40kPa (black squares), the ratios were smaller than 1; while when Et was 100kPa or 
200kPa, the ratios were larger than 1, and the differences were less than 24%. Besides, 
when Et was 100kPa (blue up triangles), the data were almost the same with the ones 
when Et was 200kPa (green down triangles). It further proves that assuming Et values 
in inversion technique would not have much impact on the deduced t1 values. 
Therefore, we are able to use assumed Et values, instead of actual Et values, to run 
simulations and iterations to determine the depth profile of bottom supported breast 
tumors accurately.  
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Figure 4.23 The ratio of deduced t1 using inversion technique to actual t1. The dashed 
line shows where the ratio is 1. 
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4.2.4 Comparison of the 2-Spring model and Inversion Technique 
Since the deduced tumor depths are not affected by the assumed Et values for 
both 2-spring model and inversion technique, the average of the depths deduced using 
Et = 40 kPa and 60 kPa was used to represent the measured tumor depth for both 
methods. In Figure 4.24, the tumor depths determined by 2-Spring model and 
inversion technique were plotted versus the actual values. The blue dashed line has a 
slope of 1. It shows that both the 2-spring model and the inversion technique are able 
to determine the depth profile of bottom supported tumor accurately. The tumor depth 
(t1) determined by 2-spring model was within 1.1 mm of the actual value and that 
estimated using inversion technique was within 0.6 mm. Although the inversion 
technique showed a slightly smaller error in deducing the tumor depth, its 
improvement over 2-spring model is very limited for breast tumors whose sizes are 
usually in centimeter scale. Besides, the inversion technique is very time consuming. 
After each iteration, the model in FEA needs to be rebuilt manually and it cannot be 
integrated into an automatic system. One the other hand, 2-spring model is based on 
simple calculations and could be done in seconds. Therefore, spring model is chosen 
for tumor depth profile determination.  
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Figure 4.24 The deduced tumor depth (t1) using the 2-spring model and the inversion 
technique versus its actual value. The blue dashed line has a slope of 1. 
 
 
 
4.3 Determine the Depth Profile of Suspended Model Breast Tumors  
4.3.1 Suspended Model Breast Tumor Samples 
Gelatin models with suspended clay inclusions were built to mimic the breast 
with lumps. The clays (Modeling Clay, Crayola, Easton, PA) were made into cuboid 
shapes with 15mm in length, 15mm in width, and different heights (5-15mm) for 
suspended inclusions. The elastic modulus of the clay was 60 kPa, and it is within the 
range of the elastic modulus of excised breast tumors (30-72 kPa) measured by PEF 
in ex vivo breast tumor study [151]. Gelatin powders were mixed with water at 80 °C 
with a concentration of 0.12 g/ml, which was chosen so that the elastic modulus of 
gelatin is about 10 kPa. The choices were consistent with the elastic moduli of the 
normal breast tissues and those of breast tumors reported in the literature, which were 
3-28 kPa and 11-106 kPa, respectively [81, 83, 155-158]. The gelatin solution was 
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poured into a 35 cm×23 cm×20 cm container and put into the 4°C refrigerator for 10 
minutes to solidify. Subsequently the clay inclusions were placed on top of the gelatin 
layer. Afterward, another gelatin solution of the same concentration was poured into 
the container to enclose the clays as inclusions. When the gelatin was solidified, the 
clay inclusion would be suspended in the gelatin matrix. The total height of the 
gelatin matrix is 34 mm. A picture of the suspended breast tumor model is shown in 
Figure 4.25. The clay inclusions in the same row had identical dimensions, but they 
were embedded at different depths. The inclusions in the same column had different 
heights, but the distances from the gelatin surface to the tops of the inclusions were 
similar. The exact values of the inclusion dimensions and the depth profiles were 
measured by a caliper and listed in Table 4.8. 
 
 
 
Figure 4.25 A picture of the suspended breast tumor model made of gelatin matrix 
with suspended clay inclusions. 
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Table 4.8 The dimensions and depths of the suspended inclusions in the model 
Inclusion 
Number 
Inclusion dimensions Inclusion depths 
Length (mm) Width (mm) Height (mm) t1 (mm) t2 (mm) 
AVE SD AVE SD AVE SD AVE SD AVE SD 
A1 14.53 0.26 15.20 0.40 4.87 0.35 2.22 0.28 7.09 0.45 
A2 15.24 0.38 15.26 0.20 4.98 0.29 4.09 0.33 9.07 0.44 
A3 15.36 0.25 15.14 0.37 5.24 0.31 5.94 0.26 11.18 0.40 
A4 15.90 0.35 15.17 0.23 4.97 0.42 7.21 0.32 12.18 0.53 
A5 15.23 0.25 15.21 0.30 5.23 0.29 10.34 0.30 15.57 0.42 
A6 15.36 0.26 15.55 0.24 5.30 0.28 11.92 0.21 17.22 0.35 
B1 14.51 0.39 14.63 0.40 8.47 0.34 3.03 0.28 11.50 0.44 
B2 15.19 0.20 15.18 0.35 7.97 0.32 4.07 0.39 12.04 0.50 
B3 14.72 0.21 15.76 0.29 7.23 0.29 6.45 0.32 13.68 0.43 
B4 15.40 0.31 15.69 0.37 7.45 0.35 9.55 0.38 17.00 0.52 
B5 15.62 0.24 15.46 0.38 7.69 0.31 11.79 0.33 19.48 0.45 
B6 15.62 0.39 15.27 0.20 7.71 0.31 11.95 0.41 19.66 0.51 
C1 16.19 0.38 16.04 0.35 9.43 0.27 5.27 0.26 14.70 0.37 
C2 16.15 0.27 15.32 0.24 9.66 0.30 7.00 0.33 16.66 0.45 
C3 15.88 0.28 15.42 0.30 9.45 0.33 8.34 0.31 17.79 0.45 
C4 15.67 0.21 16.07 0.30 9.29 0.33 11.21 0.48 20.50 0.58 
C5 15.95 0.28 15.71 0.32 9.83 0.27 12.18 0.28 22.01 0.39 
C6 15.85 0.39 16.18 0.26 9.73 0.34 13.67 0.40 23.40 0.52 
D1 14.71 0.35 15.40 0.22 11.40 0.35 4.22 0.30 15.62 0.46 
D2 14.66 0.29 14.89 0.33 11.58 0.29 6.66 0.28 18.24 0.40 
D3 14.64 0.22 15.18 0.34 11.68 0.34 10.45 0.37 22.13 0.50 
D4 14.85 0.28 14.95 0.36 11.57 0.31 12.13 0.28 23.70 0.42 
D5 14.81 0.20 15.08 0.34 11.72 0.32 15.06 0.30 26.78 0.44 
D6 15.20 0.40 14.83 0.37 11.68 0.36 16.24 0.31 27.92 0.48 
E1 15.79 0.25 15.74 0.33 14.82 0.30 3.19 0.32 18.01 0.44 
E2 15.77 0.38 15.75 0.31 15.04 0.27 6.44 0.29 21.48 0.40 
E3 15.81 0.34 16.05 0.28 15.12 0.30 8.58 0.44 23.70 0.53 
E4 15.40 0.35 15.71 0.38 15.11 0.32 10.30 0.29 25.41 0.43 
E5 15.74 0.39 15.71 0.31 15.17 0.36 13.58 0.43 28.75 0.56 
E6 15.66 0.30 15.64 0.35 14.78 0.35 15.59 0.39 30.37 0.52 
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4.3.2 Scanning Model Breast Tumor Sample with PEFs 
Before the measurement, the sample was left in room temperature for 1 hour 
to equilibrate the temperature. Four PEFs with different contact sizes as listed in 
Table 4.1 were used to measure the elastic moduli of the entire gelatin model with 
inclusions. Five repeated measurements were taken on the same location by each PEF, 
and they were averaged. The result of the PEF scan on the model tissue was presented 
as a color coded elastic modulus map. As an example, the E maps generated by PEFs 
B and D, whose contact width were 6.5±0.2 mm and 9.8±0.3 mm, respectively, are 
shown in Figure 4.26. The green color represents the elastic moduli of the gelatin 
matrix (9-12 kPa), while the yellow (14-16 kPa) and red color (18-28 kPa) represents 
the elevated elastic moduli of areas containing the clay inclusions. Since the depth 
sensitivities of these PEFs were different, distinct elastic moduli were obtained using 
these PEFs on the same location. As can be seen, PEF B could only detect the left 
half part of the inclusions. It was because PEF B had a depth sensitivity of about 13 
mm. When the inclusions were more than 13 mm deep from the gelatin surface, they 
were beyond the detectable depth of PEF B. Therefore, PEF B was unable to 
differentiate the gelatin and inclusions for the right part of the inclusions which were 
deeper embedded. Since PEF D had a depth sensitivity of 20 mm, it could detect most 
of the inclusions. However, the elastic modulus values of the inclusions in the first 
row (Inclusions A1-A6) measured by PEF D were smaller than those measured by 
PEF B. It was because those inclusions had a small height which was only about 5 
mm and the entire inclusions were within the depth sensitivity of PEF D. The 
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proportion of inclusion to the entire volume that PEF D detected was smaller 
compared with that for PEF B. And thus the effective elastic modulus measured by 
PEF D was mostly from the elastic modulus of gelatin, resulting in a smaller value.  
 
 
 
 
Figure 4.26 (a) The 2D elastic modulus map of the model generated by using the 
measurement results from PEF B, which had a contact width of 6.5±0.2 mm; (b) The 
2D elastic modulus map of the model generated by using the measurement results 
from PEF D, which had a contact width of 9.8±0.3 mm. 
 
 
(a) 
(b) 
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After the PEF measurements, the depth profile of the tumor as illustrated in 
Figure 4.27, which is the distance from the gelatin surface to the top of the inclusion 
(t1) and the distance from the gelatin surface to the bottom of the inclusion (t2), were 
measured using a caliper and listed in Table 4.8. 
4.3.3 3-Spring Model 
For suspended breast tumors, if the distance from the surface to the bottom of 
the tumor (t2) is larger than the depth sensitivity (d) of a single PEF as shown in 
Figure 4.27 (a), the normal tissue underneath the tumor and bottom part of the tumor 
beyond the depth sensitivity could not be measured by that PEF and thus they are 
negligible. The normal tissue on the top and the rest part of the tumor are like two 
elastic springs in series. Same with bottom supported breast tumors, the effective 
elastic modulus measured by that PEF can be calculated using the Equation 4-2. If the 
depth sensitivity of a single PEF is larger than t2 as shown in Figure 4.27 (b), the 
normal tissue underneath the tumor should also be taken into account in deducing the 
effective elastic modulus. The system is similar to three springs connected in series. 
And therefore, the effective elastic modulus E measured by a single PEF, can be 
expressed as 
tnntn E
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ttd
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
                              (4-4) 
where d is the depth sensitivity of a single PEF; t1 is the distance from the skin 
surface to the top of the tumor; t2 is the distance from the skin surface to the bottom 
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of the tumor; t2-t1 is the height of the tumor; En and Et are the elastic moduli of the 
gelatin and inclusion, respectively.  
 
 
 
Figure 4.27  (a) A schematic illustrating the gelatin sample with suspended inclusion 
when d<t2; (b) A schematic illustrating the gelatin sample with a suspended inclusion 
when d<t2; d is the depth sensitivity of a single PEF.  
 
 
 
4.3.4 Results Using 3-Spring Model 
Equations 4-3 and 4-4 were used to deduce the depth profile of the tumors. 
The effective elastic modulus E was measured by PEFs with different contact widths. 
The elastic modulus of normal tissue (En) could be obtained by PEF measurements on 
normal tissue area, while the elastic modulus of inclusion (Et) could not be measured 
directly, since the tumor was embedded in the sample. Similar to Section 4.2.2, Et = 
40 and 60 kPa were used to solve for t1 and t2. Extreme Et values (Et = 100 and 200 
kPa) were also used to see how the assumption of Et affected the deduced depth 
profile. 
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The deduced t1 using the spring model theory was plotted versus the actual 
values in Figure 4.28. It is clear that all the data points are close to the dash line 
which has a slope of 1. It shows that all the estimated values agreed with the actual 
values very well. When Et was 40 kPa or 60 kPa, which was within the range of the 
elastic modulus of breast tumors, the estimations of t1 values were quite good. When 
Et was 100 kPa or 200 kPa, which was much larger than the elastic modulus of the 
breast tumors, the estimations were not very different from the actual values. 
Therefore, we could draw the same conclusion with the inversion technique that the 
estimation of t1 is not sensitive to the assumed Et values. And thus it is feasible to use 
assumed Et to deduce d1 values.  
The deduced t1 versus actual t1 was fit to linear curve and the fitting results are 
listed in Table 4.9. The slopes were very close to 1, no matter which Et value was 
used for spring model theory. When Et was smaller than 100 kPa, R
2 was larger than 
0.977, indication there was good correlation between the deduced t1 and the true t1. 
When Et was 200 kPa, R
2 was slightly smaller. It was understandable since the elastic 
modulus of the tumor in the model was 60 kPa. The linear fitting further prove that 
we were able to estimate t1 accurately using spring model theory.  
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Figure 4.28 The estimated t1 values using spring theory versus the actual values. The 
dashed line has a slope of 1. 
 
 
 
Table 4.9 The linear fitting of the deduced t1 of suspended breast tumors using spring 
model theory with different Et versus the actual t1 
Et (kPa) 
Slope Intercept 
R2 
Value Standard deviation Value Standard deviation 
40 0.94 0.05 -0.08 0.29 0.9788 
60 0.93 0.04 0.45 0.27 0.9790 
100 0.93 0.04 0.80 0.25 0.9770 
200 0.91 0.04 1.03 0.24 0.9596 
 
 
 
The estimated t2 values deduced by spring model versus the actual values are 
shown in Figure 4.29. Apparently the deduced t2 had good correlation with actual 
values. Besides, it is consistent with t1 that the estimation of t2 was not sensitive to the 
assumed Et values. The linear fitting results are listed in Table 4.10. The slopes were 
close to 1 and the R2 were larger than 0.95, no matter which Et was used in the 
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equations. The slopes of the linear fitting for t2 were smaller than those for t1 and the 
intercepts were larger, indicating the estimation of t2 was not as accurate as t1.   
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Figure 4.29 The estimated t2 values using spring theory versus the actual values. The 
dashed line has a slope of 1. 
 
 
 
Table 4.10 The linear fitting of the deduced t2 of suspended breast tumors using 
spring model theory with different Et versus the actual t1 
Et (kPa) 
Slope Intercept 
R2 
Value Standard deviation Value Standard deviation 
40 0.99 0.06 0.95 0.99 0.9595 
60 0.86 0.06 2.13 0.90 0.9607 
100 0.82 0.06 2.41 0.84 0.9544 
200 0.81 0.05 2.51 0.74 0.9553 
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A schematic of the suspended breast tumor model with estimated depth profile 
is shown in Figure 4.30. The blue cuboids showed the exact locations of the 
inclusions, while the red cuboids represented the estimated sizes and locations of the 
inclusions. It should be noted that the estimated sizes and locations were averaged 
values, since we used multiple Et values to do the calculations. As can be seen, the 
red cuboids overlapped with blue cuboids for most of the inclusions and they were 
shown as a purple color. Therefore, the deduced 3D profiles of the inclusions were 
quite accurate.  
Besides, for the inclusions C6, D4-D6, and E4-E6, because their t2 values 
were larger than the maximum depth sensitivity of PEFs, we could not assess t2 using 
the four PEFs in the study. Only t1 values were deduced for them. By using the four 
PEFs listed in Table 4.1, the depth profiles of the inclusions when they were less than 
2 cm deep could be successfully determined, which was sufficient for tumors in a 
normal size breast but not for tumors whose bottom surfaces were more than 2 cm 
deep. For larger breasts and deeper tumors, PEFs with a larger contact width can be 
used.  
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Figure 4.30 A schematic of the gelatin model with suspended inclusions. The blue 
cuboids showed the location of the inclusions. The red cuboids illustrated the 
estimated locations of the inclusions.  
 
 
 
4.3.5 Deduce the Depth Profile of Spherical Suspended Tumors 
To evaluate the performance of applying spring model theory to estimating 
depths profiles of breast tumors, gelatin models with spherical suspended clay 
inclusions were also built to mimic the breast with lumps. The procedures of making 
these models were similar to those described in Section 4.3.1. The clays were made 
into spheres with different diameters.  The elastic modulus of the clay was 60 kPa, the 
same with the models in previous sections. Gelatin powders were mixed with water at 
80°C with a concentration of 0.08 g/ml so that the elastic modulus of gelatin is about 
8 kPa. The height of the gelatin matrix was 30 mm. A picture of the breast tumor 
model is shown in Figure 4.31 and the schematic of the cross section of the model is 
Real inclusions 
Predicted inclusions 
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shown in Figure 4.32. The inclusions in the same column had the same diameters but 
were embedded at different t1. The inclusions in the same row had distinct sizes but 
their t1 were similar. The exact values of the inclusion dimensions and the depth 
profiles were measured by a caliper and listed in Table 4.11.  
 
 
 
Figure 4.31 A picture of the suspended breast tumor model made of gelatin matrix 
with spherical clay inclusions. 
 
 
 
 
Figure 4.32 A schematic of the cross section of spherical suspended breast tumor 
model. t1 is the distance from the model surface to the top of the tumor and t2 is the 
distance to the bottom of the tumor. The elastic modulus of the normal tissue (En) and 
tumor (Et) were 8 and 60 kPa, respectively. 
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Table 4.11 The dimensions and depths of the spherical suspended inclusions in the 
model 
Inclusion # 
Inclusion diameter (mm) Inclusion depth t1 (mm) 
AVE SD AVE SD 
A1 10.5 0.3 3.5 0.3 
A2 15.8 0.2 3.0 0.4 
A3 20.1 0.3 2.8 0.2 
B1 10.8 0.3 5.6 0.3 
B2 16.8 0.4 5.3 0.3 
B3 20.9 0.3 4.6 0.1 
 
 
 
Five PEFs with different contact sizes, including four PEFs listed in Table 4.1 
and another with a contact width of 12.1±0.3 mm, were used to measure the elastic 
moduli of the entire gelatin model with inclusions. Five repeated measurements were 
taken on the same location by each PEF, and were averaged. The depth profiles of the 
inclusions were deduced using the spring model theory as explained in Sections 4.3.3 
and compared with the actual values in Figure 4.33. It clearly shows that the depth 
profiles of the tumors deduced with spring model theory were very close to the actual 
depths.  
The averaged t1 and t2 deduced using spring theory were plot versus their 
actual values in Figure 4.34 (a) and (b), respectively. Linear regression was 
performed and the R2 values were close to 1, indicating there was good correlation 
between the deduced and actual depths. The slopes of linear fitting were 0.983 and 
1.012 for t1 and t2, further showing that using spring model theory could estimate the 
depth profile of suspended breast tumors very accurately.  
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Figure 4.33 Comparison of the tumor depth profiles deduced with spring model 
theory and those measured using a caliper in cross section view 
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Figure 4.34 (a) the estimated t1 values using spring model theory versus the actual 
values; (b) the deduced t2 versus the actual values; 
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4.3.6 Deduce the Depth Profile of Suspended Tumors with Irregular Shapes 
As is known to all, the shape of many breast tumors is irregular. To further 
validate the spring model theory for estimating depth profile of breast tumors, gelatin 
models with irregular shaped inclusions were made to simulate the breast tumors. 
One inclusion was like two tumors merged together, and the other inclusion was a 
spherical tumor with spiculated boundaries which was a sign of malignancy. Both 
shapes could be found in excised breast tumors in previous ex vivo study [151]. The 
procedures of making the models were the same with those described in Section 4.3.1. 
A picture of the model is shown in Figure 4.35. Five PEFs with different contact sizes 
were used to measure the effective elastic modulus of the entire model. The spring 
model theory was applied to deduce the depth profiles of the inclusions and a 3D 
image was created based on the deduced results as shown in Figure 4.36. Obviously, 
the inclusion on the left looked like two tumors merged together, very consistent with 
the shape in the picture of the model (Figure 4.35). The inclusion on the right in the 
3D image had rough boundaries, similar to the shape in the picture. However, the 
spicules in the inclusion could not be fully speculated by the spring model theory. 
When two spicules were at the same lateral location but different depths, the deduced 
depth profile would show only one spicule with a larger size. It was due to the reason 
that in the 3-spring model theory, we assumed that the sample had a three-layer 
structure (normal tissue-tumor-normal tissue). If the assumption was not valid in the 
case of two spicules, the spring model theory could not accurately deduce the depth 
profile. For the inclusion on the right, although the spring model theory could not 
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speculate the spicules completely, the depth of major part of the tumor and rough 
boundary was estimated accurately enough for the diagnostics of breast tumors. 
Therefore, it can be concluded that the depth profiles of irregular shaped tumors could 
be estimated accurately using spring model theory.  
 
 
 
Figure 4.35 A picture of the suspended breast tumor model made of gelatin matrix 
with irregular shaped clay inclusions. 
 
 
Figure 4.36 The 3D image of the irregular shaped suspended inclusions deduced from 
PEF measurement results 
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4.4 Conclusions 
In this chapter, the depth sensitivity of a piezoelectric finger (PEF) in the 
housing was examined and the results showed that the depth sensitivity of a PEF is 
about the twice of the contact width. The depth sensitivity is independent on the 
elastic modulus of normal tissue (En) or that of tumor (Et). It is not affected by the 
size of the tumors unless the tumor was less than 5 mm. Since most of the breast 
tumors in the in vivo study in Chapter 3 had a size larger than 10 mm, it is safe to say 
that the depth sensitivity of the PEF in the housing is twice the contact width the 
majority of breast tumors.  
With a larger contact, a PEF can assess the elastic response of deeper tissues. 
To deduce the depth profile of breast tumor, a set of PEFs with different contact sizes 
were applied on the same sample. A 2-spring model theory was then developed to fast 
determine the depth profile of both bottom supported and suspended tumors. When 
applied to bottom supported breast tumor models, the 2-spring model theory can 
determine the depth t1 of tumors accurately, with an error of less than 1.1 mm. We 
also found that the estimated depth values were insensitive to the assumed Et in the 
spring model, consistent with the findings using inversion technique.  
An inversion technique based on finite element analysis (FEA) was also 
developed to retrieve the depth information of the tumor from PEF’s elastic modulus 
measurements. It calculated the elastic moduli from the model in FEA, compared 
with PEF results, and modified the model until the elastic moduli from FEA were the 
same with those from PEF. The inversion technique was applied to bottom supported 
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breast tumor models and it showed that the deduced tumor depth t1 agreed with the 
actual value with an error less than 0.6 mm. Besides, the deduced depths were found 
not sensitive to the initial guess of depth t1 and the Et values assumed.  
Both the 2-spring model and the inversion technique can determine the depth 
profile of bottom supported breast tumor models accurately and robustly. However, 
the inversion technique is time-consuming and requires heavy computations. The 2-
spring model theory, on the other hand, can give the results in seconds.  
A 3-spring model was then developed based on 2-spring model by adding an 
additional normal tissue layer under the tumor. It was applied to suspended breast 
tumor models, and the deduced depth profiles t1 and t2 correlated with the actual 
values very well, with an error smaller than 2.1 mm. When the tumors were irregular, 
the shapes could be restored well by the spring model theory, including some of the 
spicules at the tumor margin. Therefore, it is feasible to use spring model theory to 
estimate the tumor depth without knowing the exact Et values and the 3D image of 
the tumor could be obtained.  
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5. DETERMINE THE ELASTIC MODULUS AND DEPTH PROFILE OF 
SKIN  
Human skin is a complex material, composed of three heterogeneous layers: 
epidermis, dermis, and hypodermis. The elastic modulus and thickness of each skin 
layer vary as a function of age, body zone, hydration, and etc. Mechanical testing of 
skin contributes to detection of skin diseases and quantification of effectiveness of 
dermatologic products. Different noninvasive methods, such as suction test, torsion 
test, and tensile test, have been developed to characterize the mechanical properties of 
skin as described in detail in Chapter 1. However, during these tests, the natural state 
of stress on the skin was modified and the mechanical properties measured might be 
affected.  
In this chapter, indentation by Piezoelectric Fingers (PEFs) was used to 
measure the effective elastic modulus of the skin. Since the depth sensitivity of a PEF 
depends on the contact size, a PEF with a larger contact size can measure the stiffness 
of a deeper tissue. Therefore, the elastic modulus and thickness of the skin is deduced 
simultaneously by coupling PEF measurements with an empirical formula for a two-
layer structure. The methodology is validated using finite element analysis (FEA) 
with finite skin thickness. After that, the methodology is applied to skin phantoms 
and excised porcine skin samples to retrieve the elastic modulus and thickness of 
dermis simultaneously.   
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5.1 Skin Structure 
Human skin is a complex organ with a layered structure that varies in 
thickness depending on what part of the body it covers [85]. Skin has three main 
layers, the epidermis, the dermis and the hypodermis layer as shown in Figure 5.1. 
The epidermis, the outermost layer of skin, is relatively thin, only 0.05 mm on the 
eyelids and 1.5 mm on the palms and soles [87, 88]. It has the highest elastic modulus 
(approximately 1 MPa [138]) compared with the other skin layers. The dermis, 
beneath the epidermis, is a thick layer of fibrous and elastic tissue that gives the skin 
its flexibility and strength. The thickness of dermis ranges from 0.3 mm on the 
eyelids to 4 mm or more on the soles and palms [89]. The elastic modulus of dermis 
layer is about 88 to 300 kPa [163-166]. The hypodermis layer is made up of fat and 
connective tissue and can be 3-100 mm thick [90]. It has the lowest stiffness among 
all skin layers, only a few kPa [167].  
 
 
 
Figure 5.1 A schematic of human skin [168] 
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Since the epidermis layer of human skin is very thin compared to the other 
two layers of the skin, the effective elastic modulus measured by a PEF on the skin 
surface mostly depends on the elastic moduli of the dermis and the hypodermis layer. 
Therefore, we do not separate the epidermis from the dermis layer in the following 
chapters. For simplicity, we call the combination of the epidermis and dermis layer as 
dermis. The effective elastic modulus of the combination of the epidermis and dermis 
layer denoted as Edermis is much larger than the elastic modulus of hypodermis layer 
(Efat). Besides, both the epidermis and dermis layer are thin. Therefore, the skin can 
be modeled as a thin film of stiff material (dermis) on a soft substrate (hypodermis) as 
illustrated in Figure 5.2. 
 
 
 
 
Figure 5.2 A schematic illustrating that the skin is modeled as a film-substrate system.  
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5.2 Skin Elastic Modulus Measured by Piezoelectric Fingers (PEFs)  
5.2.1 Piezoelectric Fingers (PEFs) for Skin Measurements 
The Piezoelectric Fingers (PEFs) for skin measurements consists of 3 layers: a 
lead zirconate titanate (PZT) layer on the top, a stainless steel layer in the middle, and 
another PZT layer on the bottom as shown in Figure 3.1 (a). The top and bottom PZT 
layers are 5H4E PZT sheet (Piezo Systems Inc., Cambridge, MA) with a thickness of 
127 μm. The top layer serves as a driving layer and the bottom is the sensing layer. 
The stainless steel (Alfa Aesar, War Hill, MA) layer in the middle is 50-μm thick.  
The PEFs used in this chapter were 3.5±0.5 mm wide. The lengths of driving 
and sensing PZT layers were 22±0.5 mm and 12±0.5 mm, respectively. The stainless 
steel was 33±0.5 mm long. To make the PEF, the driving and sensing PZT were 
bonded to the stainless steel using nonconductive epoxy (Henkel Loctite, Westlake, 
OH) along the edges, and a very small patch of conductive epoxy (ITW Chemtronics, 
Kennesaw, GA) at the center. After curing overnight, different sizes of cylindrical 
probes were bonded to the PEF using nonconductive epoxy. Since the human skin has 
a small thickness, the probes of the PEF were made from thin metal wires of different 
diameters. The wires were cut into 10 mm-long segments using precision wire saw 
(WS-22, Princeton Scientific, Easton, PA) so that the contacting surfaces of the 
probes were very smooth. The PEF was then clamped to an acrylic fixture (as shown 
in Figure 3.1 (b)) made in the machine shop with 5 layers of scotch tapes (Scotch 
Magic tape, 3M, St. Paul, MN ) as a spacer. The radiuses of the probes are shown in 
Table 5.1.  
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Figure 5.3 (a) A schematic of a piezoelectric finger (PEF) with cylindrical probe for 
skin and skin cancer measurements; (b) A picture of the PEF in acrylic clamp. 
 
 
 
Table 5.1 The radiuses of the PEF probes 
PEF# Contact radius (mm) 
1 0.23±0.01 
2 0.38±0.01 
3 0.42±0.01 
4 0.52±0.01 
5 0.66±0.01 
6 0.83±0.01 
7 0.98±0.01 
8 1.05±0.11 
9 1.38±0.05 
10 1.68±0.02 
11 2.00±0.01 
12 3.80±0.11 
Clamp 
Driving Electrode 
Sensing Electrode Spacer 
(a) 
(b) 
Stainless Steel 
Cylindrical 
Probe 
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The PEF measurement system for skin consists of a PEF, a custom-build 
electronic board, and a laptop computer as shown in Figure 5.4. The electronic board 
worked to generate the applied voltages on the driving PZT of the PEF and to read the 
induced voltages from the sensing PZT of the PEF. It communicates with the laptop 
through a RS232-USB port. 
 
 
 
 
Figure 5.4 A photograph of PEF measurement system which consists of a PEF, an 
electronic board, and a laptop for control and display. 
 
 
 
5.2.2 Elastic Modulus of Skin 
As an example, the elastic modulus of a 40 mm × 40 mm × 7 mm porcine skin 
sample measured by 12 PEFs with different contact sizes is shown in Figure 5.5. The 
elastic modulus of the sample decreases with the contact size at the beginning due to 
Electronic 
board  
PEF  Sample 
Computer 
display  
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the reason that the depth sensitivity of a PEF is related to its contact size. A PEF with 
a larger contact can measure the stiffness from deeper tissues. As illustrated in Figure 
5.2, the skin can be modeled as a stiff film (dermis) on a soft substrate (hypodermis). 
The elastic modulus measured by a large contact, i.e. 2 mm in radius, is mostly 
composed of the modulus of the hypodermis, and therefore is smaller than that 
measured by a small contact. However, the measured elastic modulus by 3.8-mm 
contact size increases due to a limited thickness in skin sample. When the depth 
sensitivity of a PEF is larger than the sample thickness, it may detect the stiff 
substrate underneath the sample, for example petri dish and table top, resulting in an 
increase in the measured elastic modulus. A methodology is then developed to 
retrieve the elastic modulus and thickness of dermis from PEF measurements.  
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Figure 5.5 Elastic modulus measured by PEFs with different contact size on porcine 
skin sample 
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5.3 Determine the Elastic Modulus and Thickness of Dermis  
5.3.1 Methods to Deduce the Modulus and Thickness in a Film-Substrate 
System 
Indentation of an elastic thin film on a substrate has been extensively studied 
in the literature. Several models have been proposed to describe the relationship 
between the effective elastic modulus and the elastic properties of the film-substrate 
system, indenter geometry, and film thickness in order to allow film modulus and 
thickness to be extracted from data collected from indentation tests.  
Doerner and Nix [169] developed an empirical model including exponential 
terms depending on the relative indentation depth, h/t, where h is the indentation 
depth and t is the film thickness, multiplied by an empirically determined weight 
factor α. The expression was valid only for Berkovich indenter discussed in their 
paper. King [170] modified the model using numerical analysis and extended it for 
different indenter geometries. Battacharya and Nix [171] demonstrated that results 
from finite element method were in good agreement with King’s model for aluminum 
film on silicon substrate and vice versa. Saha and Nix [172] subsequently modified 
King’s model for non-flat indenter geometries. They applied the model to aluminum 
films of various thickness on different substrates (sapphire, silicon and aluminum). 
The calculated film modulus value was in the order of magnitude of the actual value 
for indentation depths less than 50% of the film thickness, but with rather large 
variance. Another analytical model was developed by Bec et al. [173, 174] , based on 
the indentation by cylindrical flat punch on an homogeneous film deposited onto a 
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semi-infinite substrate. The system was modelled by two spring connected in series 
and the global stiffness was calculated from the reciprocal sum of the film stiffness 
and the substrate stiffness. Gao [175] developed an analytical expression with a 
perturbation method for the film and substrate modulus, from the analysis of the 
contact between a cylindrical flat punch and a coated material. The ratio of the film 
and substrate modulus has to be between 0.5 and 2, which gives the limit of use for 
this model. Rar [176] proposed an extension of Gao’s model to become applicable to 
a larger range of film and substrate moduli mismatch, from 0.1 to 10. However, in 
Gao or Rar’s models, the Poisson’s ratios of the film and substrate have to be known, 
which brings difficulty in applying the models to skin and skin cancers.  
Recently, Perriot and Barthel [177] proposed an empirical expression derived 
from Green’s function to calculate the effective elastic modulus of a semi-infinite 
film-substrate system as illustrated in . It has been showed that the model of Perriot et 
al. had the best agreement with the results from finite element method compared with 
the models of Bec et al. and Rar et al., in the case of a rigid layer onto a compliant 
substrate [178].  
In the model of Perriot et al., the effective elastic modulus (E) of the film-
substrate system by indentation can be expressed as    
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where Ef and Es are the elastic moduli of film and substrate, respectively; t is the 
thickness of film; a is the radius of the indenter; n and x0 are adjustable variables. x0 
depends on the moduli ratio of the two layers: 
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Figure 5.6 An illustration of the indentation on a semi-infinite film-substrate system 
 
 
 
In the skin, the thin and stiff dermis layer is the film and the thick and soft 
hypodermis layer is the substrate. The effective elastic moduli measured by PEFs 
with different contact sizes on the skin surface are a combination of the respective 
moduli of the dermis and the hypodermis. The relative contribution of each individual 
layer to the effective elastic modulus is determined by the thickness of dermis and the 
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contact size of each PEF. Therefore, the effective elastic modulus E measured by PEF 
indentation can be expressed as  
n
fatdermis
fat
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
                                                   (5-3) 
where Edermis is the elastic modulus of the dermis layer and Efat is the elastic modulus 
of the hypodermis which is mostly fat; t is the thickness of dermis; a is the radius of 
the PEF contact; n and x0 are adjustable variables. x0 depends on the moduli ratio of 
the two layers: 
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The equation has been proved to be in good agreement with the results from 
finite element method when the modulus ratio between the two layers varies between 
0.01 and 100. The elastic modulus of dermis is in the range of 40 to 2000 kPa [135, 
137, 139] and the elastic modulus of hypodermis is about 10 kPa. Therefore, it is 
possible to use the model of Perriot et al. to extract the mechanical properties and 
thickness of human skins from PEF indentation results.  
5.3.2 Evaluate the Method Using Finite Element Analysis (FEA)  
The model developed by Perriot et al. was derived from semi-infinite samples, 
while human skins have finite thickness. It remains unclear whether the model could 
be applied to deduce the mechanical properties of skin. Finite element simulations 
were done to evaluate the performance of the model for skin applications.  
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5.3.2.1 FEA Model Creation 
An axisymmetric model was used to minimize the computation time, since the 
indenter was a cylindrical. The model consisted of a stiff dermis layer and a soft 
hypodermis layer as illustrated in Figure 5.7. The radius of the skin model was 125 
mm, large enough for the indentation test. The thickness of the dermis layer, t, 
changed from 1 mm to 3 mm, which was consistent with the thickness of human skin. 
The thickness of the skin model, D, changed from 10 mm to 150 mm, in order to 
include various hypodermis thickness.  
 
 
 
Figure 5.7 A schematic to illustrate the skin model created in finite element 
simulation 
 
 
 
The dermis and hypodermis in the skin model were defined as isotropic, 
linearly elastic materials. The Young’s modulus of dermis layer, Edermis, was assumed 
to be 38, 68, 100, 130, and 170 kPa in the simulations. Since the hypodermis layer 
Indenter 
Radius: a 
t 
Radius: 125 mm 
D 
 
Dermis, Edermis 
 
 
 
 
Hypodermis, Efat 
 
w 
 167 
was mostly fat tissue, the Young’s modulus of hypodermis was defined as 8 kPa. 
Poisson’s ratio of both the dermis and hypodermis was defined as 0.49999 since most 
soft tissues are nearly incompressible with Poisson’s ratio ranging from 0.49000 to 
0.49999 [160, 161]. The mesh of the skin model was set dense enough so that the 
convergence could be reached. Figure 5.8 shows a portion of the mesh in the skin 
model with a dermis thickness of 2.5 mm.  
In human skins, the dermis and hypodermis layers are bond closely. Therefore, 
the contact surfaces of dermis and hypodermis were defined as “tie” in constraint 
with the contact surface in hypodermis as “master surface” and the surface in dermis 
as “slave surface”. The boundary condition of the skin model was defined that the 
bottom of the model was “encastred”. The left edge of the model was the symmetry 
axis and it was set as “XSYMM” since it was an axisymmetric model. A uniform 
displacement (0.01 mm) was applied to the skin surface to simulate the indentation 
with rigid and flat-ended cylindrical indenters. The radius of the indenter, a, varied 
from 0.01 mm to 5.00 mm in the simulation.  
5.3.2.2 Elastic Modulus of Skin from FEA  
As an example, the simulation result of indentation on the skin model with an 
indenter of 5 mm in radius is shown in Figure 5.8. The thickness of the dermis was 
2.5 mm and the total thickness of the skin was 150 mm. The reaction forces exerted 
on the model surface were summed to calculate the effective elastic modulus. Based 
on Hayes’ solution [162], elastic modulus can be deduced using the following 
equation: 
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where E is elastic modulus; F is the indentation force, which can be calculated from 
the simulation results; ν is Poisson’s ratio, which is 0.49999 defined before 
simulations; w is the indentation depth, which is 0.01 mm as determined in the 
boundary condition; a is the radius of the indenter; h is the thickness of the tissue; κ is 
a scaling factor that depends on the aspect ratio a/h and Poisson’s ratio ν. 
FEA was performed for indenters ranging from 0.01 to 5 mm and the effective 
elastic modulus calculated from simulations was plotted versus the indenter radius in 
Figure 5.9. The total thickness of the skin model (D) was 150 mm, and the thickness 
of dermis layer (t) was 2.5 mm. Young’s moduli of dermis and hypodermis were 38 
kPa and 8 kPa, respectively. The data was fit to the Perriot’s model using the 
Equations 5-3 and 5-4 shown as the red curve in the figure. Obviously, the data fit to 
the model very well, with R2 larger than 0.999. From the fitting curve, the elastic 
moduli of the dermis and hypodermis were determined to be 37.6 kPa and 7.6 kPa, 
respectively, in good agreement with the values defined in the simulation. The 
deduced thickness of dermis was 2.56 mm, very close to the dermis thickness in the 
skin model. The result suggests that the model developed by Perriot et al. can be 
applied to determine the mechanical properties and thickness of human skins.  
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Figure 5.8 A portion of the skin with a 2.5-mm thick dermis layer simulated in 
ABAQUS. The radius of the model was 125 mm and the radius of the indenter was 5 
mm.  
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Figure 5.9 Effective elastic modulus (E) versus indenter radius from finite element 
analysis. The dermis thickness (t) was 2.5 mm and the total thickness of the model (D) 
was 150 mm.  
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5.3.2.3 Results with Finite Sample Thickness  
Skin models with different hypodermis thickness were also simulated in FEA 
to evaluate the performance of using Perriot’s Model for skins. The effective elastic 
modulus versus indenter radius when the dermis thickness was 1.0 mm is plotted in 
Figure 5.10. The elastic moduli of dermis and hypodermis were 38 kPa and 8 kPa, 
respectively. The total sample thickness (D) varied from 10 mm to 150 mm. It is clear 
that the effective elastic modulus decreases with the indenter radius, since a larger 
indenter is able the detect more of the soft hypodermis. However, when the total 
sample thickness is small, for example D = 10 mm, and indenters are large enough, 
the effective elastic moduli increase with the contact sizes. It is because in the 
simulation, the bottom of the skin was defined as fixed which was similar to the 
situation that the skin was on stiff muscles or bones in vivo or to the situation that 
excised skin tissues was placed in a petri dish on a very rigid desk. When the 
indenters were very large, the indentation test was measuring the skin as well as the 
stiff tissue or desk underneath, and thus the effective elastic modulus increased. The 
model developed by Perriot et al. was based on semi-infinite samples and did not take 
into account this effect. Therefore, it could not be directly applied to thin skin 
samples.   
To overcome this problem, data affected by the stiff tissue underneath the skin 
was excluded in the fitting. The slope of effective elastic modulus (E) versus indenter 
radius (a), which was calculated by dividing the difference in E values (ΔE) by the 
difference in the indenter radius (Δa) between two adjacent data points as shown in 
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Figure 5.10, is used as a criterion. When the slope was larger than 0, the elastic 
modulus increased with the indenter size, which means the data was affected by the 
stiff tissue underneath the skin and should be excluded in the analysis. When the 
slope was smaller than 0, the E values were plotted versus the indenter sizes and fit to 
the model developed by Perriot et al. and the elastic modulus and thickness of dermis 
could be determined.  
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Figure 5.10 Simulated effective elastic modulus (E) versus indenter radius (a) with 
different skin sample thickness (D). Elastic moduli of dermis and hypodermis were 
set as 38 kPa and 8 kPa, respectively. The dermis thickness (t) was 1.0 mm. 
 
 
 
Based on the criterion, proper data was selected for fitting and the elastic 
modulus and thickness of the dermis were determined for skin models with dermis 
thickness ranging from 1 mm to 3 mm. The deduced dermis elastic modulus was very 
close to the actual value which was 38 kPa as shown in Figure 5.11 (a). The deduced 
values were very accurate and were not affected by the dermis thickness (t) or total 
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sample thickness (D). The estimated dermis thickness was plotted versus its actual 
values in Figure 5.11 (b) and the data was all close to the dashed line which had a 
slope of 1. Linear fitting was performed and the fitted slopes and intercepts were 
listed in Table 5.2. It is obvious that there was very good correlation (R2>0.98) 
between the t deduced from the Perriot’s model and t defined in the simulation, no 
matter of the skin sample thickness. Besides, the slopes from the linear fitting were 
close to 1 with an error smaller than 11%. These results proves that we can determine 
the elastic modulus and thickness of dermis in skin samples very accurately using 
Perriot’s model combined with the criterion to exclude data affected by substrate 
underneath the skin. When the skin sample is too thin, i.e. less than 6 mm, there is not 
enough data for the fitting and thus the elastic modulus and thickness of dermis 
cannot be determined accurately.  
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Figure 5.11 (a) The deduced elastic modulus of dermis versus dermis thickness. The 
actual dermis modulus was 38 kPa as shown in green dashed line. (b) The deduced 
dermis thickness versus the actual values. The dashed line has a slope of 1.  
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Table 5.2 The linear fitting of the deduced dermis thickness (t) of skin samples versus 
the actual t values  
Total sample 
thickness D (mm) 
Intercept Slope R2 
Value Error Value Error 
150 0.11 0.30 1.11 0.16 0.9891 
60 -0.03 0.26 1.10 0.16 0.9981 
30 0.06 0.23 0.98 0.14 0.9964 
20 0.24 0.17 0.86 0.11 0.9947 
10 -0.01 0.18 0.94 0.13 0.9853 
 
 
 
 
5.3.2.4 Results with Different Edermis and Dermis Thickness 
Different Young’s moduli of dermis, 38, 68, 100, 130, and 170 kPa, were also 
tried in FEA to evaluate the methodology. The thickness of the dermis varied from 
1.0 mm to 3.0 mm with a 0.5 mm interval, within the range of human skin thickness. 
The skin sample was 10 mm thick. The elastic modulus of dermis (Edermis) was 
deduced from stiffness measurements with indenters of different sizes using the 
Perriot’s model and plotted versus the actual value in Figure 5.12 (a). It is obvious 
that Edermis were determined very accurately using the method for various dermis 
thickness. The linear fitting of the data in Table 5.3 showed that the slope was very 
close to 1 with a R2 larger than 0.9994, indicating the deduced values were very 
accurate and they were not affected by the dermis thickness. The dermis thickness 
was also determined using the model and plotted versus the actual value in Figure 
5.12. The error of the thickness determination was less than 0.5 mm for various Edermis 
values. The linear fitting results in Table 5.4 further demonstrate that the deduced 
dermis thickness was in good agreement with the actual value.  
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Figure 5.12 (a) The deduced elastic modulus of dermis (Edermis) versus its actual value 
when the dermis thickness (t) changed from 1.0 to 2.5 mm. (b) The deduced dermis 
thickness versus the actual values when the elastic modulus of dermis ranging from 
38 kPa to 170 kPa. The dashed green line in both figures has a slope of 1. 
 
 
 
Table 5.3 The linear fitting results of the deduced elastic modulus of dermis versus 
the actual Edermis for different dermis thickness (t) 
t (mm) 
Slope Intercept 
R2 
Value Standard deviation Value Standard deviation 
1.0 0.99 0.01 0.41 0.42 0.9994 
1.5 0.99 0.00 -0.22 0.36 0.9999 
2.0 0.99 0.00 -0.09 0.27 0.9999 
2.5 0.99 0.00 -0.09 0.26 0.9999 
3.0 0.99 0.00 -0.08 0.29 0.9999 
 
 
 
 Table 5.4 The linear fitting results of the deduced dermis thickness (t) versus the 
actual value for different Edermis 
Ef (kPa) 
Slope Intercept 
R2 
Value Standard deviation Value Standard deviation 
38 0.92 0.09 0.28 0.18 0.9970 
68 0.94 0.12 0.24 0.22 0.9993 
100 0.95 0.11 0.17 0.22 0.9994 
130 0.98 0.09 0.02 0.18 0.9986 
170 0.97 0.10 -0.03 0.21 0.9987 
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Based on all the FEA results above, we can get to the conclusion that the 
elastic modulus and thickness of dermis could be determined accurately from 
stiffness measurements by indenters of different sizes using the model developed by 
Perriot et al. combined with the criterion for excluding data affected by stiff substrate 
underneath the skin sample.  
5.3.3 Deduce the Elastic Modulus and Thickness of Dermis in Skin Phantoms 
Skin phantoms as illustrated in Figure 5.13 were constructed to simulate 
normal human skins. They consisted of a thin film which was Versaflex (CL2003, 
CL2000, and CL30, GLS, McHenry, Illinois), a kind of elastic polymer, and a gelatin 
substrate. The elastic moduli of Versaflex CL2003, CL2000, and CL30 were 
determined to be 38.5±2.1 kPa, 68.2±3.6 kPa, and 130.4±3.8 kPa, respectively by 
PEF measurements on bulk material. They were made into thin films to mimic the 
dermis layer in human skin. Gelatin with an elastic modulus of 8.3±1.4 kPa was used 
to simulate the hypodermis/fat layer of the skin. The diameter of the skin phantom 
was 90 mm. The thin film of Versaflex was carefully placed on the gelatin surface so 
that there was no air bubbles between the two layers. The thickness of the Versaflex 
layer varied from 0.5 to 3 mm and the total thickness of the skin phantom ranged 
from 6 to 15 mm.  
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Figure 5.13 A schematic of the skin phantom 
 
 
 
PEFs of different contact sizes ranging from 0.23 mm to 3.8 mm as listed in 
Table 5.1 were used to measure the effective elastic moduli of skin phantoms on the 
surface. As an example, the elastic modulus of the skin phantom (t = 1.19±0.13 mm 
and D = 6.1 mm) is plotted versus the PEF contact size in Figure 5.14. The data 
(black squares) which was not affected by the stiff substrate underneath the phantom 
was fitted to Perriot’s model using the criterion that the slope of modulus E versus 
indenter radius was smaller or equal to 0. The deduced elastic modulus of dermis 
from the fitting results was 34.8±1.9 kPa, matching the actual modulus of Versaflex 
(38.5±2.1 kPa). The dermis thickness was determined to be 1.38±0.15 mm, showing 
good agreement with the actual value (1.19±0.13 mm) measured by caliper.   
The elastic modulus and thickness of dermis deduced from the fitting results 
were compared with the actual values for all the 18 samples. Figure 5.15 shows the 
deduced elastic modulus for various dermis thickness. The shaded area in the figure 
indicates the actual elastic modulus of the dermis layer. As can be seen, most of the 
deduced Edermis were in the shaded areas when the dermis thickness was between 0.5 
 
x Versaflex (dermis) 
Gelatin (Hypodermis) 
t 
D: 6-15 mm 
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mm and 3.5 mm, suggesting that the methodology could be used to determine the 
elastic modulus of dermis very accurately.  
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Figure 5.14 Elastic modulus versus PEF contact radius on skin phantoms. The dermis 
thickness (t) was 1.19±0.13 mm and the total thickness of the model (D) was 6.2 mm.  
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Figure 5.15 The deduced elastic modulus of dermis (Edermis) versus dermis thickness. 
The expected values of the dermis modulus were 38.5±2.1 kPa, 68.2±3.6 kPa, and 
130.4±3.8 kPa as shown in shaded areas. 
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The dermis thickness was also gathered and plotted versus its actual value, 
which was measured with a caliper, in Figure 5.16. It is apparent that all the data 
points were close the dashed line whose slope was 1. No matter how the Edermis 
changed, the calculated dermis thickness agreed with the actual value well. Linear 
fitting was performed on the data and the fitting curve had a slope of 1.01 with an 
intercept of 0.02. R2 was 0.9878, implying there was a good linear relationship 
between the deduced and actual values.  
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Figure 5.16 The deduced dermis thickness versus its actual value. The dashed line 
had a slope of 1. 
 
 
 
From the results shown above, we can tell that the elastic modulus and 
thickness of dermis could be determined correctly by applying the Perriot’s model to 
the stiffness measurement results from PEFs of different contact sizes. If the slope of 
modulus E versus indenter radius was larger than 0, the stiffness data was excluded in 
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the model fitting due to the reason that it contained the elastic information of the 
substrate underneath the skin phantom.  
5.3.4 Deduce the Elastic Modulus and Thickness of Dermis in Porcine Skin  
A number of morphologic, anatomic, dermatologic, and immunohisto-
chemically studies have demonstrated that porcine skin has important similarities in 
morphology and cellular composition to human skin [179-182]. The epidermis of the 
pig is reported as varying in thickness from 30 to 100 µm [183] and 70 to 140 µm 
[184], thus being within a range similar to that in human, 50 to 150 µm [87, 88]. The 
dermis layer is also very similar to human skin. Collagen in the porcine dermis shows 
a remarkable similarity to human collagen [185], making the mechanical properties of 
porcine dermis very similar to that of human skin. In addition, the properties of 
porcine skin are not significantly affected by the lack of a physiological environment 
provided there is enough moisture [186]. Therefore, porcine skin was used in this 
section as an analogue of human skins.  
Fresh porcine skin was harvested from the belly part from a local abattoir. 
Each sample was cut into 40 mm × 40 mm pieces as shown in Figure 5.17. The 
muscle layer was removed if found. Only the skin and fat tissue was left in the sample. 
The total thickness of the sample was 6-10 mm. Paper tissue was damped with saline 
solution and placed on the sample to keep it moist. Effective elastic moduli were 
measured by PEFs of different contact sizes as listed in Table 5.1 on the center of the 
sample. Afterward, a 10 mm × 10 mm square was marked on the center of the sample 
and the part outside the square was cut. The hypodermis layer was removed by a 
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razor blade. The thickness of the dermis (including the epidermis layer) was 
measured with a caliper. The stress/strain curve of the 10 mm × 10 mm porcine 
dermis was measured by Bose ElectroForce® 3100 (TA Instruments, New Castle, 
DE) as shown in Figure 5.18 using compression testing to deduce the elastic modulus 
of the dermis layer.  
 
 
 
Figure 5.17 A picture of the porcine skin sample 
 
 
 
 
Figure 5.18 The Bose ElectroForce® 3100 for compression test 
Dermis 
2.96 mm 
Hypodermis 
4.25 mm 
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As an example, the effective elastic moduli of the porcine skin sample shown 
in Figure 5.17 measured by PEFs were shown in Figure 5.19. The data with 
monotonic decrease was fit to Equations 5-3 and 5-4 in Perriot’s model. From the 
fitting results, the elastic modulus of dermis was determined to be 127.8±9.8 kPa. The 
thickness of the dermis was calculated to be 2.87±0.38 mm, which agreed well with 
that measured by a caliper, 2.96±0.18 mm, after the hypodermis layer was removed 
by a razor blade. The stress/strain curve of the dermis layer of the same sample was 
measured by Bose system as shown in Figure 5.20. Linear fitting was performed on 
the relatively linear region of loading data where the strain was less than 2.5%. The 
slope of the fitting, which represented the elastic modulus of the dermis, was 
determined to be 118.9 kPa. Three independent compression tests were done for the 
same sample and the averaged value of the dermis modulus was 121.9±5.3 kPa. It 
suggests that the dermis modulus deduced from PEF measurements was very accurate.  
Six porcine skin samples were tested in this study. The elastic modulus and 
thickness of the dermis determined by PEFs were compared with other methods in 
Table 5.5. The dermis moduli deduced from PEF measurement results were quite 
consistent with those calculated from the stress/strain curve for all the six samples, 
with an error less than 15 kPa, which was calculated by taking the difference between 
Edemis deduced by PEF and by Bose. The dermis thickness determined by PEF was 
also in good agreement with the value measured by caliper, with a maximum error of 
0.39 mm.   
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Figure 5.19 Elastic modulus of a porcine skin sample measured by PEFs of different 
contact size. The data was fit to Perriot’s model to deduce the elastic modulus and 
thickness of dermis.  
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Figure 5.20 The stress versus strain curve of a porcine dermis in a compression test 
measured by Bose ElectroForce® 3100. The slope of the linear fitting curve is the 
elastic modulus of the dermis, 118.9 kPa.  
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Table 5.5 Elastic modulus and thickness of the dermis layer in porcine skin samples 
Sample # 
Edermis (kPa) Dermis thickness (mm) 
By Bose By PEF PEF Error By caliper By PEF PEF Error 
1 125.4 ± 10.4 124.2 ± 4.1 -1.2 2.85 ± 0.18 3.04 ± 0.21 0.19 
2 111.3 ± 14.4 125.6 ± 12.2 14.2 3.06 ± 0.17 3.31 ± 0.51 0.25 
3 121.9 ± 3.3 127.8 ± 9.8 5.9 2.96 ± 0.18 2.87 ± 0.38 -0.09 
4 127.1 ± 11.4 115.2 ± 4.2 -11.8 2.51 ± 0.21 2.30 ± 0.29 -0.21 
5 126.9 ± 8.2 128.2 ± 5.5 1.3 2.77 ± 0.23 2.38 ± 0.37 -0.39 
6 124.8 ± 12.7 139.5 ± 6.8 14.7 2.39 ± 0.19 2.19 ± 0.34 -0.20 
 
 
 
In this section, excised porcine skin samples were used to mimic human skins. 
The results showed that the elastic modulus and thickness of dermis could be 
accurately deduced from effective elastic moduli measured by PEFs using the 
combination of Perriot’s model and the criterion to exclude the data affected by stiff 
substrate for model fitting.  
5.4 Conclusions 
In this chapter, PEFs with different contact sizes were used to measure the 
elastic modulus of skin. The results show that the moduli decrease with an increase in 
PEF contact size, indicating that the effective elastic modulus measured by the PEF 
with a small contact size mainly depends on the stiff dermis layer while that measured 
by the PEF with a large contact size is more affected by the soft hypodermis layer. 
Besides, if the skin sample is not thick enough, the elastic moduli from the PEF with 
a large contact size, may be affected by the stiff substrate underneath the sample, i.e. 
petri dish and the table.  
To resolve the elastic modulus and depth profile of skin, the effective elastic 
moduli (E) were plotted versus the PEF contact radiuses. If the slope between two 
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adjacent data points was larger than 0, it means the later data point was affected by 
the sample substrate and thus was excluded for depth profile determination. The 
model developed by Perriot et al., which showed good results in the case of a rigid 
layer on a compliant substrate [177], was chosen to fit the data and the elastic 
modulus and thickness of the dermis layer in skin could be deduced from the fitting 
results.  
The methodology was first validated using finite element analysis (FEA) in 
which skin models with different dermis thickness (1-3 mm) and total thickness (10-
150 mm) were constructed and the effective elastic moduli from indenters of 0.01-
0.50 mm in radius were simulated. The deduced elastic moduli of dermis agreed with 
the defined values in FEA well with a maximum error of 2.4 kPa. The dermis 
thickness determined by the methodology was within 0.1 mm from the actual value. It 
suggests the elastic modulus and thickness of dermis can be resolved from PEF 
measurements with different contact sizes using Perriot’s model. 
 Skin phantoms were built using Versaflex CL2003, CL2000, and CL30 with 
an elastic modulus of 38.5, 68.2, and 130.4 kPa, respectively, as dermis layer and 
gelatin matrix with an elastic modulus of 8.3 kPa as hypodermis layer. PEFs with 
contact sizes ranging from 0.23 to 3.80 mm were used to measure the effective elastic 
moduli of skin phantoms. Elastic modulus of dermis was deduced from the fitting of 
Perriot’s model and showed good agreement with the actual values, with a 
discrepancy less than 7.5 kPa. The dermis thickness by PEF was within 0.2 mm of the 
actual values measured by caliper.  
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Six porcine skin samples with a size of 40 mm × 40 mm were measured by 
PEFs. The deduced elastic moduli of dermis layer from PEF were compared with 
those measured by Bose ElectroForce® 3100 using a compression test. It shows that 
PEF could determine the dermis modulus accurately, with an error less than 14.7 kPa. 
The dermis thickness estimated by PEF also matched the actual values measured by 
caliper, with an error less than 0.4 mm. 
In conclusion, the elastic modulus and thickness of dermis in skin could be 
determined accurately from PEF measurements with different contact sizes combined 
with Perriot’s model, making the PEF a good tool for skin characterization. It will 
help detect skin disease and quantify the effectiveness of dermatologic products.  
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6. DETERMINE THE 3D PROFILE OF SKIN TUMOR IN PHANTOMS 
Most nonmelanoma skin cancers, i.e. basal cell carcinoma and squamous cell 
carcinoma, are non-pigmented. It is difficult for the dermatologist to decide where to 
cut by eye. Mohs surgery, in which skin tissues are removed progressively and 
examined by pathology until only cancer-free tissue remains, is widely used for 
nonmalenoma skin cancers. However, the procedure is tedious and time-consuming 
and it requires the patient to lie under local anesthesia as histology is performed. An 
inability to remove a tumor in one day may preclude immediate reconstruction after 
complete excision. A rapid technique to identify the borders of nonmelanoma skin 
cancers is desired to reduce the time spent in surgery.  
For melanomas, the thickness of the cancer, which is the distance from the 
skin surface to the deepest point of cancer, is one of the most important prognostic 
factor. It also help the dermatologist decide the surgical margin [187, 188]. In 
removing an invasive melanoma that is 1 mm or less in thickness, the surgeon excises 
1 cm of the normal skin surrounding the tumor. If the melanoma is 2 mm thick or 
greater, a margin of 2 cm is taken. Pathological investigation is the current gold 
standard for melanoma evaluation, but it is time-consuming and can only be done 
after surgery. A method that can quantify the thickness of melanoma before the 
surgery is needed.  
It has been reported that the elastic modulus of basal cell carcinoma is much 
smaller than that of normal skin [139]. And melanoma can be either softer or stiffer 
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than normal skin [135, 140], depending on its malignancy. It is therefore feasible to 
use stiffness contrast measured to differentiate cancerous tissues from normal skin.  
In this chapter, PEF with a contact radius of 0.23±0.01 mm is used to detect 
skin cancers in phantoms and determine the lateral sizes of cancers. Then the depth 
profile of skin is estimated by coupling the elastic modulus measurements by PEFs 
with different contact sizes and a modified 2-spring model. Combining the lateral and 
depth profile of model skin cancers in porcine skins, the 3D image of the cancers is 
constructed.   
6.1 Determine the Lateral Extent of Skin Tumor in Phantoms 
6.1.1 Skin Cancer Phantoms 
Skin tumor phantoms were constructed using Versaflex CL2003, CL2000, and 
CL30 (GLS, McHenry, Illinois) and gelatin (Now Foods, Bloomingdale, IL) matrix. 
The Versaflex CL2003 and CL2000 were mixed with a ratio of 1:1 and melt at 
100 °C on a hot plate to form a thin layer (about 1 mm thick) to mimic the skin cancer 
because its elastic modulus of 55.2±3.4 kPa was similar to that of basal cell 
carcinoma reported in the literature [139]. After cooling at room temperature, they 
were cut into 4×4, 6×6, 8×8, 10×10, and 12×12 mm2 squares. The dermis layer of the 
skin tumor phantom was made of Versaflex CL2000 and CL30 with a ratio of 1:3 and 
its elastic modulus was 115.3±4.2 kPa, consistent with the elastic modulus of dermis 
measured by PEFs in porcine skins as described in Chapter 5 and that reported in 
References [163, 164, 166] which was approximately from 88 to 300 kPa. The dermis 
layer with a thickness of 1-3 mm and a diameter of 90 mm, was melt in a petri dish 
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with the same diameter at 100 °C. The skin tumor squares were then placed on the 
dermis and they gradually sank in the melt dermis until their surfaces had the same 
level. After cooling, the skin tumors were bond to the dermis tightly. They 
hypodermis/fat layer of the skin was made of gelatin with a concentration of 0.8 g/ml 
and has an elastic modulus of 8.5±1.2 kPa. The thickness of the hypodermis layer was 
4-5 mm and the diameter was 90 mm. The dermis layer with skin tumor was placed 
on the gelatin matrix carefully so that there was no air bubbles between two layers.  
 
 
 
Figure 6.1 A schematic illustration the cross section of the skin tumor phantom 
 
 
 
6.1.2 PEF Measurements on Skin Tumor Phantoms 
Since skin cancer starts from the surface of skin, using the stiffness contrast 
on the outermost of the skin is better than using that of deep tissue in order to 
differentiate skin cancers from normal tissue. Therefore, the PEF with a smallest 
contact radius (0.23±0.01 mm) whose depth sensitivity was only about 0.46 mm was 
chosen to measure the elastic modulus of the phantom. Firstly, a grid was drawn on 
the phantom surface for location tracking. The PEF was then placed on the first 
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location and the elastic modulus measurements were performed. Five repeated 
measurements were made for each location to obtain an average elastic modulus and 
standard deviation. Then the PEF was placed on the second location. It was repeated 
until the entire phantom was scanned. A 2D color coded elastic modulus map of the 
scanned skin tumor phantom was created based on the average elastic modulus.   
As an example, the 2D elastic modulus map of the skin phantom with a 4×4 
mm2 skin tumor is shown in Figure 6.2 . The green color stands for the normal tissue 
while the red color represents the decreased elastic modulus, indicating the skin 
tumor. The actual location of the cancer is marked by the black square in the figure. It 
is clear that the red region matches the location and size of the tumor very well. It 
suggests that the PEF is able to successfully detect the skin tumor and locate it in 2D 
accurately.  
 
 
 
Figure 6.2 Elastic modulus map of the phantom with a 4×4 mm2 skin cancer by PEF. 
The actual location of the cancer is marked with black squares  
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6.1.3 Lateral Tumor Size Determination  
To determine the size of the cancer quantitatively, the elastic modulus at 
certain x distance was plotted versus y distance. As an example the elastic modulus of 
the skin cancer shown in Figure 6.2 at x = 10 mm is plotted versus y in Figure 6.3. 
The data was then fitted to a Gaussian function and the half peak width was taken as 
the size of the cancer. In this example, the half peak was 76.9 kPa which wass 
calculated by averaging the baseline of the Gaussian fit (101.6 kPa) and the peak 
(52.2 kPa). The width of the bell shaped curve at the half peak provides the size of the 
cancer, 3.9 mm. It is consistent with the actual size of the cancer which is 4.1±0.2 
mm. It is reasonable since the half peak of the modulus is obtained when the PEF is 
scanning over the edge of the cancer where half of the PEF is over the cancer and the 
other half of the PEF is over the normal skin.  
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Figure 6.3 The measured elastic modulus versus y distance at x = 10 mm for the skin 
cancer phantom shown in Figure 6.2. The size of the cancer taken as the width at the 
half peak height of the Gaussian fit was 3.9 mm.  
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The lateral extent of the skin tumors in phantoms determined by PEF is listed 
in Table 6.1. The actual sizes measured with a caliper are also included. The sizes 
estimated by PEF had good agreement with the actual ones, with an error less than 
±1mm. Therefore, it can be concluded that the PEF could not only detect skin cancers 
but also determine the locations and lateral sizes of the skin cancers accurately.  
 
 
Table 6.1 Comparison of the lateral sizes of skin cancers in phantoms measured by 
PEF and their actual values by caliper 
Model 
# 
Size in X direction (mm) Size in Y direction (mm) 
Actual value 
by caliper 
Measured 
by PEF 
PEF 
Error 
Actual value 
by caliper 
Measured 
by PEF 
PEF 
Error 
1 4.1±0.2 3.9±0.4 -0.2 4.3±0.4 4.0±0.5 -0.3 
2 6.2±0.4 5.8±0.5 -0.4 6.1±0.5 6.5±0.6 0.4 
3 7.9±0.5 8.6±0.4 0.7 8.3±0.6 9.2±0.4 0.9 
4 9.8±0.4 10.6±0.6 0.8 9.7±0.5 8.9±0.7 -0.8 
5 12.2±0.5 11.3±0.8 -0.9 11.8±0.5 12.5±0.8 0.7 
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6.2 Determine the Depth Profile of Skin Tumors in Phantoms Using Spring 
Model 
6.2.1 Skin Cancer Phantoms 
Skin cancer phantoms consisting of Versaflex CL2003, CL2000, and CL30 
and gelatin matrix were built to mimic skin cancers with different depth profile. Same 
with the phantoms mentioned in Section 6.1.1, the elastic moduli of skin cancer, 
dermis and hypodermis are 55.2±3.4 kPa, 115.3±4.2 kPa, and 8.5±1.2 kPa, 
respectively. The size of the model tumors was 8×8 mm2 and the thickness of the 
tumors varied from 0.6 mm to 4.4 mm. The thickness of dermis ranged from 1.9 mm 
to 3.2 mm so that some tumors are within the dermis layer as illustrated in Figure 6.4 
(a-c) and some have invaded into hypodermis layer as shown in Figure 6.4 (d-e). The 
phantoms were all about 10 mm in total thickness.  
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Figure 6.4 A schematic illustrating the depth profile of skin cancers in phantoms A-E 
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6.2.2 Determine the Elastic Modulus and Thickness of Dermis in Phantoms 
PEFs of different contact sizes ranging from 0.23 mm to 3.8 mm as listed in 
Table 5.1 were used to measure the elastic moduli of normal tissue in phantoms. The 
data was fitted to Perriot’s model using the criterion that the slope of modulus E 
versus indenter radius was smaller or equal to 0. As an example, the elastic modulus 
of normal tissue in Phantom A versus the PEF contact size is plotted in Figure 6.5. 
The elastic modulus and thickness of dermis could be deduced from the fitting results 
and they were compared with the actual values in Table 6.2. As can be seen, the 
Edermis deduced from PEF stiffness measurements agreed with the actual value very 
well, with an error smaller than 3%. Besides, PEF could estimate the thickness of the 
dermis accurately, with an error less than 0.2 mm. It further validates that the elastic 
modulus and thickness of dermis could be estimated accurately by combining PEF 
measurement and the Perriot’s model. Moreover, the thickness of dermis will be 
compared with the thickness of cancer in the phantom in next sections to determine 
whether the cancer has invaded into the hypodermis layer or not, which is important 
for cancer staging.  
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Figure 6.5 Elastic modulus measured by PEFs with different contact sizes on normal 
region of Phantom A 
 
 
 
Table 6.2 The comparison of elastic modulus (Edermis) and thickness of dermis 
determined by PEF and the actual values in skin tumor phantoms 
Phantom 
# 
Edermis (kPa) Dermis thickness (mm) 
Actual  
Measured 
by PEF  
PEF 
Error 
Actual  
Measured 
by PEF  
PEF 
Error 
AVE SD AVE SD AVE SD AVE SD 
A 115.3 4.2 112.9 4.9 -2.4 2.1 0.2 2.3 0.3 0.2 
B 115.3 4.2 114.1 3.8 -1.2 2.5 0.3 2.6 0.3 0.1 
C 115.3 4.2 112.8 4.6 -2.5 3.2 0.3 3.1 0.4 -0.1 
D 115.3 4.2 116.2 5.1 0.9 1.9 0.2 2.1 0.2 0.2 
E 115.3 4.2 118.3 4.2 3.0 2.4 0.2 2.6 0.3 0.2 
 
 
 
6.2.3 Modified 2-Spring Model to Deduce the Depth Profile of Skin Cancers 
It is known that human skin has a layered structure with a stiff dermis layer 
(including the epidermis) on a soft hypodermis substrate as illustrated in Figure 6.6 
(a). The elastic modulus measured by PEF on the normal region is the effective 
elastic modulus of the dermis and hypodermis (Eeff) as shown in Figure 6.6 (b). Since 
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the skin cancer origins from the surface and grow into the skin, it can be modeled as 
an extra layer on top of the dermis as shown in Figure 6.6 (c). The system is then 
further simplified to a two-layer structure by combining the dermis and hypodermis 
together with an effective elastic modulus (Eeff) which can be measured by PEF on 
normal region. When the thickness of the tumor (t1), which is the distance from the 
sample surface to the bottom of the tumor, is smaller than the depth sensitivity (d) of 
a PEF as shown in Figure 6.6 (d), the tumor and part of the skin within d behave like 
two elastic springs connected in series. The effective elastic modulus E measured by 
PEF on the skin cancer surface can be expressed as  
efft E
td
E
t
E
d 11                                                             (6-1) 
where Et is the elastic modulus of skin tumor which can be measured by a PEF with a 
small contact, i.e. 0.23±0.01 mm in radius; Eeff is the effective elastic modulus of 
normal skin which can be measured by PEF on normal regions in the sample; d is the 
depth sensitivity of a PEF which is about twice the contact size; and t1 is the thickness 
of skin tumor.  
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Figure 6.6 (a) A schematic illustrating the skin with a 2-layer structure; (b) Effective 
elastic modulus of skin (Eeff) measured by PEF; (c) A schematic illustrating the 3-
layer structure of skin cancer; (d) The skin cancer is modeled as a 2-layer structure by 
combining the dermis and hypodermis together.  
 
 
 
As an example, the elastic moduli of skin and skin tumors A1 and A4 (shown 
in Figure 6.4) measured by PEFs with different contact sizes on the phantom surface 
are plotted in Figure 6.7 (a). The elastic modulus of cancer A1 measured by the PEF 
with smallest contact (0.23±0.01 mm in radius) is 53.5±6.3 kPa, the same with the 
known modulus of the phantom, 55.2±3.4 kPa. It is because the depth sensitivity of 
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that PEF is smaller than the tumor thickness and the PEF can only detect the tumor 
layer. As shown in Figure 6.7 (a), when the PEF contact size is less than 1mm, the 
measured elastic moduli of cancer increase with the contact radius due to the reason 
that the skin cancer (55.2±3.4 kPa) in the phantom is softer than the dermis layer 
(115.3±4.2 kPa). PEF with a larger contact, which has a larger depth sensitivity, can 
detect more dermis, resulting an increase in modulus. When contact radius is larger 
than 1 mm, the PEF starts to detect the soft hypodermis layer (8.5±1.2 kPa) and 
therefore the measured elastic moduli decreases with the contact radius. When the 
contact radius is larger than 1.5 mm, due to large depth sensitivity, the measured 
elastic moduli of cancer are about the same with those of skin.  
For the skin cancer A4 which has the same thickness with the dermis layer 
(about 2 mm), the measured elastic modulus is constant when the contact size is less 
than 1 mm. Then the modulus increases a little as the PEF detects the stiff dermis 
layer. When the contact size further increases, the PEF detects the soft hypodermis 
resulting in a decrease in the measured modulus. The elastic modulus of skin cancer 
A4 measured by the PEF with a contact size of 3.8 mm is larger than that of normal 
skin.  
If the skin cancer has penetrated the dermis layer and invaded into hypodermis 
as the skin cancer D3 illustrated in Figure 6.4, the elastic modulus measured by the 
PEF was constant when the contact size is small as shown in Figure 6.7 (b). Then the 
modulus decreases with the contact size as the PEF detects the hypodermis layer.  
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Figure 6.7 (a) Elastic moduli of skin and skin cancers A1 and A4 (illustrated in Figure 
6.4) measured by PEFs with different contact sizes; (b) Elastic moduli of skin and 
skin cancer D3. The thickness of dermis was about 2 mm and the thickness of skin 
cancers A1, A4, and D3 was 0.5±0.1 mm, 2.2±0.1 mm, and 3.6±0.2 mm, respectively.  
 
 
 
Assuming the modulus measured by the PEF with smallest contact on skin 
cancer was the elastic modulus of tumor (Et), the stiffness of cancer and normal skin 
measured by PEFs was used to deduce the thickness of skin cancer using the Equation 
6-1. Note that when the contact size is large, the measured elastic moduli of cancer 
may be the same with those of skin and therefore those data cannot be used for 
calculation. The deduced thickness of each tumor is averaged and compared with the 
actual value measured by caliper in Table 6.3. The skin tumors in phantoms A, B, and 
C are within the dermis layer. The estimated tumor thickness correlated with the 
actual value well, with an error less than 0.2 mm. In phantoms D and E, the tumor 
thickness was larger than the dermis thickness, simulating the situation that the skin 
tumors have penetrated the dermis layer and invaded into hypodermis layer. The 
thickness of tumor determined by PEF was still very accurate and the error was 
smaller than 0.4 mm. It suggests that PEF is able to determine the thickness of the 
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tumor accurately no matter whether the tumor has invaded into hypodermis layer or 
not.  
 
 
Table 6.3 The comparison of tumor thickness determined by PEF and the actual value 
in skin tumor phantoms 
Skin 
tumor # 
Dermis 
thickness 
(mm) 
Tumor thickness (mm) 
Actual  
Measured by 
PEF 
Error 
A1 
2.1±0.2 
0.5±0.1 0.6±0.2 0.01 
A2 1.1±0.1 1.0±0.3 -0.12 
A3 1.5±0.1 1.5±0.4 -0.06 
A4 2.2±0.1 2.2±0.4 -0.01 
B1 
2.5±0.3 
0.7±0.2 0.7±0.2 0.03 
B2 1.0±0.2 1.0±0.3 0.07 
B3 1.6±0.1 1.6±0.3 0.07 
B4 2.0±0.1 2.0±0.4 -0.06 
C1 
3.2±0.3 
0.5±0.1 0.7±0.2 0.16 
C2 1.1±0.1 1.1±0.3 0.01 
C3 1.3±0.1 1.5±0.3 0.17 
C4 2.3±0.2 2.1±0.3 -0.19 
D1 
1.9±0.2 
2.6±0.1 2.5±0.3 -0.11 
D2 3.1±0.1 2.9±0.4 -0.22 
D3 3.6±0.2 3.5±0.4 -0.06 
D4 4.2±0.1 4.1±0.5 -0.02 
E1 
2.4±0.2 
2.6±0.1 2.4±0.3 -0.16 
E2 3.1±0.2 3.3±0.4 0.19 
E3 3.7±0.2 3.9±0.5 0.26 
E4 4.1±0.2 4.4±0.7 0.36 
 
 
 
By combining the results in Table 6.2 and Table 6.3, we can find that the 
thickness of dermis and skin tumor can be accurately deduced from the measurements 
by a set of PEFs with different contact sizes. Given this information, whether the skin 
tumor has invaded into the hypodermis layer can be easily judged. Among the 20 skin 
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cancers in the phantoms, 7 of them have invaded into the deep tissue. PEF is able to 
identify 6 of them. The only cancer not identified by PEF is the cancer D1 which is a 
little thicker than the dermis layer. It will help the dermatologist decide how deep 
they should remove the tissue during surgery, so that the skin cancer can be removed 
completely while normal tissue is retained as much as possible.  
6.3 Determine the 3D Profile of Skin Tumors in Porcine Skin Sample 
Porcine skin sample with model tumors were constructed to validate the 
methodology. A 5 cm × 5 cm porcine skin was harvested from the belly part from a 
local abattoir. Two rectangular areas with a size about 10 cm in the dermis were 
removed with a razor blade. A pre-cut modeling clay was placed in the area where the 
dermis was removed in porcine skin to simulate the skin tumor as shown in Figure 6.8. 
Modeling clay was chosen because its elastic modulus of 60.3±1.6 kPa was similar to 
that of basal cell carcinoma reported in literature [139]. Another benefit of using 
modeling clay is that its shape can be adjusted so that it can fill all the gaps after the 
dermis removal. The clay was bonded to the surrounding tissue and the sample 
surface was made flat.   
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Figure 6.8 (a) A photograph of the model skin tumor embedded in porcine skin. (b) A 
schematic showing the cross section of the sample. 
 
 
 
A grid was first drawn on the sample surface for location tracking. The PEF 
with a contact radius of 0.23±0.01 mm was placed on the first location and the 
effective elastic modulus was measured five times on the surface. An average of 
elastic modulus and standard deviation was calculated for that location. Then the PEF 
was moved to the next location and the measurement was performed. It was repeated 
until the entire sample was scanned. After that elastic moduli of the tumor and normal 
tissue areas were measured using a set of PEFs with contact radius ranging from 
0.23±0.01 mm to 3.80±0.11 mm as listed in Table 5.1. The lateral size and thickness 
of the model skin tumors were measured with a caliper after PEF measurements. The 
dermis layer of the porcine skin was cut into 1 cm × 1 cm squares and the stress-strain 
curve was measured by Bose ElectroForce® 3100 using compression test 3 times. 
The average of the slopes of stress versus strain curves was the determined elastic 
modulus of dermis. The thickness of dermis was measured by caliper for comparison.  
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Figure 6.9 A flow chart showing how to determine the 3D profile of skin cancers 
based on PEF measurements. 
 
 
 
A 2D color-coded elastic modulus map was created as shown in Figure 6.10 
based on the results from the PEF with a contact radius of 0.23±0.01 mm. The green 
color represents the elastic modulus of normal tissue while the red color shows the 
decreased elastic modulus, indicating the location of the tumor. The actual locations 
of the tumors are marked by the black square. It is clear that PEF detected both 
tumors in the sample and the lower modulus regions in the map were consistent with 
the locations of the tumors. The lateral size of the tumors was deduced using the half 
peak width method as explained in Section 6.1. The comparison of the sizes 
determined by PEF and those measured by caliper is listed in Table 6.4. As can be 
seen, the sizes of model tumors estimated by PEF agreed with their actual sizes, with 
Measure entire sample by PEF with 
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Create 2D elastic modulus map 
 Detect cancer 
 Lateral location and size 
Measure on normal skin using 
PEFs with different contact sizes 
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an error less than 1 mm. It suggests that the PEF can not only detect the skin tumors 
but also determine the lateral extend of the tumors accurately.  
 
 
 
Figure 6.10 Elastic modulus map of the model skin tumors shown in Figure 6.8 
scanned by PEF with a contact radius of 0.23±0.01 mm. The actual locations of the 
tumors are marked with black squares.  
 
 
 
 
Table 6.4 Comparison of the lateral size of the skin tumors in Figure 6.8 measured by 
caliper and PEF 
tumor 
# 
Size in x direction (mm) Size in y direction (mm) 
Measured 
by caliper 
Measured 
by PEF 
PEF 
error 
Measured 
by caliper 
Measured 
by PEF 
PEF 
error 
1 13.53±0.53 12.91±0.72 -0.62 14.15±0.54 14.26±0.64 0.11 
2 14.25±0.78 13.26±0.46 -0.99 11.63±0.82 11.13±0.51 -0.50 
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The effective elastic moduli measured by a set of PEF with different contact 
sizes on normal regions were fit to Perriot’s model if the modulus E versus indenter 
radius was not greater than 0 as shown in Figure 6.11. The elastic modulus of dermis 
was estimated to be 134.7±9.0 kPa from the PEF fitting results, very close to the 
averaged value of the slopes of stress-strain curves from 3 repeated compression tests, 
143.6±7.5 kPa. As an example, the stress-strain curve of one compression test is 
plotted in Figure 6.12. The slope of the curve, 145.4 kPa, is the determined elastic 
modulus of dermis from that test. The thickness of the dermis determined by PEF was 
2.59±0.26 mm. It is within the range of the actual dermis thickness, 2.76±0.17 mm, 
measured by caliper.  
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Figure 6.11 Elastic modulus of normal skin measured by PEFs of different contact 
sizes. The data was fit to Perriot’s model to deduce the elastic modulus and thickness 
of dermis. 
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Figure 6.12 The stress versus strain curve of the dermis of porcine skin from a 
compression test performed by Bose ElectroForce® 3100. The slope of the linear 
fitting curve is the elastic modulus of the dermis, 145.4 kPa. 
 
 
 
The 2-spring model was applied to the effective elastic modulus measured by 
PEFs on tumor regions to deduce the depth profile of model skin tumors as plotted in 
a color-coded map in Figure 6.13. The navy color stands for 0 mm for the tumor 
thickness, meaning that no tumors were found in the region. The green color shows 
where the tumor thickness is about 1.5 mm. And the red color represents the 
increased tumor thickness, 3-3.5 mm. The averaged thickness of tumor 1 and 2 were 
1.75±0.27 and 3.57±0.54 mm, respectively. They showed good agreement with the 
actual thickness of tumor 1 and 2 which was 1.51±0.32 and 3.19±0.47, respectively. 
The discrepancy between the tumor thickness measured by PEF and by caliper was 
only 0.24 and 0.38 mm, indicating that the PEF is capable of determining depth 
profile of skin tumors very accurately. Besides, since the thickness of dermis in 
normal region of the porcine skin was determined to be 2.59±0.26 mm, we can easily 
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find that the model tumor 1 was within the dermis layer while the tumor 2 had 
invaded into the hypodermis layer.  
 
 
 
Figure 6.13 The thickness of the model skin tumors deduced from PEF measurements 
using spring model. The actual thickness of tumor 1 and 2 were 1.51±0.32 and 
3.19±0.47, respectively 
 
 
 
6.4 Conclusions 
In this chapter, PEFs with different contact sizes were used to measure the 
elastic modulus of skin and skin tumors in phantoms. The PEF with a contact radius 
of 0.23±0.01 mm was first used to scan the entire phantom. Since the depth 
sensitivity of the PEF was only about 0.4 mm, smaller than the dermis thickness, the 
modulus change on the skin surface could be easily captured. A 2D color-coded 
elastic modulus map was created based on the modulus results and the location of the 
skin tumor could be directly determined. Then the elastic modulus at certain x 
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distance was plotted versus y distance and fitted to Gaussian function. The size of the 
tumor at that x was determined by half peak width of the bell shaped curve. The size 
of the tumor in y direction was estimated with a similar way. Skin tumor phantoms 
were built to mimic the basal cell carcinoma with a size ranging from 4×4 to 12×12 
mm2. Lateral extend of the tumors were obtained from the PEF measurements with a 
contact radius of 0.23±0.01 mm and showed good agreement with the actual values 
measured by caliper with a difference smaller than 1 mm in both x and y directions.  
The depth profile of skin tumors was deduced from stiffness measurements 
with PEFs of different contact sizes (0.23-3.80 mm) using a modified spring model 
taking into account of the two-layer nature of skin. The estimated model tumor 
thickness ranging from 0.5 to 4 mm in phantoms were consistent with the actual 
values measured by caliper, with a difference smaller than 0.4 mm. Coupled with the 
thickness of dermis deduced from PEF measurements on normal skin regions, 
whether the skin tumor has grown into the hypodermis layer could be know.  
Modeling clays were embedded in porcine skins to simulate skin tumors. The 
lateral sizes of model skin cancers determined by PEF were within an error of 1 mm 
and the estimated depth profiles showed good agreement with the actual thickness 
with <0.4 mm discrepancy.  
In conclusion, PEF is able to detect skin cancers by tissue stiffness contrasting 
and provide the locations and lateral extend of the tumor from a 2D color-coded map. 
In addition, using a set of PEFs of different contact areas coupled with simple spring-
model calculations the depth profile of skin cancer can be accurately determined.  
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7. CONCLUSIONS AND FUTURE WORK 
7.1 Conclusions 
In this study, Piezoelectric Fingers (PEFs), a tissue stiffness sensor that can 
measure the elastic modulus of tissues have been developed into a hand-held probe to 
detect breast cancer in patients (AIM 1). It has also been investigated to not only 
image the breast cancers in 2D but also determine their depth profiles using up to four 
PEFs of different contact areas, enabling 3D imaging of breast cancers (AIM 2). In 
parallel, by measuring the effective skin stiffness up to various depths using 12 PEFs 
of different contact radiuses 0.23-3.8 mm, we were able to determine both the elastic 
modulus and thickness of skin accurately (AIM 3). With this normal skin information, 
we then can not only detect skin cancer in 2D but also accurately determine the depth 
of the skin cancer, which is essential in skin cancer staging (AIM 4). The 
accomplishments in each of the aims are summarized as follows: 
i. AIM 1: in vivo breast tumor detection 
 A hand-held probe with an array of four PEFs of the same contact area 
along the methodology was developed, tested, and validated using model 
breast tumors as well as on patients. 
 In vivo testing on 40 patients detected 46 of the 48 lesions, including 
100% of palpable and 67% non-palpable malignant tumors, indicating 
PEF was capable of detecting both palpable and non-palpable lesions.  
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 For the 28 patients with mammography reports, PEF detected 92% 
malignant tumors while mammography only detected 80%, indicating that 
PEF could detect malignant tumors not detectable by mammography. 
Furthermore, PEF detection sensitivity was unaffected by breast density, 
an advantage for detecting breast cancer in young women and women with 
dense breasts for whom mammography is not effective. 
 The detection results of PEF were unaffected by the depression depths (2-
6 mm) of the housing of the probe. 
ii. AIM 2: Breast tumor positioning and sizing in 3D 
 The depth profile of breast cancer was determined by measuring the 
effective stiffness of breast up to various depths using four PEFS of 
different contact sizes 4.1-9.8 mm coupled with spring models. In a direct 
comparison, we showed the depths of bottom-supported tumors were 
determined within 1.1 mm of the actual depths, similar to those by 
inversion simulations using FEA that requires massive computation efforts, 
clearly an advantage of PEFs.  
 For suspended tumors, we showed that the tumor depth profiles could be 
determined within 2.1 mm of the actual values using stiffness 
measurements by four PEFS of different contact sizes 4.1-9.8 mm coupled 
with a 3-spring model, clearly illustrating the potential of using a set of 
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PEFs of different contact areas coupled with spring models to determine 
tumor depth profiles.  
iii. Simultaneous skin elastic modulus and thickness quantification 
 The elastic modulus and thickness of dermis were determined 
simultaneously and accurately--within <10% of the actual values in skin 
phantoms and porcine skins--by measuring the effective skin elastic 
modulus up to various depths using a set of PEFs of contact radiuses 0.23-
3.8  mm coupled with an empirical formula for a two-layer structure 
derived from Green’s-function calculations. 
iv. Lateral skin cancer imaging and depth profiling 
 The skin cancer in phantoms was successfully detected by the PEF with a 
contact radius of 0.23±0.01 mm by contrasting the lower elastic modulus 
regions with surrounding tissues. The lateral extend of skin cancer was 
determined within 1 mm error in both x and y directions.  
 A modified spring model taking into account of the two-layer nature of 
skin was applied to determine the depth profile of skin tumors using 
stiffness measurements with PEFs of various contact sizes of <3 mm. The 
estimated model tumor thickness ranging from 0.5 to 4 mm in phantoms 
were consistent with the actual values measured by caliper, with a 
difference smaller than 0.4 mm. 
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 The lateral sizes of model skin cancers embedded in porcine skin were 
determined by PEF with an error of <1 mm and the estimated depth 
profiles showed good agreement with the actual thickness with <0.4 mm 
discrepancy. Coupled with the thickness of dermis by PEF on normal 
regions, whether the skin cancer has grown into the hypodermis layer was 
determined, making the PEF a helpful tool for skin cancer characterization. 
In conclusion, PEF is capable of detecting breast cancer with sensitivity better 
than mammography and independent of breast density. In addition, using a set of 
PEFs of different contact areas coupled with simple spring-model calculations the 
depth profiles of both breast cancer and skin cancer can be accurately determined to 
facilitate 3D breast cancer/skin cancer imaging. 
 
7.2 Future Work 
Although PEF has been proved to be able to not only detect breast tumors and 
skin cancers but also determine the 3D profile of the cancers, there is still work that 
should be done to bring the PEF to the ultimate goal of being used as a diagnostic tool 
in clinics or hospitals: 
a. Mitigate the interference of neighboring PEFs in the array and carry out 
simultaneous measurements to speed up the in vivo measurements for 
cancer detection.  
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b. Apply the PEFs of different contact sizes coupled with spring model 
theory to determine the 3D profile of breast cancers in vivo.  
c. Use the PEFs of different contact radiuses for in vivo skin elastic modulus 
and thickness characterization.  
d. Use the PEF with a contact radius of 0.23±0.01 mm for in vivo skin cancer 
detection and lateral size determination. 
e. Apply the PEFs of different contact radiuses coupled with the modified 
spring model to determine the depth profile of skin cancers in vivo.  
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